activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2051649	CHEMBL941786	Inhibition of MAP4K2	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	6516.0	CHEMBL5330	Homo sapiens	Ki	uM	6.516
	2051649	CHEMBL941786	Inhibition of MAP4K2	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	6516.0	CHEMBL5330	Homo sapiens	Ki	uM	6.516
	2470254	CHEMBL987173	Inhibition of MAP4K2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5330	Homo sapiens	INH	%	10.0
	2511994	CHEMBL974424	Inhibition of GCK at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	10.0	CHEMBL5330	Homo sapiens	INH	%	10.0
	2661586	CHEMBL1060450	Inhibition of GCK after 1 hr by mobility shift electrophoresis assay	B	COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1		CHEMBL561708	>	IC50	nM	50000.0	CHEMBL5330	Homo sapiens	IC50	uM	50.0
	2921283	CHEMBL1049116	Inhibition of MAP4K2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL5330	Homo sapiens	Activity	%	100.0
	2926263	CHEMBL1056936	Inhibition of GCK assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	109.0	CHEMBL5330	Homo sapiens	Activity	%	109.0
	2928449	CHEMBL1049151	Inhibition of GCK assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	22.0	CHEMBL5330	Homo sapiens	Activity	%	22.0
	2948180	CHEMBL1042397	Inhibition of GCK	B	O=C1Nc2ccccc2-c2ccnc3[nH]cc(c23)C1c1ccc(O)cc1		CHEMBL584052	=	Ki	nM	340.0	CHEMBL5330	Homo sapiens	Ki	microM	0.34
	2983210	CHEMBL1046257	Inhibition of GCK	B	CC1(C)CC(NC(=O)c2cccc(-c3cc4nccc(Nc5cccc(O)c5)n4n3)c2)CC(C)(C)N1[O]		CHEMBL1163016	=	IC50	nM	24.0	CHEMBL5330	Homo sapiens	IC50	uM	0.024
	3089516	CHEMBL1067356	Inhibition of GCK	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC[C@@H](N)C2)ccc2[nH]ccc12		CHEMBL606245	=	IC50	nM	2600.0	CHEMBL5330	Homo sapiens	IC50	nM	2600.0
	3213956	CHEMBL1116704	Inhibition of MAP4K2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	2.0	CHEMBL5330	Homo sapiens	INH	%	2.0
	3219856	CHEMBL1113995	Inhibition of GCK	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(S(=O)(=O)N3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL1080994	=	IC50	nM	1300.0	CHEMBL5330	Homo sapiens	IC50	nM	1300.0
	3219857	CHEMBL1113995	Inhibition of GCK	B	Cc1ncc(C#N)c(Nc2ccc3[nH]ccc3c2C)c1/C=C/c1cccc(S(=O)(=O)N2CCN(C)CC2)c1		CHEMBL1080995	>	IC50	nM	50000.0	CHEMBL5330	Homo sapiens	IC50	nM	50000.0
	3220004	CHEMBL1115853	Inhibition of GCK	B	CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccnc3c(-c4cccc(O)c4)c(-c4ccncc4)nn23)cc1		CHEMBL1087650	=	IC50	nM	4100.0	CHEMBL5330	Homo sapiens	IC50	uM	4.1
	3224866	CHEMBL1100384	Inhibition of GCK at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL5330	Homo sapiens	INH	%	50.0
	3225116	CHEMBL1100384	Inhibition of GCK at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL5330	Homo sapiens	INH	%	50.0
	3242219	CHEMBL1111605	Inhibition of GCK	B	CC(C)N1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(C5CCOCC5)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1		CHEMBL1091356	<	IC50	nM	50000.0	CHEMBL5330	Homo sapiens	IC50	uM	50.0
	3251268	CHEMBL1110591	Inhibition of GCK	B	Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccc(C(=O)NCCO)cc3)ccnc21		CHEMBL1092754	=	IC50	nM	50000.0	CHEMBL5330	Homo sapiens	IC50	uM	50.0
	3260100	CHEMBL1108068	Inhibition of GCK at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	30.0	CHEMBL5330	Homo sapiens	Activity	%	30.0
	3260518	CHEMBL1110872	Inhibition of GCK	B	O=C(Nc1cccc(-c2ccnc3cc(-c4ccncc4)nn23)c1)c1cccc(C(F)(F)F)c1		CHEMBL1089082	>	IC50	nM	50000.0	CHEMBL5330	Homo sapiens	IC50	uM	50.0
	3261373	CHEMBL1108068	Inhibition of GCK at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	48.0	CHEMBL5330	Homo sapiens	Activity	%	48.0
	3264372	CHEMBL1104641	Inhibition of GCK	B	CC(C)(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095627	>	IC50	nM	50000.0	CHEMBL5330	Homo sapiens	IC50	uM	50.0
	3271026	CHEMBL1104641	Inhibition of GCK	B	COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095626	>	IC50	nM	50000.0	CHEMBL5330	Homo sapiens	IC50	uM	50.0
	3332010	CHEMBL1166060	Inhibition of MAP4K2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	=	Inhibition	%	70.0	CHEMBL5330	Homo sapiens	INH	%	70.0
	3333425	CHEMBL1166060	Inhibition of MAP4K2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5330	Homo sapiens	INH	%	50.0
	3334830	CHEMBL1166060	Inhibition of MAP4K2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5330	Homo sapiens	INH	%	50.0
	3336250	CHEMBL1166060	Inhibition of MAP4K2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	=	Inhibition	%	92.0	CHEMBL5330	Homo sapiens	INH	%	92.0
	3341792	CHEMBL1166060	Inhibition of MAP4K2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	=	Inhibition	%	70.0	CHEMBL5330	Homo sapiens	INH	%	70.0
	3343239	CHEMBL1166060	Inhibition of MAP4K2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5330	Homo sapiens	INH	%	50.0
	3358651	CHEMBL1174893	Inhibition of MAP4K2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.0	CHEMBL5330	Homo sapiens	INH	%	0.0
	3359093	CHEMBL1174893	Inhibition of MAP4K2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.0	CHEMBL5330	Homo sapiens	INH	%	0.0
	3443438	CHEMBL1244204	Inhibition of GCK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	23.0	CHEMBL5330	Homo sapiens	INH	%	23.0
	3443655	CHEMBL1244204	Inhibition of GCK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	91.0	CHEMBL5330	Homo sapiens	INH	%	91.0
	3444810	CHEMBL1244204	Inhibition of GCK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	23.0	CHEMBL5330	Homo sapiens	INH	%	23.0
	3445182	CHEMBL1244494	Binding affinity to MAP4K2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	4.7	CHEMBL5330	Homo sapiens	Kd	nM	4.7
	3445434	CHEMBL1244204	Inhibition of GCK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	1.0	CHEMBL5330	Homo sapiens	INH	%	1.0
	3445651	CHEMBL1244204	Inhibition of GCK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	68.0	CHEMBL5330	Homo sapiens	INH	%	68.0
	3445854	CHEMBL1244204	Inhibition of GCK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	54.0	CHEMBL5330	Homo sapiens	INH	%	54.0
	3446044	CHEMBL1244204	Inhibition of GCK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	42.0	CHEMBL5330	Homo sapiens	INH	%	42.0
	3446198	CHEMBL1244338	Inhibition of MAP4K2	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	9.9	CHEMBL5330	Homo sapiens	IC50	nM	9.9
	3448487	CHEMBL1244494	Binding affinity to MAP4K2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	uM	10.0
	3448976	CHEMBL1244494	Binding affinity to MAP4K2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	2500.0	CHEMBL5330	Homo sapiens	Kd	nM	2500.0
	3449454	CHEMBL1244494	Binding affinity to MAP4K2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	2300.0	CHEMBL5330	Homo sapiens	Kd	nM	2300.0
	3449721	CHEMBL1244494	Binding affinity to MAP4K2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	uM	10.0
	3450125	CHEMBL1244494	Binding affinity to MAP4K2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	uM	10.0
	3450355	CHEMBL1244494	Binding affinity to MAP4K2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	uM	10.0
	3463272	CHEMBL1252475	Inhibition of MAP4K2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	98.0	CHEMBL5330	Homo sapiens	INH	%	98.0
	3463816	CHEMBL1252475	Inhibition of MAP4K2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	18.0	CHEMBL5330	Homo sapiens	INH	%	18.0
	3464035	CHEMBL1252475	Inhibition of MAP4K2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	97.0	CHEMBL5330	Homo sapiens	INH	%	97.0
	5120348	CHEMBL1645975	Inhibition of human GCK at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	103.0	CHEMBL5330	Homo sapiens	INH	%	103.0
	5133701	CHEMBL1648711	Inhibition of GCK assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	84.0	CHEMBL5330	Homo sapiens	Activity	%	84.0
	5133796	CHEMBL1648711	Inhibition of GCK assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	80.0	CHEMBL5330	Homo sapiens	Activity	%	80.0
	5133875	CHEMBL1648711	Inhibition of GCK assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	84.0	CHEMBL5330	Homo sapiens	Activity	%	84.0
	5191479	CHEMBL1664096	Inhibition of GCK at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	86.0	CHEMBL5330	Homo sapiens	INH	%	86.0
	5191480	CHEMBL1664096	Inhibition of GCK at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	97.0	CHEMBL5330	Homo sapiens	INH	%	97.0
	6173425	CHEMBL1769812	Inhibition of MAP4K2 at 25 uM by TR-FRET assay	B	NC(=O)c1ccsc1NC(=O)Cc1csc2ccccc12		CHEMBL1767254	=	Inhibition	%	1.0	CHEMBL5330	Homo sapiens	INH	%	1.0
	6339949	CHEMBL1826632	Activity of MAP4K2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	79.0	CHEMBL5330	Homo sapiens	Activity	%	79.0
	6352210	CHEMBL1825747	Inhibition of GCK assessed as residual activity at 10 uM by radioactivity assay in presence of 20 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	20.0	CHEMBL5330	Homo sapiens	Activity	%	20.0
	7567357	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	540.0	CHEMBL5330	Homo sapiens	Kd	nM	540.0
	7567816	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	4800.0	CHEMBL5330	Homo sapiens	Kd	nM	4800.0
	7568313	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	1200.0	CHEMBL5330	Homo sapiens	Kd	nM	1200.0
	7568745	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	1700.0	CHEMBL5330	Homo sapiens	Kd	nM	1700.0
	7569330	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7569820	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7570283	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	3600.0	CHEMBL5330	Homo sapiens	Kd	nM	3600.0
	7570710	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	33.0	CHEMBL5330	Homo sapiens	Kd	nM	33.0
	7571321	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	80.0	CHEMBL5330	Homo sapiens	Kd	nM	80.0
	7571797	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	2000.0	CHEMBL5330	Homo sapiens	Kd	nM	2000.0
	7572260	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7572676	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	190.0	CHEMBL5330	Homo sapiens	Kd	nM	190.0
	7572845	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7573302	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	1300.0	CHEMBL5330	Homo sapiens	Kd	nM	1300.0
	7573778	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	65.0	CHEMBL5330	Homo sapiens	Kd	nM	65.0
	7574247	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	2500.0	CHEMBL5330	Homo sapiens	Kd	nM	2500.0
	7574655	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7574823	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	290.0	CHEMBL5330	Homo sapiens	Kd	nM	290.0
	7575284	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7575755	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7576220	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7576628	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	2100.0	CHEMBL5330	Homo sapiens	Kd	nM	2100.0
	7576797	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7577256	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	2000.0	CHEMBL5330	Homo sapiens	Kd	nM	2000.0
	7577734	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	11.0	CHEMBL5330	Homo sapiens	Kd	nM	11.0
	7578204	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	100.0	CHEMBL5330	Homo sapiens	Kd	nM	100.0
	7578805	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	1900.0	CHEMBL5330	Homo sapiens	Kd	nM	1900.0
	7579179	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7579629	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	89.0	CHEMBL5330	Homo sapiens	Kd	nM	89.0
	7580103	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7580533	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1600.0	CHEMBL5330	Homo sapiens	Kd	nM	1600.0
	7581163	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7581548	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7581993	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7582486	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7582886	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	2600.0	CHEMBL5330	Homo sapiens	Kd	nM	2600.0
	7583509	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7583906	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7584351	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7584380	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7584842	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	670.0	CHEMBL5330	Homo sapiens	Kd	nM	670.0
	7585246	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7585839	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7586247	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7586722	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	290.0	CHEMBL5330	Homo sapiens	Kd	nM	290.0
	7587176	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	=	Kd	nM	2900.0	CHEMBL5330	Homo sapiens	Kd	nM	2900.0
	7588230	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7588701	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7589152	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7589323	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	1300.0	CHEMBL5330	Homo sapiens	Kd	nM	1300.0
	7589747	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	4.7	CHEMBL5330	Homo sapiens	Kd	nM	4.7
	7590214	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7590688	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7591139	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7591296	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7591718	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	1900.0	CHEMBL5330	Homo sapiens	Kd	nM	1900.0
	7592190	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	=	Kd	nM	3200.0	CHEMBL5330	Homo sapiens	Kd	nM	3200.0
	7592663	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7593116	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	3.1	CHEMBL5330	Homo sapiens	Kd	nM	3.1
	7593263	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	100.0	CHEMBL5330	Homo sapiens	Kd	nM	100.0
	7593698	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	5000.0	CHEMBL5330	Homo sapiens	Kd	nM	5000.0
	7594170	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7594643	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7595231	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7595675	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	330.0	CHEMBL5330	Homo sapiens	Kd	nM	330.0
	7596149	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7596625	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7597203	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7597656	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5330	Homo sapiens	Kd	nM	10000.0
	7598129	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	220.0	CHEMBL5330	Homo sapiens	Kd	nM	220.0
	7598157	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	2700.0	CHEMBL5330	Homo sapiens	Kd	nM	2700.0
	7598599	CHEMBL1908656	Binding constant for MAP4K2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	8.8	CHEMBL5330	Homo sapiens	Kd	nM	8.8
	7969724	CHEMBL1931224	Inhibition of GCK assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	59.0	CHEMBL5330	Homo sapiens	Activity	%	59.0
	7989267	CHEMBL1936349	Inhibition of human GCK at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)C(C)(C)CNC4=O)nc1C(=O)NC1CCCC1		CHEMBL1933142	>=	Inhibition	%	80.0	CHEMBL5330	Homo sapiens	INH	%	80.0
	7989268	CHEMBL1936349	Inhibition of human GCK at 3 uM	B	Cc1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)on1		CHEMBL1933143	>=	Inhibition	%	80.0	CHEMBL5330	Homo sapiens	INH	%	80.0
	7989269	CHEMBL1936349	Inhibition of human GCK at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)cn1		CHEMBL1933148	>=	Inhibition	%	80.0	CHEMBL5330	Homo sapiens	INH	%	80.0
	7989270	CHEMBL1936349	Inhibition of human GCK at 3 uM	B	Cn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933279	>=	Inhibition	%	80.0	CHEMBL5330	Homo sapiens	INH	%	80.0
	8061335	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	3.14	CHEMBL5330	Homo sapiens	Inhibition	%	3.14
	8061512	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	4.63	CHEMBL5330	Homo sapiens	Inhibition	%	4.63
	8061843	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	10.27	CHEMBL5330	Homo sapiens	Inhibition	%	10.27
	8062034	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.96	CHEMBL5330	Homo sapiens	Inhibition	%	2.96
	8062374	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	0.8	CHEMBL5330	Homo sapiens	Inhibition	%	0.8
	8062536	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	24.68	CHEMBL5330	Homo sapiens	Inhibition	%	24.68
	8062858	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	3.01	CHEMBL5330	Homo sapiens	Inhibition	%	3.01
	8063214	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	4.41	CHEMBL5330	Homo sapiens	Inhibition	%	4.41
	8063381	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.35	CHEMBL5330	Homo sapiens	Inhibition	%	0.35
	8063713	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	0.64	CHEMBL5330	Homo sapiens	Inhibition	%	0.64
	8063895	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	17.88	CHEMBL5330	Homo sapiens	Inhibition	%	17.88
	8064234	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	6.6	CHEMBL5330	Homo sapiens	Inhibition	%	6.6
	8064444	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.47	CHEMBL5330	Homo sapiens	Inhibition	%	0.47
	8064806	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	3.92	CHEMBL5330	Homo sapiens	Inhibition	%	3.92
	8064972	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.58	CHEMBL5330	Homo sapiens	Inhibition	%	0.58
	8065196	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.22	CHEMBL5330	Homo sapiens	Inhibition	%	1.22
	8065312	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.35	CHEMBL5330	Homo sapiens	Inhibition	%	2.35
	8065487	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.35	CHEMBL5330	Homo sapiens	Inhibition	%	1.35
	8065711	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	12.17	CHEMBL5330	Homo sapiens	Inhibition	%	12.17
	8065826	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	-0.28	CHEMBL5330	Homo sapiens	Inhibition	%	-0.28
	8066036	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	2.35	CHEMBL5330	Homo sapiens	Inhibition	%	2.35
	8066260	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.12	CHEMBL5330	Homo sapiens	Inhibition	%	2.12
	8066396	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	14.34	CHEMBL5330	Homo sapiens	Inhibition	%	14.34
	8066786	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.37	CHEMBL5330	Homo sapiens	Inhibition	%	0.37
	8066910	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	3.41	CHEMBL5330	Homo sapiens	Inhibition	%	3.41
	8067309	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	-0.09	CHEMBL5330	Homo sapiens	Inhibition	%	-0.09
	8067430	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	3.56	CHEMBL5330	Homo sapiens	Inhibition	%	3.56
	8067654	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	2.33	CHEMBL5330	Homo sapiens	Inhibition	%	2.33
	8067864	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.26	CHEMBL5330	Homo sapiens	Inhibition	%	2.26
	8067999	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	28.54	CHEMBL5330	Homo sapiens	Inhibition	%	28.54
	8068223	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	72.66	CHEMBL5330	Homo sapiens	Inhibition	%	72.66
	8068387	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.79	CHEMBL5330	Homo sapiens	Inhibition	%	0.79
	8068512	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	10.25	CHEMBL5330	Homo sapiens	Inhibition	%	10.25
	8068736	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.12	CHEMBL5330	Homo sapiens	Inhibition	%	0.12
	8068910	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.67	CHEMBL5330	Homo sapiens	Inhibition	%	1.67
	8069259	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	7.42	CHEMBL5330	Homo sapiens	Inhibition	%	7.42
	8069554	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	13.71	CHEMBL5330	Homo sapiens	Inhibition	%	13.71
	8069715	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.94	CHEMBL5330	Homo sapiens	Inhibition	%	2.94
	8070065	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.05	CHEMBL5330	Homo sapiens	Inhibition	%	1.05
	8070237	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.6	CHEMBL5330	Homo sapiens	Inhibition	%	0.6
	8070586	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.5	CHEMBL5330	Homo sapiens	Inhibition	%	1.5
	8070884	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	55.74	CHEMBL5330	Homo sapiens	Inhibition	%	55.74
	8071041	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.0	CHEMBL5330	Homo sapiens	Inhibition	%	1.0
	8071265	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.54	CHEMBL5330	Homo sapiens	Inhibition	%	0.54
	8071391	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.72	CHEMBL5330	Homo sapiens	Inhibition	%	1.72
	8071564	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.64	CHEMBL5330	Homo sapiens	Inhibition	%	0.64
	8071788	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	-0.14	CHEMBL5330	Homo sapiens	Inhibition	%	-0.14
	8071913	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	3.27	CHEMBL5330	Homo sapiens	Inhibition	%	3.27
	8072227	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.34	CHEMBL5330	Homo sapiens	Inhibition	%	1.34
	8072608	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.5	CHEMBL5330	Homo sapiens	Inhibition	%	1.5
	8072733	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.72	CHEMBL5330	Homo sapiens	Inhibition	%	0.72
	8073124	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.51	CHEMBL5330	Homo sapiens	Inhibition	%	2.51
	8073249	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	10.67	CHEMBL5330	Homo sapiens	Inhibition	%	10.67
	8073473	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	28.61	CHEMBL5330	Homo sapiens	Inhibition	%	28.61
	8073592	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.01	CHEMBL5330	Homo sapiens	Inhibition	%	1.01
	8073825	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	3.06	CHEMBL5330	Homo sapiens	Inhibition	%	3.06
	8074201	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	0.87	CHEMBL5330	Homo sapiens	Inhibition	%	0.87
	8074331	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.57	CHEMBL5330	Homo sapiens	Inhibition	%	0.57
	8074555	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	2.23	CHEMBL5330	Homo sapiens	Inhibition	%	2.23
	8074712	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.65	CHEMBL5330	Homo sapiens	Inhibition	%	0.65
	8075063	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	2.02	CHEMBL5330	Homo sapiens	Inhibition	%	2.02
	8075174	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	4.98	CHEMBL5330	Homo sapiens	Inhibition	%	4.98
	8075411	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.94	CHEMBL5330	Homo sapiens	Inhibition	%	1.94
	8075635	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.87	CHEMBL5330	Homo sapiens	Inhibition	%	1.87
	8075776	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	0.39	CHEMBL5330	Homo sapiens	Inhibition	%	0.39
	8076142	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.64	CHEMBL5330	Homo sapiens	Inhibition	%	0.64
	8076290	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.36	CHEMBL5330	Homo sapiens	Inhibition	%	3.36
	8076648	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	2.89	CHEMBL5330	Homo sapiens	Inhibition	%	2.89
	8076750	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.31	CHEMBL5330	Homo sapiens	Inhibition	%	2.31
	8076974	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.14	CHEMBL5330	Homo sapiens	Inhibition	%	1.14
	8077221	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	4.66	CHEMBL5330	Homo sapiens	Inhibition	%	4.66
	8077349	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.05	CHEMBL5330	Homo sapiens	Inhibition	%	2.05
	8077724	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	4.67	CHEMBL5330	Homo sapiens	Inhibition	%	4.67
	8077867	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.21	CHEMBL5330	Homo sapiens	Inhibition	%	1.21
	8078091	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	7.11	CHEMBL5330	Homo sapiens	Inhibition	%	7.11
	8078230	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.41	CHEMBL5330	Homo sapiens	Inhibition	%	0.41
	8078556	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.74	CHEMBL5330	Homo sapiens	Inhibition	%	1.74
	8078806	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	24.78	CHEMBL5330	Homo sapiens	Inhibition	%	24.78
	8078922	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	-0.38	CHEMBL5330	Homo sapiens	Inhibition	%	-0.38
	8079146	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.09	CHEMBL5330	Homo sapiens	Inhibition	%	2.09
	8079304	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	3.67	CHEMBL5330	Homo sapiens	Inhibition	%	3.67
	8079670	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.36	CHEMBL5330	Homo sapiens	Inhibition	%	0.36
	8079809	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	6.09	CHEMBL5330	Homo sapiens	Inhibition	%	6.09
	8080138	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	4.29	CHEMBL5330	Homo sapiens	Inhibition	%	4.29
	8080390	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	2.95	CHEMBL5330	Homo sapiens	Inhibition	%	2.95
	8080729	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.8	CHEMBL5330	Homo sapiens	Inhibition	%	0.8
	8080893	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	16.41	CHEMBL5330	Homo sapiens	Inhibition	%	16.41
	8081252	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.57	CHEMBL5330	Homo sapiens	Inhibition	%	1.57
	8081396	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	10.25	CHEMBL5330	Homo sapiens	Inhibition	%	10.25
	8081620	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	51.58	CHEMBL5330	Homo sapiens	Inhibition	%	51.58
	8081723	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	4.0	CHEMBL5330	Homo sapiens	Inhibition	%	4.0
	8081975	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	14.28	CHEMBL5330	Homo sapiens	Inhibition	%	14.28
	8082312	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.74	CHEMBL5330	Homo sapiens	Inhibition	%	1.74
	8082485	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.37	CHEMBL5330	Homo sapiens	Inhibition	%	-0.37
	8082709	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	4.6	CHEMBL5330	Homo sapiens	Inhibition	%	4.6
	8082832	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.91	CHEMBL5330	Homo sapiens	Inhibition	%	0.91
	8083212	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	3.32	CHEMBL5330	Homo sapiens	Inhibition	%	3.32
	8083311	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	21.31	CHEMBL5330	Homo sapiens	Inhibition	%	21.31
	8083535	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.94	CHEMBL5330	Homo sapiens	Inhibition	%	1.94
	8083565	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	3.87	CHEMBL5330	Homo sapiens	Inhibition	%	3.87
	8083789	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	20.37	CHEMBL5330	Homo sapiens	Inhibition	%	20.37
	8083899	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	0.79	CHEMBL5330	Homo sapiens	Inhibition	%	0.79
	8084308	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	11.7	CHEMBL5330	Homo sapiens	Inhibition	%	11.7
	8084426	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.04	CHEMBL5330	Homo sapiens	Inhibition	%	0.04
	8084650	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.85	CHEMBL5330	Homo sapiens	Inhibition	%	0.85
	8084811	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	8.35	CHEMBL5330	Homo sapiens	Inhibition	%	8.35
	8085133	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	2.98	CHEMBL5330	Homo sapiens	Inhibition	%	2.98
	8085389	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	0.89	CHEMBL5330	Homo sapiens	Inhibition	%	0.89
	8085497	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	5.37	CHEMBL5330	Homo sapiens	Inhibition	%	5.37
	8085721	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.51	CHEMBL5330	Homo sapiens	Inhibition	%	1.51
	8085910	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	49.84	CHEMBL5330	Homo sapiens	Inhibition	%	49.84
	8086249	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.49	CHEMBL5330	Homo sapiens	Inhibition	%	0.49
	8086411	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	4.77	CHEMBL5330	Homo sapiens	Inhibition	%	4.77
	8086734	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.41	CHEMBL5330	Homo sapiens	Inhibition	%	1.41
	8086945	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.03	CHEMBL5330	Homo sapiens	Inhibition	%	1.03
	8087327	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.41	CHEMBL5330	Homo sapiens	Inhibition	%	0.41
	8087441	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	12.7	CHEMBL5330	Homo sapiens	Inhibition	%	12.7
	8087665	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	-0.05	CHEMBL5330	Homo sapiens	Inhibition	%	-0.05
	8087803	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	13.03	CHEMBL5330	Homo sapiens	Inhibition	%	13.03
	8088169	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.14	CHEMBL5330	Homo sapiens	Inhibition	%	2.14
	8088317	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-1.83	CHEMBL5330	Homo sapiens	Inhibition	%	-1.83
	8088669	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	6.14	CHEMBL5330	Homo sapiens	Inhibition	%	6.14
	8088986	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.67	CHEMBL5330	Homo sapiens	Inhibition	%	3.67
	8089114	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.26	CHEMBL5330	Homo sapiens	Inhibition	%	1.26
	8089486	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.89	CHEMBL5330	Homo sapiens	Inhibition	%	1.89
	8089606	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	12.82	CHEMBL5330	Homo sapiens	Inhibition	%	12.82
	8089830	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.68	CHEMBL5330	Homo sapiens	Inhibition	%	0.68
	8090010	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.52	CHEMBL5330	Homo sapiens	Inhibition	%	1.52
	8090175	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.69	CHEMBL5330	Homo sapiens	Inhibition	%	1.69
	8090399	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	11.3	CHEMBL5330	Homo sapiens	Inhibition	%	11.3
	8090566	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.45	CHEMBL5330	Homo sapiens	Inhibition	%	2.45
	8090705	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	6.12	CHEMBL5330	Homo sapiens	Inhibition	%	6.12
	8090929	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	18.43	CHEMBL5330	Homo sapiens	Inhibition	%	18.43
	8091134	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	0.28	CHEMBL5330	Homo sapiens	Inhibition	%	0.28
	8091271	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	2.47	CHEMBL5330	Homo sapiens	Inhibition	%	2.47
	8091495	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	6.05	CHEMBL5330	Homo sapiens	Inhibition	%	6.05
	8091650	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.16	CHEMBL5330	Homo sapiens	Inhibition	%	1.16
	8091990	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	4.63	CHEMBL5330	Homo sapiens	Inhibition	%	4.63
	8092127	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.61	CHEMBL5330	Homo sapiens	Inhibition	%	1.61
	8092502	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	0.39	CHEMBL5330	Homo sapiens	Inhibition	%	0.39
	8092650	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.34	CHEMBL5330	Homo sapiens	Inhibition	%	1.34
	8092874	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.64	CHEMBL5330	Homo sapiens	Inhibition	%	-0.64
	8093003	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	20.2	CHEMBL5330	Homo sapiens	Inhibition	%	20.2
	8093315	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.6	CHEMBL5330	Homo sapiens	Inhibition	%	0.6
	8093455	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	9.17	CHEMBL5330	Homo sapiens	Inhibition	%	9.17
	8093679	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	0.61	CHEMBL5330	Homo sapiens	Inhibition	%	0.61
	8093818	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	6.11	CHEMBL5330	Homo sapiens	Inhibition	%	6.11
	8094162	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	5.1	CHEMBL5330	Homo sapiens	Inhibition	%	5.1
	8094342	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.39	CHEMBL5330	Homo sapiens	Inhibition	%	1.39
	8094741	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	4.5	CHEMBL5330	Homo sapiens	Inhibition	%	4.5
	8094897	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.48	CHEMBL5330	Homo sapiens	Inhibition	%	2.48
	8095261	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	69.45	CHEMBL5330	Homo sapiens	Inhibition	%	69.45
	8095464	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.58	CHEMBL5330	Homo sapiens	Inhibition	%	1.58
	8095829	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	35.51	CHEMBL5330	Homo sapiens	Inhibition	%	35.51
	8095977	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.57	CHEMBL5330	Homo sapiens	Inhibition	%	1.57
	8096318	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.0	CHEMBL5330	Homo sapiens	Inhibition	%	2.0
	8096457	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	4.65	CHEMBL5330	Homo sapiens	Inhibition	%	4.65
	8096681	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.35	CHEMBL5330	Homo sapiens	Inhibition	%	-0.35
	8096837	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	3.81	CHEMBL5330	Homo sapiens	Inhibition	%	3.81
	8097208	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.65	CHEMBL5330	Homo sapiens	Inhibition	%	1.65
	8097295	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	11.04	CHEMBL5330	Homo sapiens	Inhibition	%	11.04
	8097515	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.51	CHEMBL5330	Homo sapiens	Inhibition	%	3.51
	8097889	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	8.96	CHEMBL5330	Homo sapiens	Inhibition	%	8.96
	8098022	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.68	CHEMBL5330	Homo sapiens	Inhibition	%	0.68
	8098366	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.4	CHEMBL5330	Homo sapiens	Inhibition	%	1.4
	8098546	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.37	CHEMBL5330	Homo sapiens	Inhibition	%	1.37
	8098770	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.84	CHEMBL5330	Homo sapiens	Inhibition	%	2.84
	8098955	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	31.09	CHEMBL5330	Homo sapiens	Inhibition	%	31.09
	8099099	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	0.9	CHEMBL5330	Homo sapiens	Inhibition	%	0.9
	8099465	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.18	CHEMBL5330	Homo sapiens	Inhibition	%	2.18
	8099659	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.19	CHEMBL5330	Homo sapiens	Inhibition	%	0.19
	8100030	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	0.91	CHEMBL5330	Homo sapiens	Inhibition	%	0.91
	8100176	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.51	CHEMBL5330	Homo sapiens	Inhibition	%	1.51
	8100400	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	1.49	CHEMBL5330	Homo sapiens	Inhibition	%	1.49
	8100516	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.65	CHEMBL5330	Homo sapiens	Inhibition	%	4.65
	8100880	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.53	CHEMBL5330	Homo sapiens	Inhibition	%	1.53
	8101040	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	0.72	CHEMBL5330	Homo sapiens	Inhibition	%	0.72
	8101406	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	2.15	CHEMBL5330	Homo sapiens	Inhibition	%	2.15
	8101591	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.91	CHEMBL5330	Homo sapiens	Inhibition	%	1.91
	8101844	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	3.34	CHEMBL5330	Homo sapiens	Inhibition	%	3.34
	8102223	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	2.55	CHEMBL5330	Homo sapiens	Inhibition	%	2.55
	8102354	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.11	CHEMBL5330	Homo sapiens	Inhibition	%	1.11
	8102578	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.18	CHEMBL5330	Homo sapiens	Inhibition	%	1.18
	8102698	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	7.04	CHEMBL5330	Homo sapiens	Inhibition	%	7.04
	8103100	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.66	CHEMBL5330	Homo sapiens	Inhibition	%	2.66
	8103296	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	3.33	CHEMBL5330	Homo sapiens	Inhibition	%	3.33
	8103434	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.83	CHEMBL5330	Homo sapiens	Inhibition	%	3.83
	8103658	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.98	CHEMBL5330	Homo sapiens	Inhibition	%	0.98
	8103808	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	7.42	CHEMBL5330	Homo sapiens	Inhibition	%	7.42
	8103993	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	2.06	CHEMBL5330	Homo sapiens	Inhibition	%	2.06
	8104217	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.77	CHEMBL5330	Homo sapiens	Inhibition	%	0.77
	8104365	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	4.23	CHEMBL5330	Homo sapiens	Inhibition	%	4.23
	8104735	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	4.85	CHEMBL5330	Homo sapiens	Inhibition	%	4.85
	8104849	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	0.91	CHEMBL5330	Homo sapiens	Inhibition	%	0.91
	8105073	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	4.07	CHEMBL5330	Homo sapiens	Inhibition	%	4.07
	8105213	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.02	CHEMBL5330	Homo sapiens	Inhibition	%	1.02
	8105379	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.34	CHEMBL5330	Homo sapiens	Inhibition	%	3.34
	8105603	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.18	CHEMBL5330	Homo sapiens	Inhibition	%	2.18
	8105741	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	11.47	CHEMBL5330	Homo sapiens	Inhibition	%	11.47
	8106021	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.88	CHEMBL5330	Homo sapiens	Inhibition	%	0.88
	8106186	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	11.86	CHEMBL5330	Homo sapiens	Inhibition	%	11.86
	8106410	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	4.09	CHEMBL5330	Homo sapiens	Inhibition	%	4.09
	8106566	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	24.27	CHEMBL5330	Homo sapiens	Inhibition	%	24.27
	8106919	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.77	CHEMBL5330	Homo sapiens	Inhibition	%	1.77
	8107040	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.73	CHEMBL5330	Homo sapiens	Inhibition	%	0.73
	8107264	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	10.4	CHEMBL5330	Homo sapiens	Inhibition	%	10.4
	8107436	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.32	CHEMBL5330	Homo sapiens	Inhibition	%	1.32
	8107637	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	15.97	CHEMBL5330	Homo sapiens	Inhibition	%	15.97
	8107996	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	14.06	CHEMBL5330	Homo sapiens	Inhibition	%	14.06
	8108154	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.26	CHEMBL5330	Homo sapiens	Inhibition	%	3.26
	8108553	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	7.45	CHEMBL5330	Homo sapiens	Inhibition	%	7.45
	8108700	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	2.59	CHEMBL5330	Homo sapiens	Inhibition	%	2.59
	8109066	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.66	CHEMBL5330	Homo sapiens	Inhibition	%	0.66
	8109404	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.15	CHEMBL5330	Homo sapiens	Inhibition	%	2.15
	8109534	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	5.84	CHEMBL5330	Homo sapiens	Inhibition	%	5.84
	8109929	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	18.41	CHEMBL5330	Homo sapiens	Inhibition	%	18.41
	8110061	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	0.95	CHEMBL5330	Homo sapiens	Inhibition	%	0.95
	8110340	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.54	CHEMBL5330	Homo sapiens	Inhibition	%	1.54
	8110730	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	7.36	CHEMBL5330	Homo sapiens	Inhibition	%	7.36
	8110888	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	3.61	CHEMBL5330	Homo sapiens	Inhibition	%	3.61
	8111235	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.82	CHEMBL5330	Homo sapiens	Inhibition	%	1.82
	8111586	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	2.41	CHEMBL5330	Homo sapiens	Inhibition	%	2.41
	8111752	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	5.29	CHEMBL5330	Homo sapiens	Inhibition	%	5.29
	8111957	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.52	CHEMBL5330	Homo sapiens	Inhibition	%	1.52
	8112181	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.15	CHEMBL5330	Homo sapiens	Inhibition	%	4.15
	8112318	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.39	CHEMBL5330	Homo sapiens	Inhibition	%	-0.39
	8112486	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	7.14	CHEMBL5330	Homo sapiens	Inhibition	%	7.14
	8112710	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	6.47	CHEMBL5330	Homo sapiens	Inhibition	%	6.47
	8112882	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.72	CHEMBL5330	Homo sapiens	Inhibition	%	1.72
	8113034	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	13.94	CHEMBL5330	Homo sapiens	Inhibition	%	13.94
	8113258	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	0.49	CHEMBL5330	Homo sapiens	Inhibition	%	0.49
	8113394	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	3.12	CHEMBL5330	Homo sapiens	Inhibition	%	3.12
	8113742	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	6.26	CHEMBL5330	Homo sapiens	Inhibition	%	6.26
	8113858	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	2.43	CHEMBL5330	Homo sapiens	Inhibition	%	2.43
	8114082	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	2.47	CHEMBL5330	Homo sapiens	Inhibition	%	2.47
	8114258	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	-0.93	CHEMBL5330	Homo sapiens	Inhibition	%	-0.93
	8114390	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	7.2	CHEMBL5330	Homo sapiens	Inhibition	%	7.2
	8114614	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	1.99	CHEMBL5330	Homo sapiens	Inhibition	%	1.99
	8114666	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.78	CHEMBL5330	Homo sapiens	Inhibition	%	2.78
	8114890	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.05	CHEMBL5330	Homo sapiens	Inhibition	%	2.05
	8115056	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	35.79	CHEMBL5330	Homo sapiens	Inhibition	%	35.79
	8115221	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	4.55	CHEMBL5330	Homo sapiens	Inhibition	%	4.55
	8115445	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.81	CHEMBL5330	Homo sapiens	Inhibition	%	2.81
	8115565	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	5.21	CHEMBL5330	Homo sapiens	Inhibition	%	5.21
	8115922	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	3.31	CHEMBL5330	Homo sapiens	Inhibition	%	3.31
	8116081	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.92	CHEMBL5330	Homo sapiens	Inhibition	%	0.92
	8116508	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.3	CHEMBL5330	Homo sapiens	Inhibition	%	2.3
	8116642	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.32	CHEMBL5330	Homo sapiens	Inhibition	%	0.32
	8117038	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	31.35	CHEMBL5330	Homo sapiens	Inhibition	%	31.35
	8117209	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.42	CHEMBL5330	Homo sapiens	Inhibition	%	1.42
	8117591	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.15	CHEMBL5330	Homo sapiens	Inhibition	%	3.15
	8117721	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	3.3	CHEMBL5330	Homo sapiens	Inhibition	%	3.3
	8118083	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.35	CHEMBL5330	Homo sapiens	Inhibition	%	1.35
	8118423	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	0.59	CHEMBL5330	Homo sapiens	Inhibition	%	0.59
	8118595	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.32	CHEMBL5330	Homo sapiens	Inhibition	%	2.32
	8118955	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.87	CHEMBL5330	Homo sapiens	Inhibition	%	3.87
	8119226	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	9.71	CHEMBL5330	Homo sapiens	Inhibition	%	9.71
	8119385	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	66.34	CHEMBL5330	Homo sapiens	Inhibition	%	66.34
	8119776	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.04	CHEMBL5330	Homo sapiens	Inhibition	%	2.04
	8119895	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.34	CHEMBL5330	Homo sapiens	Inhibition	%	1.34
	8120119	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.52	CHEMBL5330	Homo sapiens	Inhibition	%	2.52
	8120258	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.07	CHEMBL5330	Homo sapiens	Inhibition	%	1.07
	8120418	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	3.15	CHEMBL5330	Homo sapiens	Inhibition	%	3.15
	8120642	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.52	CHEMBL5330	Homo sapiens	Inhibition	%	0.52
	8120843	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.12	CHEMBL5330	Homo sapiens	Inhibition	%	3.12
	8120971	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	2.41	CHEMBL5330	Homo sapiens	Inhibition	%	2.41
	8121195	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	2.01	CHEMBL5330	Homo sapiens	Inhibition	%	2.01
	8121367	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.39	CHEMBL5330	Homo sapiens	Inhibition	%	0.39
	8121534	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.75	CHEMBL5330	Homo sapiens	Inhibition	%	1.75
	8121758	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	3.46	CHEMBL5330	Homo sapiens	Inhibition	%	3.46
	8121921	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	2.47	CHEMBL5330	Homo sapiens	Inhibition	%	2.47
	8122042	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	7.74	CHEMBL5330	Homo sapiens	Inhibition	%	7.74
	8122266	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	34.36	CHEMBL5330	Homo sapiens	Inhibition	%	34.36
	8122404	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	3.76	CHEMBL5330	Homo sapiens	Inhibition	%	3.76
	8122748	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.11	CHEMBL5330	Homo sapiens	Inhibition	%	2.11
	8122915	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	-0.26	CHEMBL5330	Homo sapiens	Inhibition	%	-0.26
	8123139	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.59	CHEMBL5330	Homo sapiens	Inhibition	%	3.59
	8123281	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	4.53	CHEMBL5330	Homo sapiens	Inhibition	%	4.53
	8123559	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	43.89	CHEMBL5330	Homo sapiens	Inhibition	%	43.89
	8123709	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	4.63	CHEMBL5330	Homo sapiens	Inhibition	%	4.63
	8123933	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	19.31	CHEMBL5330	Homo sapiens	Inhibition	%	19.31
	8124100	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	1.19	CHEMBL5330	Homo sapiens	Inhibition	%	1.19
	8124443	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	17.09	CHEMBL5330	Homo sapiens	Inhibition	%	17.09
	8124582	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.41	CHEMBL5330	Homo sapiens	Inhibition	%	2.41
	8124971	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.14	CHEMBL5330	Homo sapiens	Inhibition	%	2.14
	8125172	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	1.71	CHEMBL5330	Homo sapiens	Inhibition	%	1.71
	8125526	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.63	CHEMBL5330	Homo sapiens	Inhibition	%	0.63
	8125694	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.86	CHEMBL5330	Homo sapiens	Inhibition	%	0.86
	8126082	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	2.45	CHEMBL5330	Homo sapiens	Inhibition	%	2.45
	8126246	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	8.46	CHEMBL5330	Homo sapiens	Inhibition	%	8.46
	8126585	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	65.54	CHEMBL5330	Homo sapiens	Inhibition	%	65.54
	8126721	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	12.75	CHEMBL5330	Homo sapiens	Inhibition	%	12.75
	8126945	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	52.08	CHEMBL5330	Homo sapiens	Inhibition	%	52.08
	8127067	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.54	CHEMBL5330	Homo sapiens	Inhibition	%	2.54
	8127458	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	1.31	CHEMBL5330	Homo sapiens	Inhibition	%	1.31
	8127600	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	18.1	CHEMBL5330	Homo sapiens	Inhibition	%	18.1
	8127888	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.28	CHEMBL5330	Homo sapiens	Inhibition	%	1.28
	8128264	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.39	CHEMBL5330	Homo sapiens	Inhibition	%	2.39
	8128431	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	1.25	CHEMBL5330	Homo sapiens	Inhibition	%	1.25
	8128774	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	60.1	CHEMBL5330	Homo sapiens	Inhibition	%	60.1
	8128911	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-6.79	CHEMBL5330	Homo sapiens	Inhibition	%	-6.79
	8129135	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	5.47	CHEMBL5330	Homo sapiens	Inhibition	%	5.47
	8129306	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	2.2	CHEMBL5330	Homo sapiens	Inhibition	%	2.2
	8129495	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	15.43	CHEMBL5330	Homo sapiens	Inhibition	%	15.43
	8129858	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.06	CHEMBL5330	Homo sapiens	Inhibition	%	1.06
	8130019	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-0.83	CHEMBL5330	Homo sapiens	Inhibition	%	-0.83
	8130243	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.5	CHEMBL5330	Homo sapiens	Inhibition	%	1.5
	8130415	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	3.52	CHEMBL5330	Homo sapiens	Inhibition	%	3.52
	8130575	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	3.21	CHEMBL5330	Homo sapiens	Inhibition	%	3.21
	8130915	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.86	CHEMBL5330	Homo sapiens	Inhibition	%	0.86
	8131278	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	1.58	CHEMBL5330	Homo sapiens	Inhibition	%	1.58
	8131398	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	9.5	CHEMBL5330	Homo sapiens	Inhibition	%	9.5
	8131789	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	8.13	CHEMBL5330	Homo sapiens	Inhibition	%	8.13
	8131930	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	28.74	CHEMBL5330	Homo sapiens	Inhibition	%	28.74
	8132154	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	59.25	CHEMBL5330	Homo sapiens	Inhibition	%	59.25
	8132216	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	4.18	CHEMBL5330	Homo sapiens	Inhibition	%	4.18
	8132587	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	6.67	CHEMBL5330	Homo sapiens	Inhibition	%	6.67
	8132755	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.8	CHEMBL5330	Homo sapiens	Inhibition	%	1.8
	8132979	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	2.04	CHEMBL5330	Homo sapiens	Inhibition	%	2.04
	8133100	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.75	CHEMBL5330	Homo sapiens	Inhibition	%	2.75
	8133462	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.29	CHEMBL5330	Homo sapiens	Inhibition	%	0.29
	8133634	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	5.27	CHEMBL5330	Homo sapiens	Inhibition	%	5.27
	8133814	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	4.67	CHEMBL5330	Homo sapiens	Inhibition	%	4.67
	8134038	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	32.68	CHEMBL5330	Homo sapiens	Inhibition	%	32.68
	8134186	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	2.31	CHEMBL5330	Homo sapiens	Inhibition	%	2.31
	8134570	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.94	CHEMBL5330	Homo sapiens	Inhibition	%	-0.94
	8134754	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	2.65	CHEMBL5330	Homo sapiens	Inhibition	%	2.65
	8134914	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	21.17	CHEMBL5330	Homo sapiens	Inhibition	%	21.17
	8135138	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	-1.16	CHEMBL5330	Homo sapiens	Inhibition	%	-1.16
	8135253	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.41	CHEMBL5330	Homo sapiens	Inhibition	%	2.41
	8135618	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	9.76	CHEMBL5330	Homo sapiens	Inhibition	%	9.76
	8135739	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-0.24	CHEMBL5330	Homo sapiens	Inhibition	%	-0.24
	8135963	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.81	CHEMBL5330	Homo sapiens	Inhibition	%	0.81
	8136131	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	-0.07	CHEMBL5330	Homo sapiens	Inhibition	%	-0.07
	8136499	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	1.35	CHEMBL5330	Homo sapiens	Inhibition	%	1.35
	8136565	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	2.17	CHEMBL5330	Homo sapiens	Inhibition	%	2.17
	8136789	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	3.67	CHEMBL5330	Homo sapiens	Inhibition	%	3.67
	8136924	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-1.16	CHEMBL5330	Homo sapiens	Inhibition	%	-1.16
	8137311	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.16	CHEMBL5330	Homo sapiens	Inhibition	%	1.16
	8137431	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	9.93	CHEMBL5330	Homo sapiens	Inhibition	%	9.93
	8137803	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	5.3	CHEMBL5330	Homo sapiens	Inhibition	%	5.3
	8137969	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.34	CHEMBL5330	Homo sapiens	Inhibition	%	1.34
	8138372	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-0.19	CHEMBL5330	Homo sapiens	Inhibition	%	-0.19
	8138520	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	4.72	CHEMBL5330	Homo sapiens	Inhibition	%	4.72
	8138902	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.39	CHEMBL5330	Homo sapiens	Inhibition	%	0.39
	8139087	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	18.57	CHEMBL5330	Homo sapiens	Inhibition	%	18.57
	8139470	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	3.53	CHEMBL5330	Homo sapiens	Inhibition	%	3.53
	8139584	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	0.85	CHEMBL5330	Homo sapiens	Inhibition	%	0.85
	8139808	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.46	CHEMBL5330	Homo sapiens	Inhibition	%	1.46
	8139949	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	1.81	CHEMBL5330	Homo sapiens	Inhibition	%	1.81
	8140296	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	-1.44	CHEMBL5330	Homo sapiens	Inhibition	%	-1.44
	8140455	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.67	CHEMBL5330	Homo sapiens	Inhibition	%	2.67
	8140822	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	9.73	CHEMBL5330	Homo sapiens	Inhibition	%	9.73
	8141124	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.88	CHEMBL5330	Homo sapiens	Inhibition	%	0.88
	8141254	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.61	CHEMBL5330	Homo sapiens	Inhibition	%	1.61
	8141478	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.49	CHEMBL5330	Homo sapiens	Inhibition	%	0.49
	8141638	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	3.57	CHEMBL5330	Homo sapiens	Inhibition	%	3.57
	8141757	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.91	CHEMBL5330	Homo sapiens	Inhibition	%	0.91
	8141981	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	4.59	CHEMBL5330	Homo sapiens	Inhibition	%	4.59
	8142142	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.69	CHEMBL5330	Homo sapiens	Inhibition	%	0.69
	8142310	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	2.61	CHEMBL5330	Homo sapiens	Inhibition	%	2.61
	8142534	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	1.86	CHEMBL5330	Homo sapiens	Inhibition	%	1.86
	8142710	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	3.96	CHEMBL5330	Homo sapiens	Inhibition	%	3.96
	8142859	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.39	CHEMBL5330	Homo sapiens	Inhibition	%	-0.39
	8143083	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	1.59	CHEMBL5330	Homo sapiens	Inhibition	%	1.59
	8143238	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.2	CHEMBL5330	Homo sapiens	Inhibition	%	0.2
	8143425	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	0.93	CHEMBL5330	Homo sapiens	Inhibition	%	0.93
	8143649	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.6	CHEMBL5330	Homo sapiens	Inhibition	%	3.6
	8143808	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	-0.05	CHEMBL5330	Homo sapiens	Inhibition	%	-0.05
	8144146	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	0.72	CHEMBL5330	Homo sapiens	Inhibition	%	0.72
	8144285	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	5.19	CHEMBL5330	Homo sapiens	Inhibition	%	5.19
	8144639	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.57	CHEMBL5330	Homo sapiens	Inhibition	%	1.57
	8144792	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.0	CHEMBL5330	Homo sapiens	Inhibition	%	1.0
	8145016	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.67	CHEMBL5330	Homo sapiens	Inhibition	%	0.67
	8145153	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.04	CHEMBL5330	Homo sapiens	Inhibition	%	2.04
	8145466	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.15	CHEMBL5330	Homo sapiens	Inhibition	%	3.15
	8145814	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	4.84	CHEMBL5330	Homo sapiens	Inhibition	%	4.84
	8145975	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	11.5	CHEMBL5330	Homo sapiens	Inhibition	%	11.5
	8146319	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	7.11	CHEMBL5330	Homo sapiens	Inhibition	%	7.11
	8146479	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	4.16	CHEMBL5330	Homo sapiens	Inhibition	%	4.16
	8146870	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	12.06	CHEMBL5330	Homo sapiens	Inhibition	%	12.06
	8147039	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	3.87	CHEMBL5330	Homo sapiens	Inhibition	%	3.87
	8147405	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.58	CHEMBL5330	Homo sapiens	Inhibition	%	0.58
	8147558	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.98	CHEMBL5330	Homo sapiens	Inhibition	%	1.98
	8147969	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	1.53	CHEMBL5330	Homo sapiens	Inhibition	%	1.53
	8148127	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	9.38	CHEMBL5330	Homo sapiens	Inhibition	%	9.38
	8148465	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	0.4	CHEMBL5330	Homo sapiens	Inhibition	%	0.4
	8148604	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.38	CHEMBL5330	Homo sapiens	Inhibition	%	3.38
	8148828	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	25.93	CHEMBL5330	Homo sapiens	Inhibition	%	25.93
	8148966	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	-0.61	CHEMBL5330	Homo sapiens	Inhibition	%	-0.61
	8149349	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.14	CHEMBL5330	Homo sapiens	Inhibition	%	-0.14
	8149483	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	5.59	CHEMBL5330	Homo sapiens	Inhibition	%	5.59
	8149805	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.92	CHEMBL5330	Homo sapiens	Inhibition	%	0.92
	8150154	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	2.98	CHEMBL5330	Homo sapiens	Inhibition	%	2.98
	8150314	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	32.85	CHEMBL5330	Homo sapiens	Inhibition	%	32.85
	8150658	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	27.46	CHEMBL5330	Homo sapiens	Inhibition	%	27.46
	8150823	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.63	CHEMBL5330	Homo sapiens	Inhibition	%	1.63
	8151047	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	11.8	CHEMBL5330	Homo sapiens	Inhibition	%	11.8
	8151210	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.74	CHEMBL5330	Homo sapiens	Inhibition	%	-1.74
	8151387	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	19.88	CHEMBL5330	Homo sapiens	Inhibition	%	19.88
	8151611	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.96	CHEMBL5330	Homo sapiens	Inhibition	%	0.96
	8151749	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.4	CHEMBL5330	Homo sapiens	Inhibition	%	2.4
	8151903	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.11	CHEMBL5330	Homo sapiens	Inhibition	%	2.11
	8152127	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.6	CHEMBL5330	Homo sapiens	Inhibition	%	1.6
	8152315	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	4.06	CHEMBL5330	Homo sapiens	Inhibition	%	4.06
	8152473	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	1.03	CHEMBL5330	Homo sapiens	Inhibition	%	1.03
	8152697	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	5.7	CHEMBL5330	Homo sapiens	Inhibition	%	5.7
	8152811	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	0.17	CHEMBL5330	Homo sapiens	Inhibition	%	0.17
	8153174	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.1	CHEMBL5330	Homo sapiens	Inhibition	%	2.1
	8153311	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	1.55	CHEMBL5330	Homo sapiens	Inhibition	%	1.55
	8153535	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.51	CHEMBL5330	Homo sapiens	Inhibition	%	1.51
	8153692	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.7	CHEMBL5330	Homo sapiens	Inhibition	%	-0.7
	8153825	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	0.67	CHEMBL5330	Homo sapiens	Inhibition	%	0.67
	8154049	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.62	CHEMBL5330	Homo sapiens	Inhibition	%	3.62
	8154146	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	5.49	CHEMBL5330	Homo sapiens	Inhibition	%	5.49
	8154370	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.98	CHEMBL5330	Homo sapiens	Inhibition	%	0.98
	8154496	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	28.89	CHEMBL5330	Homo sapiens	Inhibition	%	28.89
	8154655	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-1.31	CHEMBL5330	Homo sapiens	Inhibition	%	-1.31
	8154879	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.34	CHEMBL5330	Homo sapiens	Inhibition	%	0.34
	8154999	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	2.33	CHEMBL5330	Homo sapiens	Inhibition	%	2.33
	8155399	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	2.23	CHEMBL5330	Homo sapiens	Inhibition	%	2.23
	8155560	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	5.05	CHEMBL5330	Homo sapiens	Inhibition	%	5.05
	8155962	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.67	CHEMBL5330	Homo sapiens	Inhibition	%	3.67
	8156100	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.42	CHEMBL5330	Homo sapiens	Inhibition	%	0.42
	8156312	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	-0.42	CHEMBL5330	Homo sapiens	Inhibition	%	-0.42
	8156536	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	0.9	CHEMBL5330	Homo sapiens	Inhibition	%	0.9
	8156686	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.22	CHEMBL5330	Homo sapiens	Inhibition	%	3.22
	8157053	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	8.73	CHEMBL5330	Homo sapiens	Inhibition	%	8.73
	8157173	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	0.76	CHEMBL5330	Homo sapiens	Inhibition	%	0.76
	8157397	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	3.74	CHEMBL5330	Homo sapiens	Inhibition	%	3.74
	8157538	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	-0.1	CHEMBL5330	Homo sapiens	Inhibition	%	-0.1
	8157892	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.42	CHEMBL5330	Homo sapiens	Inhibition	%	1.42
	8158053	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	3.99	CHEMBL5330	Homo sapiens	Inhibition	%	3.99
	8158303	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	0.3	CHEMBL5330	Homo sapiens	Inhibition	%	0.3
	8158685	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	13.53	CHEMBL5330	Homo sapiens	Inhibition	%	13.53
	8158854	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	0.39	CHEMBL5330	Homo sapiens	Inhibition	%	0.39
	8159213	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	1.53	CHEMBL5330	Homo sapiens	Inhibition	%	1.53
	8159333	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	3.92	CHEMBL5330	Homo sapiens	Inhibition	%	3.92
	8159557	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.02	CHEMBL5330	Homo sapiens	Inhibition	%	1.02
	8159688	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	10.66	CHEMBL5330	Homo sapiens	Inhibition	%	10.66
	8160053	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.78	CHEMBL5330	Homo sapiens	Inhibition	%	2.78
	8160190	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.71	CHEMBL5330	Homo sapiens	Inhibition	%	1.71
	8160564	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	2.53	CHEMBL5330	Homo sapiens	Inhibition	%	2.53
	8160858	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.12	CHEMBL5330	Homo sapiens	Inhibition	%	2.12
	8161008	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	0.62	CHEMBL5330	Homo sapiens	Inhibition	%	0.62
	8161375	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	13.6	CHEMBL5330	Homo sapiens	Inhibition	%	13.6
	8161724	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.12	CHEMBL5330	Homo sapiens	Inhibition	%	1.12
	8161862	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	7.98	CHEMBL5330	Homo sapiens	Inhibition	%	7.98
	8162216	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	13.27	CHEMBL5330	Homo sapiens	Inhibition	%	13.27
	8162376	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	3.12	CHEMBL5330	Homo sapiens	Inhibition	%	3.12
	8162600	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	8.26	CHEMBL5330	Homo sapiens	Inhibition	%	8.26
	8162629	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	0.43	CHEMBL5330	Homo sapiens	Inhibition	%	0.43
	8162853	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	2.34	CHEMBL5330	Homo sapiens	Inhibition	%	2.34
	8163001	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	27.23	CHEMBL5330	Homo sapiens	Inhibition	%	27.23
	8163170	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	5.06	CHEMBL5330	Homo sapiens	Inhibition	%	5.06
	8163394	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.92	CHEMBL5330	Homo sapiens	Inhibition	%	1.92
	8163528	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	0.84	CHEMBL5330	Homo sapiens	Inhibition	%	0.84
	8163875	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	3.03	CHEMBL5330	Homo sapiens	Inhibition	%	3.03
	8164009	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	9.87	CHEMBL5330	Homo sapiens	Inhibition	%	9.87
	8164233	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	48.92	CHEMBL5330	Homo sapiens	Inhibition	%	48.92
	8164373	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.36	CHEMBL5330	Homo sapiens	Inhibition	%	1.36
	8164528	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.67	CHEMBL5330	Homo sapiens	Inhibition	%	2.67
	8164752	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	11.01	CHEMBL5330	Homo sapiens	Inhibition	%	11.01
	8164896	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	16.21	CHEMBL5330	Homo sapiens	Inhibition	%	16.21
	8165190	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	1.56	CHEMBL5330	Homo sapiens	Inhibition	%	1.56
	8165331	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	3.53	CHEMBL5330	Homo sapiens	Inhibition	%	3.53
	8165555	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	-0.01	CHEMBL5330	Homo sapiens	Inhibition	%	-0.01
	8165698	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	56.47	CHEMBL5330	Homo sapiens	Inhibition	%	56.47
	8166048	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.09	CHEMBL5330	Homo sapiens	Inhibition	%	2.09
	8166186	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.41	CHEMBL5330	Homo sapiens	Inhibition	%	1.41
	8166410	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	4.93	CHEMBL5330	Homo sapiens	Inhibition	%	4.93
	8166540	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	0.57	CHEMBL5330	Homo sapiens	Inhibition	%	0.57
	8166865	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	7.42	CHEMBL5330	Homo sapiens	Inhibition	%	7.42
	8167177	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	0.13	CHEMBL5330	Homo sapiens	Inhibition	%	0.13
	8167318	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	66.45	CHEMBL5330	Homo sapiens	Inhibition	%	66.45
	8167706	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	4.41	CHEMBL5330	Homo sapiens	Inhibition	%	4.41
	8167839	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	1.16	CHEMBL5330	Homo sapiens	Inhibition	%	1.16
	8168187	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.97	CHEMBL5330	Homo sapiens	Inhibition	%	1.97
	8168552	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	1.47	CHEMBL5330	Homo sapiens	Inhibition	%	1.47
	8168688	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	2.09	CHEMBL5330	Homo sapiens	Inhibition	%	2.09
	8169076	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	45.77	CHEMBL5330	Homo sapiens	Inhibition	%	45.77
	8169218	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.04	CHEMBL5330	Homo sapiens	Inhibition	%	1.04
	8169522	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	4.18	CHEMBL5330	Homo sapiens	Inhibition	%	4.18
	8169880	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.7	CHEMBL5330	Homo sapiens	Inhibition	%	2.7
	8170025	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	15.7	CHEMBL5330	Homo sapiens	Inhibition	%	15.7
	8170249	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	48.94	CHEMBL5330	Homo sapiens	Inhibition	%	48.94
	8170374	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	0.93	CHEMBL5330	Homo sapiens	Inhibition	%	0.93
	8170738	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	1.42	CHEMBL5330	Homo sapiens	Inhibition	%	1.42
	8170873	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	4.27	CHEMBL5330	Homo sapiens	Inhibition	%	4.27
	8171294	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	3.12	CHEMBL5330	Homo sapiens	Inhibition	%	3.12
	8171511	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	-1.08	CHEMBL5330	Homo sapiens	Inhibition	%	-1.08
	8171652	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	4.1	CHEMBL5330	Homo sapiens	Inhibition	%	4.1
	8171876	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	22.64	CHEMBL5330	Homo sapiens	Inhibition	%	22.64
	8172029	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.55	CHEMBL5330	Homo sapiens	Inhibition	%	1.55
	8172161	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	2.01	CHEMBL5330	Homo sapiens	Inhibition	%	2.01
	8172385	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	1.3	CHEMBL5330	Homo sapiens	Inhibition	%	1.3
	8172513	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.21	CHEMBL5330	Homo sapiens	Inhibition	%	3.21
	8172879	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	7.29	CHEMBL5330	Homo sapiens	Inhibition	%	7.29
	8173015	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	2.11	CHEMBL5330	Homo sapiens	Inhibition	%	2.11
	8173239	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	7.37	CHEMBL5330	Homo sapiens	Inhibition	%	7.37
	8173404	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	2.12	CHEMBL5330	Homo sapiens	Inhibition	%	2.12
	8173545	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	5.76	CHEMBL5330	Homo sapiens	Inhibition	%	5.76
	8173769	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.24	CHEMBL5330	Homo sapiens	Inhibition	%	1.24
	8173856	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	1.62	CHEMBL5330	Homo sapiens	Inhibition	%	1.62
	8174080	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	6.59	CHEMBL5330	Homo sapiens	Inhibition	%	6.59
	8174212	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	0.34	CHEMBL5330	Homo sapiens	Inhibition	%	0.34
	8174584	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.43	CHEMBL5330	Homo sapiens	Inhibition	%	1.43
	8174706	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	0.8	CHEMBL5330	Homo sapiens	Inhibition	%	0.8
	8175073	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	1.95	CHEMBL5330	Homo sapiens	Inhibition	%	1.95
	8175209	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	1.97	CHEMBL5330	Homo sapiens	Inhibition	%	1.97
	8175433	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	23.38	CHEMBL5330	Homo sapiens	Inhibition	%	23.38
	8175465	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.9	CHEMBL5330	Homo sapiens	Inhibition	%	2.9
	8175689	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	12.58	CHEMBL5330	Homo sapiens	Inhibition	%	12.58
	8175852	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	7.42	CHEMBL5330	Homo sapiens	Inhibition	%	7.42
	8176229	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	3.62	CHEMBL5330	Homo sapiens	Inhibition	%	3.62
	8176378	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	4.59	CHEMBL5330	Homo sapiens	Inhibition	%	4.59
	8176734	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	15.16	CHEMBL5330	Homo sapiens	Inhibition	%	15.16
	8176864	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	3.67	CHEMBL5330	Homo sapiens	Inhibition	%	3.67
	8177088	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	7.08	CHEMBL5330	Homo sapiens	Inhibition	%	7.08
	8177230	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	1.25	CHEMBL5330	Homo sapiens	Inhibition	%	1.25
	8177592	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	2.06	CHEMBL5330	Homo sapiens	Inhibition	%	2.06
	8177756	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	7.06	CHEMBL5330	Homo sapiens	Inhibition	%	7.06
	8178120	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.93	CHEMBL5330	Homo sapiens	Inhibition	%	2.93
	8178432	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	0.82	CHEMBL5330	Homo sapiens	Inhibition	%	0.82
	8178559	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	4.75	CHEMBL5330	Homo sapiens	Inhibition	%	4.75
	8178932	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.37	CHEMBL5330	Homo sapiens	Inhibition	%	2.37
	8179055	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	0.18	CHEMBL5330	Homo sapiens	Inhibition	%	0.18
	8179279	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.21	CHEMBL5330	Homo sapiens	Inhibition	%	2.21
	8179423	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	0.75	CHEMBL5330	Homo sapiens	Inhibition	%	0.75
	8179784	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.84	CHEMBL5330	Homo sapiens	Inhibition	%	0.84
	8180041	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	0.73	CHEMBL5330	Homo sapiens	Inhibition	%	0.73
	8180195	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	30.94	CHEMBL5330	Homo sapiens	Inhibition	%	30.94
	8180575	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	18.19	CHEMBL5330	Homo sapiens	Inhibition	%	18.19
	8180723	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	5.66	CHEMBL5330	Homo sapiens	Inhibition	%	5.66
	8180947	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	29.85	CHEMBL5330	Homo sapiens	Inhibition	%	29.85
	8181080	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	5.18	CHEMBL5330	Homo sapiens	Inhibition	%	5.18
	8181435	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	1.58	CHEMBL5330	Homo sapiens	Inhibition	%	1.58
	8181575	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	5.33	CHEMBL5330	Homo sapiens	Inhibition	%	5.33
	8181938	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	12.1	CHEMBL5330	Homo sapiens	Inhibition	%	12.1
	8182101	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	2.4	CHEMBL5330	Homo sapiens	Inhibition	%	2.4
	8182325	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.82	CHEMBL5330	Homo sapiens	Inhibition	%	3.82
	8182465	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.94	CHEMBL5330	Homo sapiens	Inhibition	%	0.94
	8182781	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.78	CHEMBL5330	Homo sapiens	Inhibition	%	2.78
	8182903	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	0.43	CHEMBL5330	Homo sapiens	Inhibition	%	0.43
	8183127	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	0.63	CHEMBL5330	Homo sapiens	Inhibition	%	0.63
	8183276	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.39	CHEMBL5330	Homo sapiens	Inhibition	%	1.39
	8183629	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.41	CHEMBL5330	Homo sapiens	Inhibition	%	6.41
	8183771	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	4.07	CHEMBL5330	Homo sapiens	Inhibition	%	4.07
	8184131	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	2.9	CHEMBL5330	Homo sapiens	Inhibition	%	2.9
	8184397	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.35	CHEMBL5330	Homo sapiens	Inhibition	%	3.35
	8184544	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	0.55	CHEMBL5330	Homo sapiens	Inhibition	%	0.55
	8184768	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	4.58	CHEMBL5330	Homo sapiens	Inhibition	%	4.58
	8184925	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	1.14	CHEMBL5330	Homo sapiens	Inhibition	%	1.14
	8185298	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.67	CHEMBL5330	Homo sapiens	Inhibition	%	0.67
	8185429	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	30.97	CHEMBL5330	Homo sapiens	Inhibition	%	30.97
	8185784	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	17.7	CHEMBL5330	Homo sapiens	Inhibition	%	17.7
	8185923	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	1.56	CHEMBL5330	Homo sapiens	Inhibition	%	1.56
	8186147	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.2	CHEMBL5330	Homo sapiens	Inhibition	%	4.2
	8186288	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	2.1	CHEMBL5330	Homo sapiens	Inhibition	%	2.1
	8186676	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	0.85	CHEMBL5330	Homo sapiens	Inhibition	%	0.85
	8186815	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.77	CHEMBL5330	Homo sapiens	Inhibition	%	1.77
	8187137	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.32	CHEMBL5330	Homo sapiens	Inhibition	%	2.32
	8187485	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	0.05	CHEMBL5330	Homo sapiens	Inhibition	%	0.05
	8187633	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	6.14	CHEMBL5330	Homo sapiens	Inhibition	%	6.14
	8187986	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.88	CHEMBL5330	Homo sapiens	Inhibition	%	6.88
	8188129	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	0.49	CHEMBL5330	Homo sapiens	Inhibition	%	0.49
	8188353	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.26	CHEMBL5330	Homo sapiens	Inhibition	%	3.26
	8188488	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.47	CHEMBL5330	Homo sapiens	Inhibition	%	0.47
	8188762	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.95	CHEMBL5330	Homo sapiens	Inhibition	%	1.95
	8189134	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	2.5	CHEMBL5330	Homo sapiens	Inhibition	%	2.5
	8189290	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	12.13	CHEMBL5330	Homo sapiens	Inhibition	%	12.13
	8189663	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	3.21	CHEMBL5330	Homo sapiens	Inhibition	%	3.21
	8189795	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	1.44	CHEMBL5330	Homo sapiens	Inhibition	%	1.44
	8190019	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	5.3	CHEMBL5330	Homo sapiens	Inhibition	%	5.3
	8190151	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	0.42	CHEMBL5330	Homo sapiens	Inhibition	%	0.42
	8190515	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	0.27	CHEMBL5330	Homo sapiens	Inhibition	%	0.27
	8190652	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	1.49	CHEMBL5330	Homo sapiens	Inhibition	%	1.49
	8190876	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.01	CHEMBL5330	Homo sapiens	Inhibition	%	1.01
	8191040	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.95	CHEMBL5330	Homo sapiens	Inhibition	%	4.95
	8191178	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	0.59	CHEMBL5330	Homo sapiens	Inhibition	%	0.59
	8191402	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.02	CHEMBL5330	Homo sapiens	Inhibition	%	2.02
	8191498	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	8.96	CHEMBL5330	Homo sapiens	Inhibition	%	8.96
	8191844	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.46	CHEMBL5330	Homo sapiens	Inhibition	%	5.46
	8191993	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.77	CHEMBL5330	Homo sapiens	Inhibition	%	0.77
	8192217	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.32	CHEMBL5330	Homo sapiens	Inhibition	%	0.32
	8192346	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	4.0	CHEMBL5330	Homo sapiens	Inhibition	%	4.0
	8192714	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	0.94	CHEMBL5330	Homo sapiens	Inhibition	%	0.94
	8192850	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.9	CHEMBL5330	Homo sapiens	Inhibition	%	0.9
	8193074	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.08	CHEMBL5330	Homo sapiens	Inhibition	%	0.08
	8193122	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	8.01	CHEMBL5330	Homo sapiens	Inhibition	%	8.01
	8193346	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	0.12	CHEMBL5330	Homo sapiens	Inhibition	%	0.12
	8193491	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	9.5	CHEMBL5330	Homo sapiens	Inhibition	%	9.5
	8193648	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	4.14	CHEMBL5330	Homo sapiens	Inhibition	%	4.14
	8193872	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	28.9	CHEMBL5330	Homo sapiens	Inhibition	%	28.9
	8194021	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	1.22	CHEMBL5330	Homo sapiens	Inhibition	%	1.22
	8194376	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	2.26	CHEMBL5330	Homo sapiens	Inhibition	%	2.26
	8194507	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	5.34	CHEMBL5330	Homo sapiens	Inhibition	%	5.34
	8194731	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.87	CHEMBL5330	Homo sapiens	Inhibition	%	1.87
	8194874	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	0.97	CHEMBL5330	Homo sapiens	Inhibition	%	0.97
	8195231	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.59	CHEMBL5330	Homo sapiens	Inhibition	%	1.59
	8195395	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	1.22	CHEMBL5330	Homo sapiens	Inhibition	%	1.22
	8195758	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.15	CHEMBL5330	Homo sapiens	Inhibition	%	1.15
	8195856	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.59	CHEMBL5330	Homo sapiens	Inhibition	%	1.59
	8196080	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.35	CHEMBL5330	Homo sapiens	Inhibition	%	2.35
	8196197	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	0.75	CHEMBL5330	Homo sapiens	Inhibition	%	0.75
	8196571	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	0.67	CHEMBL5330	Homo sapiens	Inhibition	%	0.67
	8196699	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	6.93	CHEMBL5330	Homo sapiens	Inhibition	%	6.93
	8196923	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	10.78	CHEMBL5330	Homo sapiens	Inhibition	%	10.78
	8197064	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.16	CHEMBL5330	Homo sapiens	Inhibition	%	2.16
	8197425	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.69	CHEMBL5330	Homo sapiens	Inhibition	%	2.69
	8197700	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.33	CHEMBL5330	Homo sapiens	Inhibition	%	2.33
	8197840	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	7.0	CHEMBL5330	Homo sapiens	Inhibition	%	7.0
	8198221	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.36	CHEMBL5330	Homo sapiens	Inhibition	%	1.36
	8198359	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	4.2	CHEMBL5330	Homo sapiens	Inhibition	%	4.2
	8198713	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	5.63	CHEMBL5330	Homo sapiens	Inhibition	%	5.63
	8199068	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	6.3	CHEMBL5330	Homo sapiens	Inhibition	%	6.3
	8199216	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	1.35	CHEMBL5330	Homo sapiens	Inhibition	%	1.35
	8199574	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	0.81	CHEMBL5330	Homo sapiens	Inhibition	%	0.81
	8199737	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	7.56	CHEMBL5330	Homo sapiens	Inhibition	%	7.56
	8200099	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.87	CHEMBL5330	Homo sapiens	Inhibition	%	2.87
	8200427	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.09	CHEMBL5330	Homo sapiens	Inhibition	%	1.09
	8200542	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	6.22	CHEMBL5330	Homo sapiens	Inhibition	%	6.22
	8200766	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	1.7	CHEMBL5330	Homo sapiens	Inhibition	%	1.7
	8200916	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	3.98	CHEMBL5330	Homo sapiens	Inhibition	%	3.98
	8201270	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	35.99	CHEMBL5330	Homo sapiens	Inhibition	%	35.99
	8201405	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-0.94	CHEMBL5330	Homo sapiens	Inhibition	%	-0.94
	8201762	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.16	CHEMBL5330	Homo sapiens	Inhibition	%	-0.16
	8202041	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.28	CHEMBL5330	Homo sapiens	Inhibition	%	1.28
	8202181	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	30.83	CHEMBL5330	Homo sapiens	Inhibition	%	30.83
	8202405	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	1.39	CHEMBL5330	Homo sapiens	Inhibition	%	1.39
	8202572	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	6.73	CHEMBL5330	Homo sapiens	Inhibition	%	6.73
	8202697	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	-0.05	CHEMBL5330	Homo sapiens	Inhibition	%	-0.05
	8202921	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	1.6	CHEMBL5330	Homo sapiens	Inhibition	%	1.6
	8203051	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	2.02	CHEMBL5330	Homo sapiens	Inhibition	%	2.02
	8203406	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	7.77	CHEMBL5330	Homo sapiens	Inhibition	%	7.77
	8203552	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.07	CHEMBL5330	Homo sapiens	Inhibition	%	2.07
	8203776	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	-0.2	CHEMBL5330	Homo sapiens	Inhibition	%	-0.2
	8203910	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	0.54	CHEMBL5330	Homo sapiens	Inhibition	%	0.54
	8204076	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.5	CHEMBL5330	Homo sapiens	Inhibition	%	2.5
	8204300	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	7.97	CHEMBL5330	Homo sapiens	Inhibition	%	7.97
	8204437	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	3.74	CHEMBL5330	Homo sapiens	Inhibition	%	3.74
	8204766	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	5.08	CHEMBL5330	Homo sapiens	Inhibition	%	5.08
	8205105	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	9.66	CHEMBL5330	Homo sapiens	Inhibition	%	9.66
	8205254	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	-0.22	CHEMBL5330	Homo sapiens	Inhibition	%	-0.22
	8205614	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	5.01	CHEMBL5330	Homo sapiens	Inhibition	%	5.01
	8205753	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.03	CHEMBL5330	Homo sapiens	Inhibition	%	2.03
	8205977	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	0.05	CHEMBL5330	Homo sapiens	Inhibition	%	0.05
	8206109	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.1	CHEMBL5330	Homo sapiens	Inhibition	%	0.1
	8206385	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.47	CHEMBL5330	Homo sapiens	Inhibition	%	2.47
	8206752	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	5.61	CHEMBL5330	Homo sapiens	Inhibition	%	5.61
	8206932	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.05	CHEMBL5330	Homo sapiens	Inhibition	%	2.05
	8207282	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	1.48	CHEMBL5330	Homo sapiens	Inhibition	%	1.48
	8207412	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	7.67	CHEMBL5330	Homo sapiens	Inhibition	%	7.67
	8207636	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	7.0	CHEMBL5330	Homo sapiens	Inhibition	%	7.0
	8207768	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	41.01	CHEMBL5330	Homo sapiens	Inhibition	%	41.01
	8208137	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.94	CHEMBL5330	Homo sapiens	Inhibition	%	1.94
	8208269	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	1.74	CHEMBL5330	Homo sapiens	Inhibition	%	1.74
	8208659	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.47	CHEMBL5330	Homo sapiens	Inhibition	%	1.47
	8208792	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	26.42	CHEMBL5330	Homo sapiens	Inhibition	%	26.42
	8209016	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.53	CHEMBL5330	Homo sapiens	Inhibition	%	3.53
	8209121	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.69	CHEMBL5330	Homo sapiens	Inhibition	%	1.69
	8209461	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	0.08	CHEMBL5330	Homo sapiens	Inhibition	%	0.08
	8209611	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	5.78	CHEMBL5330	Homo sapiens	Inhibition	%	5.78
	8209835	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	-0.26	CHEMBL5330	Homo sapiens	Inhibition	%	-0.26
	8209971	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	10.59	CHEMBL5330	Homo sapiens	Inhibition	%	10.59
	8210336	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	3.42	CHEMBL5330	Homo sapiens	Inhibition	%	3.42
	8210472	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.32	CHEMBL5330	Homo sapiens	Inhibition	%	0.32
	8210731	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.46	CHEMBL5330	Homo sapiens	Inhibition	%	1.46
	8211099	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	-0.16	CHEMBL5330	Homo sapiens	Inhibition	%	-0.16
	8211269	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.37	CHEMBL5330	Homo sapiens	Inhibition	%	4.37
	8211616	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.7	CHEMBL5330	Homo sapiens	Inhibition	%	3.7
	8211969	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	34.44	CHEMBL5330	Homo sapiens	Inhibition	%	34.44
	8212101	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.01	CHEMBL5330	Homo sapiens	Inhibition	%	3.01
	8212466	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.48	CHEMBL5330	Homo sapiens	Inhibition	%	1.48
	8212599	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.15	CHEMBL5330	Homo sapiens	Inhibition	%	2.15
	8212823	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	1.46	CHEMBL5330	Homo sapiens	Inhibition	%	1.46
	8212993	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.14	CHEMBL5330	Homo sapiens	Inhibition	%	3.14
	8213346	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	14.29	CHEMBL5330	Homo sapiens	Inhibition	%	14.29
	8213450	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	2.38	CHEMBL5330	Homo sapiens	Inhibition	%	2.38
	8213674	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.42	CHEMBL5330	Homo sapiens	Inhibition	%	0.42
	8213787	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.92	CHEMBL5330	Homo sapiens	Inhibition	%	2.92
	8214158	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.11	CHEMBL5330	Homo sapiens	Inhibition	%	2.11
	8214295	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	13.55	CHEMBL5330	Homo sapiens	Inhibition	%	13.55
	8214653	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	2.07	CHEMBL5330	Homo sapiens	Inhibition	%	2.07
	8214805	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	2.2	CHEMBL5330	Homo sapiens	Inhibition	%	2.2
	8215029	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	6.4	CHEMBL5330	Homo sapiens	Inhibition	%	6.4
	8215056	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.6	CHEMBL5330	Homo sapiens	Inhibition	%	1.6
	8215280	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.02	CHEMBL5330	Homo sapiens	Inhibition	%	2.02
	8215433	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.42	CHEMBL5330	Homo sapiens	Inhibition	%	3.42
	8215597	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.18	CHEMBL5330	Homo sapiens	Inhibition	%	1.18
	8215821	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.82	CHEMBL5330	Homo sapiens	Inhibition	%	2.82
	8215940	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.34	CHEMBL5330	Homo sapiens	Inhibition	%	1.34
	8216283	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	0.79	CHEMBL5330	Homo sapiens	Inhibition	%	0.79
	8216419	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	10.22	CHEMBL5330	Homo sapiens	Inhibition	%	10.22
	8216643	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	12.05	CHEMBL5330	Homo sapiens	Inhibition	%	12.05
	8216781	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	5.08	CHEMBL5330	Homo sapiens	Inhibition	%	5.08
	8217139	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.14	CHEMBL5330	Homo sapiens	Inhibition	%	3.14
	8217313	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.08	CHEMBL5330	Homo sapiens	Inhibition	%	1.08
	8217668	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	8.65	CHEMBL5330	Homo sapiens	Inhibition	%	8.65
	8217993	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	2.85	CHEMBL5330	Homo sapiens	Inhibition	%	2.85
	8218108	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	0.69	CHEMBL5330	Homo sapiens	Inhibition	%	0.69
	8218459	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	3.89	CHEMBL5330	Homo sapiens	Inhibition	%	3.89
	8218602	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	47.44	CHEMBL5330	Homo sapiens	Inhibition	%	47.44
	8218826	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	8.42	CHEMBL5330	Homo sapiens	Inhibition	%	8.42
	8218957	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	8.97	CHEMBL5330	Homo sapiens	Inhibition	%	8.97
	8219341	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	7.48	CHEMBL5330	Homo sapiens	Inhibition	%	7.48
	8219591	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	-0.39	CHEMBL5330	Homo sapiens	Inhibition	%	-0.39
	8219752	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.83	CHEMBL5330	Homo sapiens	Inhibition	%	1.83
	8220145	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	0.93	CHEMBL5330	Homo sapiens	Inhibition	%	0.93
	8220274	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.33	CHEMBL5330	Homo sapiens	Inhibition	%	1.33
	8220498	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.6	CHEMBL5330	Homo sapiens	Inhibition	%	1.6
	8220612	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	8.19	CHEMBL5330	Homo sapiens	Inhibition	%	8.19
	8220974	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	52.62	CHEMBL5330	Homo sapiens	Inhibition	%	52.62
	8221110	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.38	CHEMBL5330	Homo sapiens	Inhibition	%	3.38
	8221334	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	12.76	CHEMBL5330	Homo sapiens	Inhibition	%	12.76
	8221467	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	0.91	CHEMBL5330	Homo sapiens	Inhibition	%	0.91
	8221632	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.62	CHEMBL5330	Homo sapiens	Inhibition	%	1.62
	8221856	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.0	CHEMBL5330	Homo sapiens	Inhibition	%	2.0
	8221987	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	41.33	CHEMBL5330	Homo sapiens	Inhibition	%	41.33
	8222309	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	-0.26	CHEMBL5330	Homo sapiens	Inhibition	%	-0.26
	8222443	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.44	CHEMBL5330	Homo sapiens	Inhibition	%	3.44
	8222667	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.1	CHEMBL5330	Homo sapiens	Inhibition	%	1.1
	8222785	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	21.76	CHEMBL5330	Homo sapiens	Inhibition	%	21.76
	8223153	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	47.17	CHEMBL5330	Homo sapiens	Inhibition	%	47.17
	8223282	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.6	CHEMBL5330	Homo sapiens	Inhibition	%	1.6
	8223506	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	18.98	CHEMBL5330	Homo sapiens	Inhibition	%	18.98
	8223667	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	3.72	CHEMBL5330	Homo sapiens	Inhibition	%	3.72
	8223917	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	0.86	CHEMBL5330	Homo sapiens	Inhibition	%	0.86
	8224079	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	6.08	CHEMBL5330	Homo sapiens	Inhibition	%	6.08
	8224303	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	3.82	CHEMBL5330	Homo sapiens	Inhibition	%	3.82
	8224473	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.73	CHEMBL5330	Homo sapiens	Inhibition	%	1.73
	8224832	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.18	CHEMBL5330	Homo sapiens	Inhibition	%	1.18
	8224946	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.0	CHEMBL5330	Homo sapiens	Inhibition	%	2.0
	8225304	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.13	CHEMBL5330	Homo sapiens	Inhibition	%	2.13
	8225666	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.19	CHEMBL5330	Homo sapiens	Inhibition	%	2.19
	8225801	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.18	CHEMBL5330	Homo sapiens	Inhibition	%	3.18
	8226183	CHEMBL1962203	GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.83	CHEMBL5330	Homo sapiens	Inhibition	%	3.83
	8226308	CHEMBL1962202	GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.38	CHEMBL5330	Homo sapiens	Inhibition	%	1.38
active	9599295	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	=	Ki	nM	794.33	CHEMBL5330	Homo sapiens	pKi		6.1
inactive	9599296	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9599297	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
inactive	9599298	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9599299	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9599300	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9599301	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	63.1	CHEMBL5330	Homo sapiens	pKi		7.2
active	9599302	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	=	Ki	nM	63.1	CHEMBL5330	Homo sapiens	pKi		7.2
active	9599303	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL1980435	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
inactive	9599304	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9599305	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
inactive	9599306	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9599307	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
active	9599308	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	15.85	CHEMBL5330	Homo sapiens	pKi		7.8
inactive	9599309	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9599310	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9599311	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9599312	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	50.12	CHEMBL5330	Homo sapiens	pKi		7.3
inactive	9599313	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9599314	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9599315	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	79.43	CHEMBL5330	Homo sapiens	pKi		7.1
inactive	9599316	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9599317	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1[nH][nH]c2cccc(-c3ccccc3)c12		CHEMBL1989834	<	Ki	nM	12589.25	CHEMBL5330	Homo sapiens	pKi		4.9
inactive	9599318	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9599319	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	3.162	CHEMBL5330	Homo sapiens	pKi		8.5
inactive	9599320	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9599321	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9599322	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9599323	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9599324	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	39.81	CHEMBL5330	Homo sapiens	pKi		7.4
active	9599325	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	c1ccc(Nc2ncnc3ccccc23)cc1		CHEMBL289959	=	Ki	nM	50118.72	CHEMBL5330	Homo sapiens	pKi		4.3
inactive	9599326	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9599327	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccccc1-c1cccc2c1c(Nc1ccccc1)c(C(=O)O)n2CCCOc1cccc2ccccc12		CHEMBL2001646	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
active	9599328	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9599329	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	19.95	CHEMBL5330	Homo sapiens	pKi		7.7
active	9599330	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	=	Ki	nM	3162.28	CHEMBL5330	Homo sapiens	pKi		5.5
inactive	9599331	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9599332	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9599333	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)CNS(C)(=O)=O		CHEMBL1971172	=	Ki	nM	1000.0	CHEMBL5330	Homo sapiens	pKi		6.0
inactive	9599334	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9599335	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9599336	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9599337	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	=	Ki	nM	251.19	CHEMBL5330	Homo sapiens	pKi		6.6
inactive	9599338	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9599339	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	794.33	CHEMBL5330	Homo sapiens	pKi		6.1
active	9599340	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	=	Ki	nM	12.59	CHEMBL5330	Homo sapiens	pKi		7.9
inactive	9599341	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9599342	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9599343	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1NCc2c1cccc2-c1cccs1		CHEMBL1991782	<	Ki	nM	50118.72	CHEMBL5330	Homo sapiens	pKi		4.3
active	9599344	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1n[nH]c2ncc(Br)cc12		CHEMBL2002105	=	Ki	nM	15848.93	CHEMBL5330	Homo sapiens	pKi		4.8
active	9599345	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
active	9599346	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
inactive	9602906	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9602907	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	15.85	CHEMBL5330	Homo sapiens	pKi		7.8
active	9602908	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncnc2c1C(=O)Nc1ccccc1N2		CHEMBL1980671	=	Ki	nM	100000.0	CHEMBL5330	Homo sapiens	pKi		4.0
inactive	9602909	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9602910	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9602911	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9602912	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9602913	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9602914	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9602915	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
active	9602916	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1983589	=	Ki	nM	158.49	CHEMBL5330	Homo sapiens	pKi		6.8
active	9602917	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	c1ccc2c(c1)Cc1c[nH]nc1-2		CHEMBL1989423	=	Ki	nM	100000.0	CHEMBL5330	Homo sapiens	pKi		4.0
inactive	9602918	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9602919	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	Ki	nM	50.12	CHEMBL5330	Homo sapiens	pKi		7.3
active	9602920	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	=	Ki	nM	1000.0	CHEMBL5330	Homo sapiens	pKi		6.0
active	9602921	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CS(=O)(=O)NCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2005718	=	Ki	nM	251.19	CHEMBL5330	Homo sapiens	pKi		6.6
inactive	9602922	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9602923	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9602924	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=CN(O)C(CS(=O)(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1)c1ccc(O)cc1		CHEMBL1971227	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
active	9602925	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1967998	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
active	9602926	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	=	Ki	nM	125.89	CHEMBL5330	Homo sapiens	pKi		6.9
active	9602927	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9602928	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	5.012	CHEMBL5330	Homo sapiens	pKi		8.3
active	9602929	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	=	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
active	9602930	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(O)c1csc2c1NCCNC2=O		CHEMBL1974875	=	Ki	nM	39810.72	CHEMBL5330	Homo sapiens	pKi		4.4
active	9602931	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	=	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
inactive	9602932	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9602933	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9602934	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9602935	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9602936	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9602937	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	=	Ki	nM	251.19	CHEMBL5330	Homo sapiens	pKi		6.6
inactive	9602938	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9602939	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9602940	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9602941	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1966842	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
inactive	9602942	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9602943	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9602944	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	125.89	CHEMBL5330	Homo sapiens	pKi		6.9
inactive	9602945	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9602946	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9602947	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9602948	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	251.19	CHEMBL5330	Homo sapiens	pKi		6.6
inactive	9602949	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9602950	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9602951	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9602952	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(CN)CNc1cc(-c2c[nH]c3ncccc23)cc(F)n1		CHEMBL1987261	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
inactive	9602953	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9602954	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9602955	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	794.33	CHEMBL5330	Homo sapiens	pKi		6.1
active	9602956	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	=	Ki	nM	794.33	CHEMBL5330	Homo sapiens	pKi		6.1
active	9602957	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	=	Ki	nM	158.49	CHEMBL5330	Homo sapiens	pKi		6.8
inactive	9602958	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9602959	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9602960	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9602961	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	=	Ki	nM	63.1	CHEMBL5330	Homo sapiens	pKi		7.2
active	9602962	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9602963	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1n[nH]c2cccc(-c3ccc(F)cc3)c12		CHEMBL1971519	=	Ki	nM	31622.78	CHEMBL5330	Homo sapiens	pKi		4.5
active	9602964	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
active	9602965	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
active	9602966	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
active	9602967	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
inactive	9602968	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9602969	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9602970	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1nnc(-c2ccccc2)c(C#N)n1		CHEMBL1994808	=	Ki	nM	63095.73	CHEMBL5330	Homo sapiens	pKi		4.2
inactive	9602971	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9602972	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(CN)CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1985723	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
inactive	9602973	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9602974	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	63.1	CHEMBL5330	Homo sapiens	pKi		7.2
inactive	9602975	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9602976	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9602977	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
active	9602978	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	31.62	CHEMBL5330	Homo sapiens	pKi		7.5
inactive	9602979	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9602980	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#Cc1cccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL1977128	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9602981	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9602982	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	125.89	CHEMBL5330	Homo sapiens	pKi		6.9
active	9602983	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9602984	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9602985	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)C1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1965702	=	Ki	nM	794.33	CHEMBL5330	Homo sapiens	pKi		6.1
inactive	9602986	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9602987	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	251.19	CHEMBL5330	Homo sapiens	pKi		6.6
active	9602988	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	=	Ki	nM	3162.28	CHEMBL5330	Homo sapiens	pKi		5.5
inactive	9602989	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9602990	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	=	Ki	nM	1000.0	CHEMBL5330	Homo sapiens	pKi		6.0
inactive	9602991	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9602992	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	=	Ki	nM	1000.0	CHEMBL5330	Homo sapiens	pKi		6.0
active	9602993	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	=	Ki	nM	794.33	CHEMBL5330	Homo sapiens	pKi		6.1
active	9602994	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	=	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9602995	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9602996	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
inactive	9602997	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9602998	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCOn1c2ccc(Cl)cc2c(=O)c2c(C)nn(C)c21		CHEMBL207253	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9602999	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9603000	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC1CCCN1CCc1cc2cc(-c3ccc(OC(F)(F)F)cc3)ccc2[nH]1		CHEMBL1990635	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
active	9603001	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	3162.28	CHEMBL5330	Homo sapiens	pKi		5.5
active	9603002	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9603003	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(N)=O)cc2)n1		CHEMBL1977634	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9603004	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603005	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603006	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)CNC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2006456	=	Ki	nM	199.53	CHEMBL5330	Homo sapiens	pKi		6.7
active	9603007	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
inactive	9603008	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603009	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9603010	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2)c1		CHEMBL1971606	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9603011	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603012	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603013	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
active	9603014	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	125.89	CHEMBL5330	Homo sapiens	pKi		6.9
active	9603015	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	=	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
active	9603016	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	630.96	CHEMBL5330	Homo sapiens	pKi		6.2
inactive	9603017	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9603018	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9603019	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9603020	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
inactive	9603021	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9603022	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1Cl)c1ccccc1F		CHEMBL2001228	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9603023	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1CN=C(c2ccc(F)cc2)c2cn[nH]c2N1		CHEMBL1994056	=	Ki	nM	63095.73	CHEMBL5330	Homo sapiens	pKi		4.2
inactive	9603024	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603025	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
active	9603026	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	=	Ki	nM	15848.93	CHEMBL5330	Homo sapiens	pKi		4.8
inactive	9603027	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9603028	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Ki	nM	79.43	CHEMBL5330	Homo sapiens	pKi		7.1
inactive	9603029	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603030	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	=	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603031	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9603032	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	=	Ki	nM	3162.28	CHEMBL5330	Homo sapiens	pKi		5.5
active	9603033	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	79.43	CHEMBL5330	Homo sapiens	pKi		7.1
inactive	9603034	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603035	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9603036	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
inactive	9603037	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9603038	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9603039	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	=	Ki	nM	630.96	CHEMBL5330	Homo sapiens	pKi		6.2
inactive	9603040	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603041	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
inactive	9603042	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9603043	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	=	Ki	nM	158.49	CHEMBL5330	Homo sapiens	pKi		6.8
active	9603044	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	c1ccc(CNc2nc(Nc3cc(C4CC4)[nH]n3)c3sccc3n2)cc1		CHEMBL1997924	=	Ki	nM	63.1	CHEMBL5330	Homo sapiens	pKi		7.2
inactive	9603045	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603046	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603047	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
inactive	9603048	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603049	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)c1ccccc1		CHEMBL1978267	=	Ki	nM	1000.0	CHEMBL5330	Homo sapiens	pKi		6.0
inactive	9603050	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603051	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603052	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
active	9603053	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1980178	=	Ki	nM	630.96	CHEMBL5330	Homo sapiens	pKi		6.2
inactive	9603054	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603055	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603056	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603057	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603058	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	79.43	CHEMBL5330	Homo sapiens	pKi		7.1
inactive	9603059	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603060	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	199.53	CHEMBL5330	Homo sapiens	pKi		6.7
active	9603061	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9603062	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
active	9603063	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1[nH]c2cc(Br)cnc2[nH]1		CHEMBL1975921	=	Ki	nM	12589.25	CHEMBL5330	Homo sapiens	pKi		4.9
inactive	9603064	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603065	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3ccc(Cl)cc3c(O)c21		CHEMBL117217	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9603066	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603067	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603068	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1[nH]n2ccccc2c1Br		CHEMBL2004033	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9603069	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(CCC(=O)O)(c1ccc(O)c(N)c1)c1ccc(O)c(N)c1		CHEMBL1975923	<	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
inactive	9603070	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9603071	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(O)C1CN(Cc2ccc(OCc3ccccc3)cc2Cl)C1		CHEMBL1987998	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9603072	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603073	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603074	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1cc2ccncc2s1		CHEMBL1971534	=	Ki	nM	10000.0	CHEMBL5330	Homo sapiens	pKi		5.0
inactive	9603075	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
active	9603076	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
active	9603077	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9603078	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1nc2ncc(-c3ccccc3)cn2n1		CHEMBL2002480	=	Ki	nM	79432.82	CHEMBL5330	Homo sapiens	pKi		4.1
active	9603079	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
inactive	9603080	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603081	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603082	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9603083	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9603084	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603085	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
active	9603086	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
inactive	9603087	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603088	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603089	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	100.0	CHEMBL5330	Homo sapiens	pKi		7.0
active	9603090	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	=	Ki	nM	31.62	CHEMBL5330	Homo sapiens	pKi		7.5
inactive	9603091	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(Cl)cc4)c3)c12		CHEMBL1990590	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9603092	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603093	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9603094	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603095	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	OCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1974617	=	Ki	nM	39810.72	CHEMBL5330	Homo sapiens	pKi		4.4
active	9603096	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	199.53	CHEMBL5330	Homo sapiens	pKi		6.7
active	9603097	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(Nc2ncnc(N3CCCc4cc(C)ccc43)n2)cc(OC)c1OC		CHEMBL1992125	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9603098	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	=	Ki	nM	125.89	CHEMBL5330	Homo sapiens	pKi		6.9
active	9603099	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1972290	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
inactive	9603100	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603101	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	=	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603102	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603103	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	39.81	CHEMBL5330	Homo sapiens	pKi		7.4
active	9603104	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	251.19	CHEMBL5330	Homo sapiens	pKi		6.6
active	9603105	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	=	Ki	nM	630.96	CHEMBL5330	Homo sapiens	pKi		6.2
inactive	9603106	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603107	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603108	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603109	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603110	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	5.012	CHEMBL5330	Homo sapiens	pKi		8.3
active	9603111	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cn1cc(Nc2ncc(Cl)c(Nc3ccccc3C(N)=O)n2)cn1		CHEMBL1984548	=	Ki	nM	3.162	CHEMBL5330	Homo sapiens	pKi		8.5
inactive	9603112	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603113	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
inactive	9603114	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603115	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	39.81	CHEMBL5330	Homo sapiens	pKi		7.4
inactive	9603116	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603117	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603118	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	=	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
inactive	9603119	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603120	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603121	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Cc1cccs1)Nc1nc2ccccc2s1		CHEMBL1421720	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
active	9603122	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	=	Ki	nM	199.53	CHEMBL5330	Homo sapiens	pKi		6.7
active	9603123	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9603124	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	=	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
active	9603125	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
active	9603126	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	158.49	CHEMBL5330	Homo sapiens	pKi		6.8
active	9603127	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9603128	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
inactive	9603129	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603130	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
inactive	9603131	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603132	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
inactive	9603133	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603134	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	=	Ki	nM	630.96	CHEMBL5330	Homo sapiens	pKi		6.2
inactive	9603135	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603136	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1[nH]cnc2c(Cl)cccc12		CHEMBL1949855	=	Ki	nM	10000.0	CHEMBL5330	Homo sapiens	pKi		5.0
inactive	9603137	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603138	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9603139	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1972339	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
active	9603140	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
active	9603141	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
active	9603142	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
inactive	9603143	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603144	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9603145	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606711	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(OCc2ccc(Cl)c(Cl)c2)ccc1CN1CC(C(=O)O)C1		CHEMBL1990223	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9606712	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606713	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606714	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	=	Ki	nM	1000.0	CHEMBL5330	Homo sapiens	pKi		6.0
inactive	9606715	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606716	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	=	Ki	nM	3162.28	CHEMBL5330	Homo sapiens	pKi		5.5
active	9606717	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
inactive	9606718	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606719	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	794.33	CHEMBL5330	Homo sapiens	pKi		6.1
inactive	9606720	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(Cl)c1		CHEMBL1983595	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606721	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	79.43	CHEMBL5330	Homo sapiens	pKi		7.1
inactive	9606722	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606723	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	=	Ki	nM	125.89	CHEMBL5330	Homo sapiens	pKi		6.9
active	9606724	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
active	9606725	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	=	Ki	nM	251.19	CHEMBL5330	Homo sapiens	pKi		6.6
inactive	9606726	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606727	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	199.53	CHEMBL5330	Homo sapiens	pKi		6.7
active	9606728	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCOCC2)n1		CHEMBL1980253	=	Ki	nM	199.53	CHEMBL5330	Homo sapiens	pKi		6.7
active	9606729	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Oc1ccc(Cl)cc1C1=NNC(c2ccc3c(c2)OCCO3)C1		CHEMBL1965789	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606730	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
inactive	9606731	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606732	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
active	9606733	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	1000.0	CHEMBL5330	Homo sapiens	pKi		6.0
active	9606734	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606735	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
inactive	9606736	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606737	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	630.96	CHEMBL5330	Homo sapiens	pKi		6.2
active	9606738	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)S(=O)(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2006631	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9606739	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606740	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	=	Ki	nM	3162.28	CHEMBL5330	Homo sapiens	pKi		5.5
inactive	9606741	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606742	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	63.1	CHEMBL5330	Homo sapiens	pKi		7.2
inactive	9606743	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606744	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606745	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606746	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606747	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNCC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1996980	=	Ki	nM	50.12	CHEMBL5330	Homo sapiens	pKi		7.3
active	9606748	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
inactive	9606749	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606750	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cn1cc(Nc2ncc(Br)c(Nc3ccccc3C(N)=O)n2)cn1		CHEMBL1994669	=	Ki	nM	1.995	CHEMBL5330	Homo sapiens	pKi		8.7
inactive	9606751	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606752	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
inactive	9606753	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	31622.78	CHEMBL5330	Homo sapiens	pKi		4.5
active	9606754	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	1000.0	CHEMBL5330	Homo sapiens	pKi		6.0
inactive	9606755	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606756	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	Ki	nM	79.43	CHEMBL5330	Homo sapiens	pKi		7.1
active	9606757	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9606758	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#Cc1ccc2nc(N)n(-c3nccs3)c2c1		CHEMBL1988805	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9606759	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	<	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9606760	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606761	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
inactive	9606762	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606763	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	50.12	CHEMBL5330	Homo sapiens	pKi		7.3
inactive	9606764	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9606765	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9606766	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606767	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	=	Ki	nM	79.43	CHEMBL5330	Homo sapiens	pKi		7.1
inactive	9606768	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606769	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	50.12	CHEMBL5330	Homo sapiens	pKi		7.3
active	9606770	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606771	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
inactive	9606772	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606773	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606774	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606775	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9606776	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606777	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
inactive	9606778	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606779	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
inactive	9606780	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606781	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(O)c1ccccc1Nc1ncnc(Nc2ccc(F)cc2)n1		CHEMBL1992231	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606782	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	39.81	CHEMBL5330	Homo sapiens	pKi		7.4
inactive	9606783	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606784	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606785	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606786	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606787	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
inactive	9606788	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606789	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9606790	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606791	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606792	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
inactive	9606793	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606794	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
inactive	9606795	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606796	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	=	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
active	9606797	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncnc2scc(-c3ccccc3)c12		CHEMBL1975212	=	Ki	nM	25118.86	CHEMBL5330	Homo sapiens	pKi		4.6
active	9606798	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	31622.78	CHEMBL5330	Homo sapiens	pKi		4.5
inactive	9606799	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9606800	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc2[nH]cc(C=C3C(=O)Nc4ccccc43)c2c1		CHEMBL1997275	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606801	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	=	Ki	nM	39.81	CHEMBL5330	Homo sapiens	pKi		7.4
active	9606802	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC1CCCCC1Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL1994438	=	Ki	nM	31.62	CHEMBL5330	Homo sapiens	pKi		7.5
active	9606803	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(-c2cccc3onc(N)c23)c1		CHEMBL1980376	=	Ki	nM	3162.28	CHEMBL5330	Homo sapiens	pKi		5.5
inactive	9606804	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9606805	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(C#N)cc4)c3)c12		CHEMBL2000724	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9606806	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9606807	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606808	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	199.53	CHEMBL5330	Homo sapiens	pKi		6.7
active	9606809	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
active	9606810	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
inactive	9606811	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606812	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606813	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606814	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
inactive	9606815	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9606816	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606817	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
inactive	9606818	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606819	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9606820	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
active	9606821	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	=	Ki	nM	794.33	CHEMBL5330	Homo sapiens	pKi		6.1
active	9606822	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1981133	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
inactive	9606823	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)Oc1cc(Nc2nc(NC(C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2007421	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9606824	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606825	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606826	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9606827	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606828	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1[nH]c2ccc(Cl)cc2c2ncnn12		CHEMBL1992673	=	Ki	nM	63095.73	CHEMBL5330	Homo sapiens	pKi		4.2
active	9606829	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
active	9606830	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
active	9606831	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
inactive	9606832	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606833	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COC(=O)c1c(N)nc2ccccn12		CHEMBL1981492	=	Ki	nM	50118.72	CHEMBL5330	Homo sapiens	pKi		4.3
active	9606834	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
inactive	9606835	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606836	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL2007574	=	Ki	nM	794.33	CHEMBL5330	Homo sapiens	pKi		6.1
active	9606837	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
active	9606838	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9606839	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	=	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
active	9606840	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	=	Ki	nM	39.81	CHEMBL5330	Homo sapiens	pKi		7.4
inactive	9606841	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606842	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)NCCO)c2)n1		CHEMBL1998680	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9606843	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606844	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9606845	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
active	9606846	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	=	Ki	nM	3162.28	CHEMBL5330	Homo sapiens	pKi		5.5
inactive	9606847	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(OC)cc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL2002613	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9606848	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606849	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606850	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606851	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	=	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
inactive	9606852	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606853	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
active	9606854	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
inactive	9606855	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606856	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606857	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	=	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606858	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606859	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606860	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
active	9606861	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	79.43	CHEMBL5330	Homo sapiens	pKi		7.1
active	9606862	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4c(F)cccc4F)c3)nc3sccn23)n1		CHEMBL1997051	=	Ki	nM	794.33	CHEMBL5330	Homo sapiens	pKi		6.1
active	9606863	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1998432	=	Ki	nM	199.53	CHEMBL5330	Homo sapiens	pKi		6.7
active	9606864	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
active	9606865	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	=	Ki	nM	630.96	CHEMBL5330	Homo sapiens	pKi		6.2
inactive	9606866	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606867	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606868	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCC(N)C3)c21		CHEMBL1870106	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606869	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
active	9606870	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
inactive	9606871	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606872	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606873	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	39.81	CHEMBL5330	Homo sapiens	pKi		7.4
active	9606874	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	c1ccc(-c2ccnc3[nH]ccc23)cc1		CHEMBL482538	=	Ki	nM	10000.0	CHEMBL5330	Homo sapiens	pKi		5.0
inactive	9606875	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606876	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606877	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	=	Ki	nM	15.85	CHEMBL5330	Homo sapiens	pKi		7.8
active	9606878	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC1=CN2CC(=O)NN=C2C=C1		CHEMBL1964718	=	Ki	nM	79432.82	CHEMBL5330	Homo sapiens	pKi		4.1
active	9606879	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
inactive	9606880	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606881	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
inactive	9606882	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606883	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
inactive	9606884	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606885	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCOCCO)c2)n1		CHEMBL1978271	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606886	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	=	Ki	nM	1000.0	CHEMBL5330	Homo sapiens	pKi		6.0
inactive	9606887	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9606888	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	3162.28	CHEMBL5330	Homo sapiens	pKi		5.5
inactive	9606889	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(CCC(=O)Nc1cc(C(F)(F)F)ccc1Cl)NN=Cc1c[nH]c2ccccc12		CHEMBL1994308	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606890	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
inactive	9606891	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606892	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
inactive	9606893	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606894	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL1985507	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
active	9606895	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
active	9606896	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	19.95	CHEMBL5330	Homo sapiens	pKi		7.7
active	9606897	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
active	9606898	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(F)c2)n1		CHEMBL243298	=	Ki	nM	79.43	CHEMBL5330	Homo sapiens	pKi		7.1
inactive	9606899	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606900	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606901	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	=	Ki	nM	79.43	CHEMBL5330	Homo sapiens	pKi		7.1
inactive	9606902	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606903	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
active	9606904	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
active	9606905	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
inactive	9606906	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606907	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	=	Ki	nM	630.96	CHEMBL5330	Homo sapiens	pKi		6.2
active	9606908	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9606909	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606910	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccc(F)cc1		CHEMBL1966204	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
inactive	9606911	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606912	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
active	9606913	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	=	Ki	nM	794.33	CHEMBL5330	Homo sapiens	pKi		6.1
active	9606914	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	1000.0	CHEMBL5330	Homo sapiens	pKi		6.0
inactive	9606915	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9606916	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9606917	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606918	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606919	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncc2cccc(-c3ccccc3)n12		CHEMBL1997119	=	Ki	nM	39810.72	CHEMBL5330	Homo sapiens	pKi		4.4
active	9606920	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
active	9606921	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	7.943	CHEMBL5330	Homo sapiens	pKi		8.1
inactive	9606922	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
inactive	9606923	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606924	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL1969483	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606925	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	=	Ki	nM	31.62	CHEMBL5330	Homo sapiens	pKi		7.5
active	9606926	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	c1nc(-c2ccc3c(c2)OCO3)c2cc[nH]c2n1		CHEMBL2004515	=	Ki	nM	39810.72	CHEMBL5330	Homo sapiens	pKi		4.4
active	9606927	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	1000.0	CHEMBL5330	Homo sapiens	pKi		6.0
active	9606928	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	=	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
active	9606929	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
inactive	9606930	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606931	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9606932	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606933	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9606934	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
inactive	9606935	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606936	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606937	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606938	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN(CC)CCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1970290	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
active	9606939	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	251.19	CHEMBL5330	Homo sapiens	pKi		6.6
inactive	9606940	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606941	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	=	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606942	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9606943	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9606944	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	=	Ki	nM	39.81	CHEMBL5330	Homo sapiens	pKi		7.4
active	9606945	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	=	Ki	nM	630.96	CHEMBL5330	Homo sapiens	pKi		6.2
inactive	9606946	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	3162.28	CHEMBL5330	Homo sapiens	pKi		5.5
active	9606947	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
inactive	9606948	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9606949	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9606950	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(NC(=O)N2CCC(c3nc4c(C(N)=O)cccc4[nH]3)CC2)c1		CHEMBL1973363	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9610513	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	79.43	CHEMBL5330	Homo sapiens	pKi		7.1
inactive	9610514	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610515	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
inactive	9610516	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610517	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610518	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610519	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
active	9610520	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
inactive	9610521	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	3162.28	CHEMBL5330	Homo sapiens	pKi		5.5
inactive	9610522	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610523	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610524	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCO)c2)n1		CHEMBL1994977	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610525	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Oc1ccc2nc(-c3ccc(Sc4ccc(-c5nc6ccc(O)cc6[nH]5)cc4)cc3)[nH]c2c1		CHEMBL2001149	=	Ki	nM	794.33	CHEMBL5330	Homo sapiens	pKi		6.1
inactive	9610526	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610527	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccc(Cl)cc1		CHEMBL1987073	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610528	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCOc1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL2000078	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610529	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	=	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
active	9610530	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	7.943	CHEMBL5330	Homo sapiens	pKi		8.1
active	9610531	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	=	Ki	nM	1000.0	CHEMBL5330	Homo sapiens	pKi		6.0
active	9610532	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)CC(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1995712	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
inactive	9610533	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610534	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610535	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610536	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	c1ccc(-c2cccc3nccn23)cc1		CHEMBL1992723	=	Ki	nM	100000.0	CHEMBL5330	Homo sapiens	pKi		4.0
active	9610537	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Cc1ccccc1)Nc1cc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)ccc1Cl		CHEMBL2005482	=	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
active	9610538	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	=	Ki	nM	79.43	CHEMBL5330	Homo sapiens	pKi		7.1
inactive	9610539	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	3162.28	CHEMBL5330	Homo sapiens	pKi		5.5
active	9610540	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1997909	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610541	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610542	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	OCCNc1cc2cc(-c3ccncc3)ccc2cn1		CHEMBL1998435	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610543	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
active	9610544	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	=	Ki	nM	3162.28	CHEMBL5330	Homo sapiens	pKi		5.5
active	9610545	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9610546	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
active	9610547	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	3162.28	CHEMBL5330	Homo sapiens	pKi		5.5
inactive	9610548	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
inactive	9610549	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610550	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	7.943	CHEMBL5330	Homo sapiens	pKi		8.1
active	9610551	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	251.19	CHEMBL5330	Homo sapiens	pKi		6.6
active	9610552	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncnc2c1N=C(c1ccccc1)CCN2		CHEMBL262623	=	Ki	nM	10000.0	CHEMBL5330	Homo sapiens	pKi		5.0
inactive	9610553	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610554	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	=	Ki	nM	630.96	CHEMBL5330	Homo sapiens	pKi		6.2
active	9610555	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1cc(S(=O)(=O)NC(=O)c2ccc(-c3ccc(F)cc3)cc2)ccc1NC1CCCCC1		CHEMBL1996795	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
inactive	9610556	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610557	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
active	9610558	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
active	9610559	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	=	Ki	nM	794.33	CHEMBL5330	Homo sapiens	pKi		6.1
active	9610560	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Ki	nM	125.89	CHEMBL5330	Homo sapiens	pKi		6.9
active	9610561	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(C)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1995211	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
active	9610562	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
active	9610563	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	125.89	CHEMBL5330	Homo sapiens	pKi		6.9
inactive	9610564	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610565	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CS(=O)(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1980562	=	Ki	nM	79.43	CHEMBL5330	Homo sapiens	pKi		7.1
inactive	9610566	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610567	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN1c2cc(N)ccc2-c2ccc(N)cc2C1(O)c1ccccc1		CHEMBL1991818	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
active	9610568	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
active	9610569	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	=	Ki	nM	794.33	CHEMBL5330	Homo sapiens	pKi		6.1
inactive	9610570	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610571	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610572	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610573	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610574	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(O)c1ccccc1Nc1ncnc(Nc2cccc(F)c2)n1		CHEMBL1979933	=	Ki	nM	794.33	CHEMBL5330	Homo sapiens	pKi		6.1
active	9610575	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
inactive	9610576	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610577	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
inactive	9610578	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610579	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(O)c1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL2001641	=	Ki	nM	50118.72	CHEMBL5330	Homo sapiens	pKi		4.3
active	9610580	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	OC1CCCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1976936	=	Ki	nM	79.43	CHEMBL5330	Homo sapiens	pKi		7.1
inactive	9610581	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)s1		CHEMBL1997193	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610582	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610583	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610584	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610585	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610586	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610587	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9610588	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Clc1cc(-c2c[nH]c3ncccc23)ncn1		CHEMBL1972988	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610589	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	=	Ki	nM	100.0	CHEMBL5330	Homo sapiens	pKi		7.0
inactive	9610590	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610591	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Clc1cc2nnc(-c3ccccc3)n2cn1		CHEMBL1998228	=	Ki	nM	12589.25	CHEMBL5330	Homo sapiens	pKi		4.9
active	9610592	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9610593	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	=	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
active	9610594	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	=	Ki	nM	630.96	CHEMBL5330	Homo sapiens	pKi		6.2
inactive	9610595	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610596	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610597	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
active	9610598	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1987448	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
inactive	9610599	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610600	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610601	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
inactive	9610602	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610603	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610604	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610605	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
inactive	9610606	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610607	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610608	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610609	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CS(=O)(=O)NC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2005216	=	Ki	nM	39.81	CHEMBL5330	Homo sapiens	pKi		7.4
inactive	9610610	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610611	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	=	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
active	9610612	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
inactive	9610613	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610614	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(=O)c1ccccc1-c1ncnc2[nH]ccc12		CHEMBL1977931	=	Ki	nM	25118.86	CHEMBL5330	Homo sapiens	pKi		4.6
inactive	9610615	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610616	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610617	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610618	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610619	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	63.1	CHEMBL5330	Homo sapiens	pKi		7.2
active	9610620	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9610621	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4ccc(OC(F)F)cc4)cc3)c12		CHEMBL1972220	=	Ki	nM	19.95	CHEMBL5330	Homo sapiens	pKi		7.7
active	9610622	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	25.12	CHEMBL5330	Homo sapiens	pKi		7.6
active	9610623	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Fc1cccc(CNc2ncnc3[nH]cnc23)c1		CHEMBL2003785	=	Ki	nM	79432.82	CHEMBL5330	Homo sapiens	pKi		4.1
active	9610624	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	63.1	CHEMBL5330	Homo sapiens	pKi		7.2
inactive	9610625	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610626	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610627	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610628	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610629	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCOc1ccccc1-c1cccc(-c2n[nH]c3nc(O)cc(C)c23)c1		CHEMBL1983070	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610630	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610631	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610632	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610633	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610634	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610635	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610636	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
inactive	9610637	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610638	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	=	Ki	nM	630.96	CHEMBL5330	Homo sapiens	pKi		6.2
inactive	9610639	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610640	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610641	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610642	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCOC(=O)c1nc2c(=O)[nH]c3cc([N+](=O)[O-])c(NC(C)=O)cc3n2c1C		CHEMBL1997611	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610643	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
inactive	9610644	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610645	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
active	9610646	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	39.81	CHEMBL5330	Homo sapiens	pKi		7.4
inactive	9610647	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610648	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
active	9610649	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	=	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610650	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9610651	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610652	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610653	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	63.1	CHEMBL5330	Homo sapiens	pKi		7.2
inactive	9610654	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Brc1ccc2cnc(Nc3ccncn3)cc2c1		CHEMBL1984686	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610655	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	=	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610656	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610657	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
inactive	9610658	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610659	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610660	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	=	Ki	nM	3162.28	CHEMBL5330	Homo sapiens	pKi		5.5
inactive	9610661	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610662	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610663	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	5.012	CHEMBL5330	Homo sapiens	pKi		8.3
inactive	9610664	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1992073	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610665	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
inactive	9610666	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610667	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610668	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610669	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncnc2sccc12		CHEMBL1972934	=	Ki	nM	19952.62	CHEMBL5330	Homo sapiens	pKi		4.7
inactive	9610670	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610671	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	=	Ki	nM	251.19	CHEMBL5330	Homo sapiens	pKi		6.6
active	9610672	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	Ki	nM	125.89	CHEMBL5330	Homo sapiens	pKi		6.9
active	9610673	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	=	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
inactive	9610674	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610675	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	125.89	CHEMBL5330	Homo sapiens	pKi		6.9
active	9610676	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCCN4)cc3F)nc12		CHEMBL1089101	=	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610677	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
active	9610678	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	=	Ki	nM	19.95	CHEMBL5330	Homo sapiens	pKi		7.7
active	9610679	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
active	9610680	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
inactive	9610681	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(=O)OCCn1nc(-c2cccc(Br)c2)c2c(C(F)(F)F)cc(=O)[nH]c21		CHEMBL1984847	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610682	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610683	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	=	Ki	nM	100.0	CHEMBL5330	Homo sapiens	pKi		7.0
inactive	9610684	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610685	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4ccccc4)c3)nc3sccn23)n1		CHEMBL1988076	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610686	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	3162.28	CHEMBL5330	Homo sapiens	pKi		5.5
active	9610687	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
active	9610688	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	=	Ki	nM	100.0	CHEMBL5330	Homo sapiens	pKi		7.0
inactive	9610689	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610690	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)c1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1		CHEMBL1992363	=	Ki	nM	39.81	CHEMBL5330	Homo sapiens	pKi		7.4
active	9610691	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9610692	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	=	Ki	nM	794.33	CHEMBL5330	Homo sapiens	pKi		6.1
inactive	9610693	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610694	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610695	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610696	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	=	Ki	nM	794.33	CHEMBL5330	Homo sapiens	pKi		6.1
active	9610697	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	=	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
inactive	9610698	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610699	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)CC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1982271	=	Ki	nM	125.89	CHEMBL5330	Homo sapiens	pKi		6.9
active	9610700	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610701	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610702	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9610703	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610704	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	5.012	CHEMBL5330	Homo sapiens	pKi		8.3
active	9610705	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	=	Ki	nM	1000.0	CHEMBL5330	Homo sapiens	pKi		6.0
active	9610706	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	=	Ki	nM	63.1	CHEMBL5330	Homo sapiens	pKi		7.2
active	9610707	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
inactive	9610708	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610709	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
inactive	9610710	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610711	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610712	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610713	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	10.0	CHEMBL5330	Homo sapiens	pKi		8.0
active	9610714	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	=	Ki	nM	630.96	CHEMBL5330	Homo sapiens	pKi		6.2
active	9610715	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	Ki	nM	1000.0	CHEMBL5330	Homo sapiens	pKi		6.0
inactive	9610716	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610717	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	=	Ki	nM	630.96	CHEMBL5330	Homo sapiens	pKi		6.2
inactive	9610718	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1966175	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610719	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610720	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610721	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610722	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Ki	nM	125.89	CHEMBL5330	Homo sapiens	pKi		6.9
inactive	9610723	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	<	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9610724	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610725	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	c1cc2c(s1)CCc1cn[nH]c1-2		CHEMBL2001539	=	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610726	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(-c2ncnc3[nH]ccc23)ccc1F		CHEMBL1997041	=	Ki	nM	63095.73	CHEMBL5330	Homo sapiens	pKi		4.2
active	9610727	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
active	9610728	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610729	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(O)c1ccccc1Nc1ncnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL1986666	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
active	9610730	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610731	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
inactive	9610732	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9610733	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
active	9610734	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
inactive	9610735	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610736	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610737	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610738	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610739	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610740	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9610741	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
active	9610742	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	79.43	CHEMBL5330	Homo sapiens	pKi		7.1
inactive	9610743	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9610744	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610745	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9610746	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610747	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610748	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
inactive	9610749	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610750	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610751	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9610752	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9614315	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
active	9614316	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9614317	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	630.96	CHEMBL5330	Homo sapiens	pKi		6.2
active	9614318	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1cc2c(Oc3ccc(Cl)cc3)cncc2s1		CHEMBL2002471	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9614319	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614320	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	=	Ki	nM	19.95	CHEMBL5330	Homo sapiens	pKi		7.7
active	9614321	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	251.19	CHEMBL5330	Homo sapiens	pKi		6.6
inactive	9614322	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614323	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#Cc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1		CHEMBL1990162	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9614324	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCNC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1992220	=	Ki	nM	50.12	CHEMBL5330	Homo sapiens	pKi		7.3
active	9614325	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	39.81	CHEMBL5330	Homo sapiens	pKi		7.4
active	9614326	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
inactive	9614327	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	3162.28	CHEMBL5330	Homo sapiens	pKi		5.5
inactive	9614328	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9614329	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614330	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
active	9614331	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
active	9614332	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	79.43	CHEMBL5330	Homo sapiens	pKi		7.1
inactive	9614333	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9614334	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	=	Ki	nM	12.59	CHEMBL5330	Homo sapiens	pKi		7.9
inactive	9614335	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1		CHEMBL1968868	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9614336	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614337	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
active	9614338	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
active	9614339	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	63.1	CHEMBL5330	Homo sapiens	pKi		7.2
active	9614340	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	=	Ki	nM	1000.0	CHEMBL5330	Homo sapiens	pKi		6.0
inactive	9614341	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)Nc1nccc(Nc2ncc(-c3ccccc3)s2)n1		CHEMBL2002432	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9614342	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614343	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CS(=O)(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1987948	=	Ki	nM	630.96	CHEMBL5330	Homo sapiens	pKi		6.2
inactive	9614344	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9614345	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1Cc2cc(-c3ccccc3)cnc2N1		CHEMBL1983630	=	Ki	nM	31622.78	CHEMBL5330	Homo sapiens	pKi		4.5
active	9614346	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
inactive	9614347	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614348	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	1000.0	CHEMBL5330	Homo sapiens	pKi		6.0
active	9614349	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	63.1	CHEMBL5330	Homo sapiens	pKi		7.2
inactive	9614350	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614351	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
active	9614352	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
active	9614353	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	=	Ki	nM	100.0	CHEMBL5330	Homo sapiens	pKi		7.0
active	9614354	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9614355	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
active	9614356	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
active	9614357	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1cc(=O)[nH]n1-c1ccccn1		CHEMBL1995765	=	Ki	nM	10000.0	CHEMBL5330	Homo sapiens	pKi		5.0
inactive	9614358	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9614359	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614360	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
active	9614361	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	=	Ki	nM	1584.89	CHEMBL5330	Homo sapiens	pKi		5.8
active	9614362	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	=	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9614363	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9614364	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9614365	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614366	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
active	9614367	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
active	9614368	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(CN)CNc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL1968930	=	Ki	nM	50.12	CHEMBL5330	Homo sapiens	pKi		7.3
inactive	9614369	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614370	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
inactive	9614371	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9614372	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614373	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(-c2ccc(N)cc2)c2cnoc12		CHEMBL2002450	=	Ki	nM	63095.73	CHEMBL5330	Homo sapiens	pKi		4.2
active	9614374	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
inactive	9614375	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9614376	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9614377	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9614378	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9614379	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614380	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
active	9614381	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
inactive	9614382	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9614383	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9614384	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9614385	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614386	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	=	Ki	nM	25.12	CHEMBL5330	Homo sapiens	pKi		7.6
active	9614387	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	158.49	CHEMBL5330	Homo sapiens	pKi		6.8
active	9614388	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
active	9614389	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	=	Ki	nM	199.53	CHEMBL5330	Homo sapiens	pKi		6.7
inactive	9614390	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9614391	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
inactive	9614392	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9614393	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9614394	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1		CHEMBL1984236	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9614395	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9614396	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	=	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
inactive	9614397	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9614398	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(N3CC4COCC4C3)cc12		CHEMBL2002599	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9614399	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614400	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL1967252	=	Ki	nM	3981.07	CHEMBL5330	Homo sapiens	pKi		5.4
active	9614401	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2004637	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
inactive	9614402	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1		CHEMBL1993374	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9614403	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9614404	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCC(=O)O)c2)n1		CHEMBL1999506	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9614405	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	100.0	CHEMBL5330	Homo sapiens	pKi		7.0
active	9614406	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2005509	=	Ki	nM	50.12	CHEMBL5330	Homo sapiens	pKi		7.3
inactive	9614407	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9614408	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9614409	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614410	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	=	Ki	nM	158.49	CHEMBL5330	Homo sapiens	pKi		6.8
inactive	9614411	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9614412	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9614413	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
active	9614414	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9614415	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9614416	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614417	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
inactive	9614418	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614419	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	=	Ki	nM	63.1	CHEMBL5330	Homo sapiens	pKi		7.2
active	9614420	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	=	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614421	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9614422	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614423	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	=	Ki	nM	3162.28	CHEMBL5330	Homo sapiens	pKi		5.5
active	9614424	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc(CNc2cc(-c3c[nH]c4ncccc34)cc(F)n2)cc1		CHEMBL1986855	=	Ki	nM	15.85	CHEMBL5330	Homo sapiens	pKi		7.8
active	9614425	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9614426	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
active	9614427	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(C)OC(=O)n1cc(-c2cncn2C2CCCCC2)c2ccccc21		CHEMBL1975357	=	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614428	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	=	Ki	nM	501.19	CHEMBL5330	Homo sapiens	pKi		6.3
active	9614429	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	Ki	nM	63.1	CHEMBL5330	Homo sapiens	pKi		7.2
inactive	9614430	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614431	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	3162.28	CHEMBL5330	Homo sapiens	pKi		5.5
active	9614432	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	=	Ki	nM	1995.26	CHEMBL5330	Homo sapiens	pKi		5.7
inactive	9614433	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9614434	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9614435	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	<	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
active	9614436	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	=	Ki	nM	1000.0	CHEMBL5330	Homo sapiens	pKi		6.0
inactive	9614437	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614438	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	=	Ki	nM	1258.93	CHEMBL5330	Homo sapiens	pKi		5.9
active	9614439	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	=	Ki	nM	794.33	CHEMBL5330	Homo sapiens	pKi		6.1
active	9614440	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	7.943	CHEMBL5330	Homo sapiens	pKi		8.1
active	9614441	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	=	Ki	nM	2511.89	CHEMBL5330	Homo sapiens	pKi		5.6
inactive	9614442	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614443	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	=	Ki	nM	25.12	CHEMBL5330	Homo sapiens	pKi		7.6
active	9614444	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	19.95	CHEMBL5330	Homo sapiens	pKi		7.7
inactive	9614445	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	5011.87	CHEMBL5330	Homo sapiens	pKi		5.3
active	9614446	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	=	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9614447	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	<	Ki	nM	5.012	CHEMBL5330	Homo sapiens	pKi		8.3
active	9614448	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	=	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
inactive	9614449	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	<	Ki	nM	6309.57	CHEMBL5330	Homo sapiens	pKi		5.2
active	9614450	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	398.11	CHEMBL5330	Homo sapiens	pKi		6.4
active	9614451	CHEMBL1963772	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K2	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	=	Ki	nM	316.23	CHEMBL5330	Homo sapiens	pKi		6.5
	10839392	CHEMBL2014958	Inhibition of MAP4K2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	75.0	CHEMBL5330	Homo sapiens	INH	%	75.0
	10840367	CHEMBL2016262	Inhibition of GCK assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	45.0	CHEMBL5330	Homo sapiens	Activity	%	45.0
	10840504	CHEMBL2015018	Inhibition of GCK assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	17.0	CHEMBL5330	Homo sapiens	Activity	%	17.0
	10981537	CHEMBL2067609	Inhibition of human GCK at 1 uM	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	>=	Inhibition	%	90.0	CHEMBL5330	Homo sapiens	INH	%	90.0
	10981552	CHEMBL2067594	Inhibition of human GCK	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	=	IC50	nM	60.0	CHEMBL5330	Homo sapiens	IC50	nM	60.0
	12046314	CHEMBL2156644	Inhibition of GCK at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-8.3	CHEMBL5330	Homo sapiens	INH	%	-8.3
	12104323	CHEMBL2175670	Inhibition of human MAP4K2 assessed as residual enzyme activity at 1 uM by Ambit kinome assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cc(F)cc(F)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172315	=	Activity	%	0.35	CHEMBL5330	Homo sapiens	Activity	%	0.35
	12104324	CHEMBL2175670	Inhibition of human MAP4K2 assessed as residual enzyme activity at 1 uM by Ambit kinome assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172308	=	Activity	%	0.05	CHEMBL5330	Homo sapiens	Activity	%	0.05
	12105247	CHEMBL2176249	Binding affinity to human MAP4K2 by Ambit titration assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cc(F)cc(F)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172315	=	Kd	nM	25.0	CHEMBL5330	Homo sapiens	Kd	nM	25.0
	12105248	CHEMBL2176249	Binding affinity to human MAP4K2 by Ambit titration assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172308	=	Kd	nM	11.0	CHEMBL5330	Homo sapiens	Kd	nM	11.0
	12170808	CHEMBL2210332	Inhibition of GCK assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	82.0	CHEMBL5330	Homo sapiens	Activity	%	82.0
	12172109	CHEMBL2213935	Inhibition of GCK assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	89.0	CHEMBL5330	Homo sapiens	Activity	%	89.0
	12172366	CHEMBL2210631	Inhibition of MAP4K2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL5330	Homo sapiens	Activity	%	100.0
	12183858	CHEMBL2211530	Inhibition of MAP4K2	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL5330	Homo sapiens	pIC50		5.0
	12209082	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	113.0	CHEMBL5330	Homo sapiens	Residual Activity	%	113.0
	12209083	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	80.0	CHEMBL5330	Homo sapiens	Residual Activity	%	80.0
	12211924	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	100.0	CHEMBL5330	Homo sapiens	Residual Activity	%	100.0
	12211925	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	93.0	CHEMBL5330	Homo sapiens	Residual Activity	%	93.0
	12211926	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	81.0	CHEMBL5330	Homo sapiens	Residual Activity	%	81.0
	12211927	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	100.0	CHEMBL5330	Homo sapiens	Residual Activity	%	100.0
	12211928	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	7.0	CHEMBL5330	Homo sapiens	Residual Activity	%	7.0
	12211929	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	96.0	CHEMBL5330	Homo sapiens	Residual Activity	%	96.0
	12211930	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	110.0	CHEMBL5330	Homo sapiens	Residual Activity	%	110.0
	12211931	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	86.0	CHEMBL5330	Homo sapiens	Residual Activity	%	86.0
	12211932	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	91.0	CHEMBL5330	Homo sapiens	Residual Activity	%	91.0
	12211933	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	70.0	CHEMBL5330	Homo sapiens	Residual Activity	%	70.0
	12211934	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	77.0	CHEMBL5330	Homo sapiens	Residual Activity	%	77.0
	12211935	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	83.0	CHEMBL5330	Homo sapiens	Residual Activity	%	83.0
	12211936	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	13.0	CHEMBL5330	Homo sapiens	Residual Activity	%	13.0
	12211937	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	89.0	CHEMBL5330	Homo sapiens	Residual Activity	%	89.0
	12211938	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	103.0	CHEMBL5330	Homo sapiens	Residual Activity	%	103.0
	12211939	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	103.0	CHEMBL5330	Homo sapiens	Residual Activity	%	103.0
	12211940	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	81.0	CHEMBL5330	Homo sapiens	Residual Activity	%	81.0
	12211941	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	19.0	CHEMBL5330	Homo sapiens	Residual Activity	%	19.0
	12211942	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	86.0	CHEMBL5330	Homo sapiens	Residual Activity	%	86.0
	12211943	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	81.0	CHEMBL5330	Homo sapiens	Residual Activity	%	81.0
	12211944	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	92.0	CHEMBL5330	Homo sapiens	Residual Activity	%	92.0
	12211945	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	92.0	CHEMBL5330	Homo sapiens	Residual Activity	%	92.0
	12211946	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	98.0	CHEMBL5330	Homo sapiens	Residual Activity	%	98.0
	12211947	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	78.0	CHEMBL5330	Homo sapiens	Residual Activity	%	78.0
	12211948	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	24.0	CHEMBL5330	Homo sapiens	Residual Activity	%	24.0
	12211949	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	52.0	CHEMBL5330	Homo sapiens	Residual Activity	%	52.0
	12211950	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	80.0	CHEMBL5330	Homo sapiens	Residual Activity	%	80.0
	12211951	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	54.0	CHEMBL5330	Homo sapiens	Residual Activity	%	54.0
	12211952	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	43.0	CHEMBL5330	Homo sapiens	Residual Activity	%	43.0
	12211953	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	47.0	CHEMBL5330	Homo sapiens	Residual Activity	%	47.0
	12211954	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	101.0	CHEMBL5330	Homo sapiens	Residual Activity	%	101.0
	12211955	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	91.0	CHEMBL5330	Homo sapiens	Residual Activity	%	91.0
	12211956	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	83.0	CHEMBL5330	Homo sapiens	Residual Activity	%	83.0
	12211957	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	82.0	CHEMBL5330	Homo sapiens	Residual Activity	%	82.0
	12211958	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	78.0	CHEMBL5330	Homo sapiens	Residual Activity	%	78.0
	12211959	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	85.0	CHEMBL5330	Homo sapiens	Residual Activity	%	85.0
	12211960	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	96.0	CHEMBL5330	Homo sapiens	Residual Activity	%	96.0
	12211961	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	24.0	CHEMBL5330	Homo sapiens	Residual Activity	%	24.0
	12211962	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	109.0	CHEMBL5330	Homo sapiens	Residual Activity	%	109.0
	12211963	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	91.0	CHEMBL5330	Homo sapiens	Residual Activity	%	91.0
	12211964	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	2.0	CHEMBL5330	Homo sapiens	Residual Activity	%	2.0
	12211965	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	3.0	CHEMBL5330	Homo sapiens	Residual Activity	%	3.0
	12211966	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	68.0	CHEMBL5330	Homo sapiens	Residual Activity	%	68.0
	12211967	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	86.0	CHEMBL5330	Homo sapiens	Residual Activity	%	86.0
	12211968	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	89.0	CHEMBL5330	Homo sapiens	Residual Activity	%	89.0
	12211969	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	57.0	CHEMBL5330	Homo sapiens	Residual Activity	%	57.0
	12211970	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	107.0	CHEMBL5330	Homo sapiens	Residual Activity	%	107.0
	12211971	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	101.0	CHEMBL5330	Homo sapiens	Residual Activity	%	101.0
	12211972	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	75.0	CHEMBL5330	Homo sapiens	Residual Activity	%	75.0
	12211973	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	87.0	CHEMBL5330	Homo sapiens	Residual Activity	%	87.0
	12211974	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	7.0	CHEMBL5330	Homo sapiens	Residual Activity	%	7.0
	12211975	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	82.0	CHEMBL5330	Homo sapiens	Residual Activity	%	82.0
	12211976	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	97.0	CHEMBL5330	Homo sapiens	Residual Activity	%	97.0
	12211977	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	96.0	CHEMBL5330	Homo sapiens	Residual Activity	%	96.0
	12211978	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	107.0	CHEMBL5330	Homo sapiens	Residual Activity	%	107.0
	12211979	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	93.0	CHEMBL5330	Homo sapiens	Residual Activity	%	93.0
	12211980	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	84.0	CHEMBL5330	Homo sapiens	Residual Activity	%	84.0
	12211981	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	82.0	CHEMBL5330	Homo sapiens	Residual Activity	%	82.0
	12211982	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	46.0	CHEMBL5330	Homo sapiens	Residual Activity	%	46.0
	12211983	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	4.0	CHEMBL5330	Homo sapiens	Residual Activity	%	4.0
	12211984	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	84.0	CHEMBL5330	Homo sapiens	Residual Activity	%	84.0
	12211985	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	95.0	CHEMBL5330	Homo sapiens	Residual Activity	%	95.0
	12211986	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	110.0	CHEMBL5330	Homo sapiens	Residual Activity	%	110.0
	12211987	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	83.0	CHEMBL5330	Homo sapiens	Residual Activity	%	83.0
	12211988	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	92.0	CHEMBL5330	Homo sapiens	Residual Activity	%	92.0
	12211989	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	90.0	CHEMBL5330	Homo sapiens	Residual Activity	%	90.0
	12211990	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	75.0	CHEMBL5330	Homo sapiens	Residual Activity	%	75.0
	12211991	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	101.0	CHEMBL5330	Homo sapiens	Residual Activity	%	101.0
	12211992	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	98.0	CHEMBL5330	Homo sapiens	Residual Activity	%	98.0
	12211993	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	97.0	CHEMBL5330	Homo sapiens	Residual Activity	%	97.0
	12211994	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	75.0	CHEMBL5330	Homo sapiens	Residual Activity	%	75.0
	12211995	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	101.0	CHEMBL5330	Homo sapiens	Residual Activity	%	101.0
	12211996	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	100.0	CHEMBL5330	Homo sapiens	Residual Activity	%	100.0
	12211997	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	33.0	CHEMBL5330	Homo sapiens	Residual Activity	%	33.0
	12211998	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	106.0	CHEMBL5330	Homo sapiens	Residual Activity	%	106.0
	12211999	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	5.0	CHEMBL5330	Homo sapiens	Residual Activity	%	5.0
	12212000	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	96.0	CHEMBL5330	Homo sapiens	Residual Activity	%	96.0
	12212001	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL5330	Homo sapiens	Residual Activity	%	-1.0
	12212002	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	111.0	CHEMBL5330	Homo sapiens	Residual Activity	%	111.0
	12212003	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	33.0	CHEMBL5330	Homo sapiens	Residual Activity	%	33.0
	12212004	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	88.0	CHEMBL5330	Homo sapiens	Residual Activity	%	88.0
	12212005	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	93.0	CHEMBL5330	Homo sapiens	Residual Activity	%	93.0
	12212006	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	5.0	CHEMBL5330	Homo sapiens	Residual Activity	%	5.0
	12212007	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	96.0	CHEMBL5330	Homo sapiens	Residual Activity	%	96.0
	12212008	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	75.0	CHEMBL5330	Homo sapiens	Residual Activity	%	75.0
	12212009	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	104.0	CHEMBL5330	Homo sapiens	Residual Activity	%	104.0
	12212010	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	101.0	CHEMBL5330	Homo sapiens	Residual Activity	%	101.0
	12212011	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	13.0	CHEMBL5330	Homo sapiens	Residual Activity	%	13.0
	12212012	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	90.0	CHEMBL5330	Homo sapiens	Residual Activity	%	90.0
	12212013	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	67.0	CHEMBL5330	Homo sapiens	Residual Activity	%	67.0
	12212014	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	38.0	CHEMBL5330	Homo sapiens	Residual Activity	%	38.0
	12212015	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	89.0	CHEMBL5330	Homo sapiens	Residual Activity	%	89.0
	12212016	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	106.0	CHEMBL5330	Homo sapiens	Residual Activity	%	106.0
	12212017	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	104.0	CHEMBL5330	Homo sapiens	Residual Activity	%	104.0
	12212018	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	88.0	CHEMBL5330	Homo sapiens	Residual Activity	%	88.0
	12212019	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	90.0	CHEMBL5330	Homo sapiens	Residual Activity	%	90.0
	12212020	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	86.0	CHEMBL5330	Homo sapiens	Residual Activity	%	86.0
	12212021	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	82.0	CHEMBL5330	Homo sapiens	Residual Activity	%	82.0
	12212022	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	58.0	CHEMBL5330	Homo sapiens	Residual Activity	%	58.0
	12212023	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL5330	Homo sapiens	Residual Activity	%	0.0
	12212024	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	91.0	CHEMBL5330	Homo sapiens	Residual Activity	%	91.0
	12212025	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	20.0	CHEMBL5330	Homo sapiens	Residual Activity	%	20.0
	12212026	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	2.0	CHEMBL5330	Homo sapiens	Residual Activity	%	2.0
	12212027	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	87.0	CHEMBL5330	Homo sapiens	Residual Activity	%	87.0
	12212028	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	74.0	CHEMBL5330	Homo sapiens	Residual Activity	%	74.0
	12212029	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	75.0	CHEMBL5330	Homo sapiens	Residual Activity	%	75.0
	12212030	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	95.0	CHEMBL5330	Homo sapiens	Residual Activity	%	95.0
	12212031	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	6.0	CHEMBL5330	Homo sapiens	Residual Activity	%	6.0
	12212032	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	99.0	CHEMBL5330	Homo sapiens	Residual Activity	%	99.0
	12212033	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	91.0	CHEMBL5330	Homo sapiens	Residual Activity	%	91.0
	12212034	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	2.0	CHEMBL5330	Homo sapiens	Residual Activity	%	2.0
	12212035	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	88.0	CHEMBL5330	Homo sapiens	Residual Activity	%	88.0
	12212036	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	44.0	CHEMBL5330	Homo sapiens	Residual Activity	%	44.0
	12212037	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	88.0	CHEMBL5330	Homo sapiens	Residual Activity	%	88.0
	12212038	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	25.0	CHEMBL5330	Homo sapiens	Residual Activity	%	25.0
	12212039	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	85.0	CHEMBL5330	Homo sapiens	Residual Activity	%	85.0
	12212040	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	82.0	CHEMBL5330	Homo sapiens	Residual Activity	%	82.0
	12212041	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	102.0	CHEMBL5330	Homo sapiens	Residual Activity	%	102.0
	12212042	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	7.0	CHEMBL5330	Homo sapiens	Residual Activity	%	7.0
	12212043	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	43.0	CHEMBL5330	Homo sapiens	Residual Activity	%	43.0
	12212044	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	35.0	CHEMBL5330	Homo sapiens	Residual Activity	%	35.0
	12212045	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	49.0	CHEMBL5330	Homo sapiens	Residual Activity	%	49.0
	12212046	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	20.0	CHEMBL5330	Homo sapiens	Residual Activity	%	20.0
	12212047	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	95.0	CHEMBL5330	Homo sapiens	Residual Activity	%	95.0
	12212048	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	75.0	CHEMBL5330	Homo sapiens	Residual Activity	%	75.0
	12212049	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	97.0	CHEMBL5330	Homo sapiens	Residual Activity	%	97.0
	12212050	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	22.0	CHEMBL5330	Homo sapiens	Residual Activity	%	22.0
	12212051	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	1.0	CHEMBL5330	Homo sapiens	Residual Activity	%	1.0
	12212052	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	78.0	CHEMBL5330	Homo sapiens	Residual Activity	%	78.0
	12212053	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	83.0	CHEMBL5330	Homo sapiens	Residual Activity	%	83.0
	12212054	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	16.0	CHEMBL5330	Homo sapiens	Residual Activity	%	16.0
	12212055	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	90.0	CHEMBL5330	Homo sapiens	Residual Activity	%	90.0
	12212056	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	42.0	CHEMBL5330	Homo sapiens	Residual Activity	%	42.0
	12212057	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	61.0	CHEMBL5330	Homo sapiens	Residual Activity	%	61.0
	12212058	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	78.0	CHEMBL5330	Homo sapiens	Residual Activity	%	78.0
	12212059	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	33.0	CHEMBL5330	Homo sapiens	Residual Activity	%	33.0
	12212060	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	16.0	CHEMBL5330	Homo sapiens	Residual Activity	%	16.0
	12212061	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	60.0	CHEMBL5330	Homo sapiens	Residual Activity	%	60.0
	12212062	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	69.0	CHEMBL5330	Homo sapiens	Residual Activity	%	69.0
	12212063	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	76.0	CHEMBL5330	Homo sapiens	Residual Activity	%	76.0
	12212064	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	38.0	CHEMBL5330	Homo sapiens	Residual Activity	%	38.0
	12212065	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	10.0	CHEMBL5330	Homo sapiens	Residual Activity	%	10.0
	12212066	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	106.0	CHEMBL5330	Homo sapiens	Residual Activity	%	106.0
	12212067	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	99.0	CHEMBL5330	Homo sapiens	Residual Activity	%	99.0
	12212068	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	67.0	CHEMBL5330	Homo sapiens	Residual Activity	%	67.0
	12212069	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	79.0	CHEMBL5330	Homo sapiens	Residual Activity	%	79.0
	12212070	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	98.0	CHEMBL5330	Homo sapiens	Residual Activity	%	98.0
	12212071	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	104.0	CHEMBL5330	Homo sapiens	Residual Activity	%	104.0
	12212072	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	23.0	CHEMBL5330	Homo sapiens	Residual Activity	%	23.0
	12212073	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	100.0	CHEMBL5330	Homo sapiens	Residual Activity	%	100.0
	12212074	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	103.0	CHEMBL5330	Homo sapiens	Residual Activity	%	103.0
	12212075	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	86.0	CHEMBL5330	Homo sapiens	Residual Activity	%	86.0
	12212076	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	103.0	CHEMBL5330	Homo sapiens	Residual Activity	%	103.0
	12212077	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	72.0	CHEMBL5330	Homo sapiens	Residual Activity	%	72.0
	12212078	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	106.0	CHEMBL5330	Homo sapiens	Residual Activity	%	106.0
	12212079	CHEMBL2219086	Millipore: Percentage of residual kinase activity of GCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	6.0	CHEMBL5330	Homo sapiens	Residual Activity	%	6.0
	12212080	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	91.0	CHEMBL5330	Homo sapiens	Residual Activity	%	91.0
	12212081	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	19.0	CHEMBL5330	Homo sapiens	Residual Activity	%	19.0
	12212082	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	70.0	CHEMBL5330	Homo sapiens	Residual Activity	%	70.0
	12212083	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	77.0	CHEMBL5330	Homo sapiens	Residual Activity	%	77.0
	12212084	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	34.0	CHEMBL5330	Homo sapiens	Residual Activity	%	34.0
	12212085	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	71.0	CHEMBL5330	Homo sapiens	Residual Activity	%	71.0
	12212086	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	1.0	CHEMBL5330	Homo sapiens	Residual Activity	%	1.0
	12212087	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	50.0	CHEMBL5330	Homo sapiens	Residual Activity	%	50.0
	12212088	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	85.0	CHEMBL5330	Homo sapiens	Residual Activity	%	85.0
	12212089	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	70.0	CHEMBL5330	Homo sapiens	Residual Activity	%	70.0
	12212090	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	84.0	CHEMBL5330	Homo sapiens	Residual Activity	%	84.0
	12212091	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	67.0	CHEMBL5330	Homo sapiens	Residual Activity	%	67.0
	12212092	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	69.0	CHEMBL5330	Homo sapiens	Residual Activity	%	69.0
	12212093	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	44.0	CHEMBL5330	Homo sapiens	Residual Activity	%	44.0
	12212094	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	0.0	CHEMBL5330	Homo sapiens	Residual Activity	%	0.0
	12212095	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	77.0	CHEMBL5330	Homo sapiens	Residual Activity	%	77.0
	12212096	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	73.0	CHEMBL5330	Homo sapiens	Residual Activity	%	73.0
	12212097	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	72.0	CHEMBL5330	Homo sapiens	Residual Activity	%	72.0
	12212098	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	81.0	CHEMBL5330	Homo sapiens	Residual Activity	%	81.0
	12212099	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	11.0	CHEMBL5330	Homo sapiens	Residual Activity	%	11.0
	12212100	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	70.0	CHEMBL5330	Homo sapiens	Residual Activity	%	70.0
	12212101	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	71.0	CHEMBL5330	Homo sapiens	Residual Activity	%	71.0
	12212102	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	86.0	CHEMBL5330	Homo sapiens	Residual Activity	%	86.0
	12212103	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	58.0	CHEMBL5330	Homo sapiens	Residual Activity	%	58.0
	12212104	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	87.0	CHEMBL5330	Homo sapiens	Residual Activity	%	87.0
	12212105	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	39.0	CHEMBL5330	Homo sapiens	Residual Activity	%	39.0
	12212106	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	4.0	CHEMBL5330	Homo sapiens	Residual Activity	%	4.0
	12212107	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	18.0	CHEMBL5330	Homo sapiens	Residual Activity	%	18.0
	12212108	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	69.0	CHEMBL5330	Homo sapiens	Residual Activity	%	69.0
	12212109	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	13.0	CHEMBL5330	Homo sapiens	Residual Activity	%	13.0
	12212110	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	27.0	CHEMBL5330	Homo sapiens	Residual Activity	%	27.0
	12212111	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	17.0	CHEMBL5330	Homo sapiens	Residual Activity	%	17.0
	12212112	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	80.0	CHEMBL5330	Homo sapiens	Residual Activity	%	80.0
	12212113	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	86.0	CHEMBL5330	Homo sapiens	Residual Activity	%	86.0
	12212114	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	63.0	CHEMBL5330	Homo sapiens	Residual Activity	%	63.0
	12212115	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	80.0	CHEMBL5330	Homo sapiens	Residual Activity	%	80.0
	12212116	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	44.0	CHEMBL5330	Homo sapiens	Residual Activity	%	44.0
	12212117	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	79.0	CHEMBL5330	Homo sapiens	Residual Activity	%	79.0
	12212118	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	83.0	CHEMBL5330	Homo sapiens	Residual Activity	%	83.0
	12212119	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	42.0	CHEMBL5330	Homo sapiens	Residual Activity	%	42.0
	12212120	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	91.0	CHEMBL5330	Homo sapiens	Residual Activity	%	91.0
	12212121	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	89.0	CHEMBL5330	Homo sapiens	Residual Activity	%	89.0
	12212122	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	1.0	CHEMBL5330	Homo sapiens	Residual Activity	%	1.0
	12212123	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	0.0	CHEMBL5330	Homo sapiens	Residual Activity	%	0.0
	12212124	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	44.0	CHEMBL5330	Homo sapiens	Residual Activity	%	44.0
	12212125	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	50.0	CHEMBL5330	Homo sapiens	Residual Activity	%	50.0
	12212126	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	90.0	CHEMBL5330	Homo sapiens	Residual Activity	%	90.0
	12212127	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	11.0	CHEMBL5330	Homo sapiens	Residual Activity	%	11.0
	12212128	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	92.0	CHEMBL5330	Homo sapiens	Residual Activity	%	92.0
	12212129	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	85.0	CHEMBL5330	Homo sapiens	Residual Activity	%	85.0
	12212130	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	30.0	CHEMBL5330	Homo sapiens	Residual Activity	%	30.0
	12212131	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	54.0	CHEMBL5330	Homo sapiens	Residual Activity	%	54.0
	12212132	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	1.0	CHEMBL5330	Homo sapiens	Residual Activity	%	1.0
	12212133	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	46.0	CHEMBL5330	Homo sapiens	Residual Activity	%	46.0
	12212134	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	85.0	CHEMBL5330	Homo sapiens	Residual Activity	%	85.0
	12212135	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	83.0	CHEMBL5330	Homo sapiens	Residual Activity	%	83.0
	12212136	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	70.0	CHEMBL5330	Homo sapiens	Residual Activity	%	70.0
	12212137	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	82.0	CHEMBL5330	Homo sapiens	Residual Activity	%	82.0
	12212138	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	30.0	CHEMBL5330	Homo sapiens	Residual Activity	%	30.0
	12212139	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	70.0	CHEMBL5330	Homo sapiens	Residual Activity	%	70.0
	12212140	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	14.0	CHEMBL5330	Homo sapiens	Residual Activity	%	14.0
	12212141	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	0.0	CHEMBL5330	Homo sapiens	Residual Activity	%	0.0
	12212142	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	61.0	CHEMBL5330	Homo sapiens	Residual Activity	%	61.0
	12212143	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	89.0	CHEMBL5330	Homo sapiens	Residual Activity	%	89.0
	12212144	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	88.0	CHEMBL5330	Homo sapiens	Residual Activity	%	88.0
	12212145	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	25.0	CHEMBL5330	Homo sapiens	Residual Activity	%	25.0
	12212146	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	81.0	CHEMBL5330	Homo sapiens	Residual Activity	%	81.0
	12212147	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	83.0	CHEMBL5330	Homo sapiens	Residual Activity	%	83.0
	12212148	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	26.0	CHEMBL5330	Homo sapiens	Residual Activity	%	26.0
	12212149	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	77.0	CHEMBL5330	Homo sapiens	Residual Activity	%	77.0
	12212150	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	90.0	CHEMBL5330	Homo sapiens	Residual Activity	%	90.0
	12212151	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	32.0	CHEMBL5330	Homo sapiens	Residual Activity	%	32.0
	12212152	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	22.0	CHEMBL5330	Homo sapiens	Residual Activity	%	22.0
	12212153	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	85.0	CHEMBL5330	Homo sapiens	Residual Activity	%	85.0
	12212154	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	39.0	CHEMBL5330	Homo sapiens	Residual Activity	%	39.0
	12212155	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	9.0	CHEMBL5330	Homo sapiens	Residual Activity	%	9.0
	12212156	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	87.0	CHEMBL5330	Homo sapiens	Residual Activity	%	87.0
	12212157	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	0.0	CHEMBL5330	Homo sapiens	Residual Activity	%	0.0
	12214984	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	90.0	CHEMBL5330	Homo sapiens	Residual Activity	%	90.0
	12214985	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL5330	Homo sapiens	Residual Activity	%	0.0
	12214986	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	101.0	CHEMBL5330	Homo sapiens	Residual Activity	%	101.0
	12214987	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	6.0	CHEMBL5330	Homo sapiens	Residual Activity	%	6.0
	12214988	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	74.0	CHEMBL5330	Homo sapiens	Residual Activity	%	74.0
	12214989	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	88.0	CHEMBL5330	Homo sapiens	Residual Activity	%	88.0
	12214990	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	5.0	CHEMBL5330	Homo sapiens	Residual Activity	%	5.0
	12214991	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	89.0	CHEMBL5330	Homo sapiens	Residual Activity	%	89.0
	12214992	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	56.0	CHEMBL5330	Homo sapiens	Residual Activity	%	56.0
	12214993	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	100.0	CHEMBL5330	Homo sapiens	Residual Activity	%	100.0
	12214994	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	101.0	CHEMBL5330	Homo sapiens	Residual Activity	%	101.0
	12214995	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	1.0	CHEMBL5330	Homo sapiens	Residual Activity	%	1.0
	12214996	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	80.0	CHEMBL5330	Homo sapiens	Residual Activity	%	80.0
	12214997	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	24.0	CHEMBL5330	Homo sapiens	Residual Activity	%	24.0
	12214998	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	6.0	CHEMBL5330	Homo sapiens	Residual Activity	%	6.0
	12214999	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	72.0	CHEMBL5330	Homo sapiens	Residual Activity	%	72.0
	12215000	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	84.0	CHEMBL5330	Homo sapiens	Residual Activity	%	84.0
	12215001	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	83.0	CHEMBL5330	Homo sapiens	Residual Activity	%	83.0
	12215002	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	74.0	CHEMBL5330	Homo sapiens	Residual Activity	%	74.0
	12215003	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	89.0	CHEMBL5330	Homo sapiens	Residual Activity	%	89.0
	12215004	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	76.0	CHEMBL5330	Homo sapiens	Residual Activity	%	76.0
	12215005	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	75.0	CHEMBL5330	Homo sapiens	Residual Activity	%	75.0
	12215006	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	53.0	CHEMBL5330	Homo sapiens	Residual Activity	%	53.0
	12215007	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL5330	Homo sapiens	Residual Activity	%	1.0
	12215008	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	82.0	CHEMBL5330	Homo sapiens	Residual Activity	%	82.0
	12215009	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	10.0	CHEMBL5330	Homo sapiens	Residual Activity	%	10.0
	12215010	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	5.0	CHEMBL5330	Homo sapiens	Residual Activity	%	5.0
	12215011	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	75.0	CHEMBL5330	Homo sapiens	Residual Activity	%	75.0
	12215012	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	55.0	CHEMBL5330	Homo sapiens	Residual Activity	%	55.0
	12215013	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	73.0	CHEMBL5330	Homo sapiens	Residual Activity	%	73.0
	12215014	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	86.0	CHEMBL5330	Homo sapiens	Residual Activity	%	86.0
	12215015	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	-1.0	CHEMBL5330	Homo sapiens	Residual Activity	%	-1.0
	12215016	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	91.0	CHEMBL5330	Homo sapiens	Residual Activity	%	91.0
	12215017	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	77.0	CHEMBL5330	Homo sapiens	Residual Activity	%	77.0
	12215018	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	2.0	CHEMBL5330	Homo sapiens	Residual Activity	%	2.0
	12215019	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	69.0	CHEMBL5330	Homo sapiens	Residual Activity	%	69.0
	12215020	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	10.0	CHEMBL5330	Homo sapiens	Residual Activity	%	10.0
	12215021	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	81.0	CHEMBL5330	Homo sapiens	Residual Activity	%	81.0
	12215022	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	5.0	CHEMBL5330	Homo sapiens	Residual Activity	%	5.0
	12215023	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	81.0	CHEMBL5330	Homo sapiens	Residual Activity	%	81.0
	12215024	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	61.0	CHEMBL5330	Homo sapiens	Residual Activity	%	61.0
	12215025	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	83.0	CHEMBL5330	Homo sapiens	Residual Activity	%	83.0
	12215026	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	4.0	CHEMBL5330	Homo sapiens	Residual Activity	%	4.0
	12215027	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	7.0	CHEMBL5330	Homo sapiens	Residual Activity	%	7.0
	12215028	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	19.0	CHEMBL5330	Homo sapiens	Residual Activity	%	19.0
	12215029	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	35.0	CHEMBL5330	Homo sapiens	Residual Activity	%	35.0
	12215030	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	4.0	CHEMBL5330	Homo sapiens	Residual Activity	%	4.0
	12215031	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	83.0	CHEMBL5330	Homo sapiens	Residual Activity	%	83.0
	12215032	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	23.0	CHEMBL5330	Homo sapiens	Residual Activity	%	23.0
	12215033	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	60.0	CHEMBL5330	Homo sapiens	Residual Activity	%	60.0
	12215034	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	32.0	CHEMBL5330	Homo sapiens	Residual Activity	%	32.0
	12215035	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-1.0	CHEMBL5330	Homo sapiens	Residual Activity	%	-1.0
	12215036	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	78.0	CHEMBL5330	Homo sapiens	Residual Activity	%	78.0
	12215037	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	81.0	CHEMBL5330	Homo sapiens	Residual Activity	%	81.0
	12215038	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	2.0	CHEMBL5330	Homo sapiens	Residual Activity	%	2.0
	12215039	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	89.0	CHEMBL5330	Homo sapiens	Residual Activity	%	89.0
	12215040	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	8.0	CHEMBL5330	Homo sapiens	Residual Activity	%	8.0
	12215041	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	16.0	CHEMBL5330	Homo sapiens	Residual Activity	%	16.0
	12215042	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	37.0	CHEMBL5330	Homo sapiens	Residual Activity	%	37.0
	12215043	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	3.0	CHEMBL5330	Homo sapiens	Residual Activity	%	3.0
	12215044	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	25.0	CHEMBL5330	Homo sapiens	Residual Activity	%	25.0
	12215045	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	19.0	CHEMBL5330	Homo sapiens	Residual Activity	%	19.0
	12215046	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	72.0	CHEMBL5330	Homo sapiens	Residual Activity	%	72.0
	12215047	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	42.0	CHEMBL5330	Homo sapiens	Residual Activity	%	42.0
	12215048	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	21.0	CHEMBL5330	Homo sapiens	Residual Activity	%	21.0
	12215049	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	1.0	CHEMBL5330	Homo sapiens	Residual Activity	%	1.0
	12215050	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	94.0	CHEMBL5330	Homo sapiens	Residual Activity	%	94.0
	12215051	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	70.0	CHEMBL5330	Homo sapiens	Residual Activity	%	70.0
	12215052	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	23.0	CHEMBL5330	Homo sapiens	Residual Activity	%	23.0
	12215053	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	18.0	CHEMBL5330	Homo sapiens	Residual Activity	%	18.0
	12215054	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	49.0	CHEMBL5330	Homo sapiens	Residual Activity	%	49.0
	12215055	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	94.0	CHEMBL5330	Homo sapiens	Residual Activity	%	94.0
	12215056	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	3.0	CHEMBL5330	Homo sapiens	Residual Activity	%	3.0
	12215057	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	72.0	CHEMBL5330	Homo sapiens	Residual Activity	%	72.0
	12215058	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	87.0	CHEMBL5330	Homo sapiens	Residual Activity	%	87.0
	12215059	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	79.0	CHEMBL5330	Homo sapiens	Residual Activity	%	79.0
	12215060	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	90.0	CHEMBL5330	Homo sapiens	Residual Activity	%	90.0
	12215061	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	68.0	CHEMBL5330	Homo sapiens	Residual Activity	%	68.0
	12215062	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	87.0	CHEMBL5330	Homo sapiens	Residual Activity	%	87.0
	12215063	CHEMBL2219087	Millipore: Percentage of residual kinase activity of GCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	3.0	CHEMBL5330	Homo sapiens	Residual Activity	%	3.0
	12673041	CHEMBL2339747	Inhibition of recombinant GCK (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	10.0	CHEMBL5330	Homo sapiens	Activity	%	10.0
	12673042	CHEMBL2339747	Inhibition of recombinant GCK (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	15.0	CHEMBL5330	Homo sapiens	Activity	%	15.0
	12693235	CHEMBL2343921	Inhibition of GCK (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL5330	Homo sapiens	IC50	nM	10000.0
	12728814	CHEMBL2352887	Inhibition of GCK (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	112.0	CHEMBL5330	Homo sapiens	Activity	%	112.0
	12729059	CHEMBL2351965	Inhibition of GCK (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	99.0	CHEMBL5330	Homo sapiens	Activity	%	99.0
	12729758	CHEMBL2349761	Inhibition of GCK (unknown origin) using [gamma-33P]ATP	B	CCc1ccc(-c2ccc3c(c2)-c2c(cnn2CC)S(=O)(=O)N3C)cc1		CHEMBL2333436	>	IC50	nM	10000.0	CHEMBL5330	Homo sapiens	IC50	uM	10.0
	12729759	CHEMBL2349761	Inhibition of GCK (unknown origin) using [gamma-33P]ATP	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	IC50	nM	3000.0	CHEMBL5330	Homo sapiens	IC50	uM	3.0
	12729950	CHEMBL2352186	Inhibition of GCK (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	40.0	CHEMBL5330	Homo sapiens	Activity	%	40.0
	12730202	CHEMBL2352887	Inhibition of GCK (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	93.0	CHEMBL5330	Homo sapiens	Activity	%	93.0
Active	13300197	CHEMBL2384446	Inhibition of human GCK at 1 uM	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687		Inhibition	%		CHEMBL5330	Homo sapiens	INH		
	13352102	CHEMBL2399040	Inhibition of MAP4K2 (unknown origin)	B	Cc1nc(NC(=O)[C@H](C)CC(F)(F)F)sc1-c1ccc(N)nc1		CHEMBL2397314	=	IC50	nM	9700.0	CHEMBL5330	Homo sapiens	IC50	uM	9.7
	13375801	CHEMBL2404312	Inhibition of GCK (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	-5.0	CHEMBL5330	Homo sapiens	INH	%	-5.0
Active	13488442	CHEMBL2439434	Inhibition of human GCK at 1 uM	B	Clc1ccc2ncc(Br)n2n1		CHEMBL2436439		Inhibition	%		CHEMBL5330	Homo sapiens	INH		
Active	13488443	CHEMBL2439434	Inhibition of human GCK at 1 uM	B	CN1CCC(Nc2ccc3ncc(-c4cnn(-c5ccc(C#N)cc5)c4)n3n2)CC1		CHEMBL2436446		Inhibition	%		CHEMBL5330	Homo sapiens	INH		
Active	13488444	CHEMBL2439434	Inhibition of human GCK at 1 uM	B	c1ccc(-n2cc(-c3cnc4ccc(NC5CCNCC5)nn34)cn2)cc1		CHEMBL2436454		Inhibition	%		CHEMBL5330	Homo sapiens	INH		
	13872137	CHEMBL3101762	Inhibition of human GCK assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	102.0	CHEMBL5330	Homo sapiens	Activity	%	102.0
	14648144	CHEMBL3267029	Inhibition of human GCK at 1 uM relative to control	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687	=	Inhibition	%	50.0	CHEMBL5330	Homo sapiens	INH	%	50.0
	14648145	CHEMBL3267029	Inhibition of human GCK at 1 uM relative to control	B	N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1		CHEMBL3264059	<	Inhibition	%	50.0	CHEMBL5330	Homo sapiens	INH	%	50.0
	14980850	CHEMBL3372968	Inhibition of MAP4K2 (unknown origin) in presence of 1 mM ATP	B	CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355482	>	IC50	nM	100000.0	CHEMBL5330	Homo sapiens	IC50	uM	100.0
	15018602	CHEMBL3366826	Inhibition of GCK (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	2.9	CHEMBL5330	Homo sapiens	INH	%	2.9
	15072401	CHEMBL3388087	Inhibition of GCK (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	112.0	CHEMBL5330	Homo sapiens	Activity	%	112.0
	15122479	CHEMBL3367687	Inhibition of human GCK assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3ccc(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331445	=	Activity	%	87.0	CHEMBL5330	Homo sapiens	Activity	%	87.0
	15126958	CHEMBL3367687	Inhibition of human GCK assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3cc(O)c(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331446	=	Activity	%	87.0	CHEMBL5330	Homo sapiens	Activity	%	87.0
	15126990	CHEMBL3367687	Inhibition of human GCK assessed as residual activity at 10 uM by KinaseProfiler assay	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Activity	%	92.0	CHEMBL5330	Homo sapiens	Activity	%	92.0
	15251883	CHEMBL3427819	Inhibition of GCK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	15.0	CHEMBL5330	Homo sapiens	Activity	%	15.0
	15251914	CHEMBL3427819	Inhibition of GCK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	32.0	CHEMBL5330	Homo sapiens	Activity	%	32.0
	15252016	CHEMBL3427819	Inhibition of GCK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	67.0	CHEMBL5330	Homo sapiens	Activity	%	67.0
	15252661	CHEMBL3427819	Inhibition of GCK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	69.0	CHEMBL5330	Homo sapiens	Activity	%	69.0
	15252763	CHEMBL3427819	Inhibition of GCK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	72.0	CHEMBL5330	Homo sapiens	Activity	%	72.0
	15252865	CHEMBL3427819	Inhibition of GCK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	73.0	CHEMBL5330	Homo sapiens	Activity	%	73.0
	15253539	CHEMBL3427819	Inhibition of GCK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	68.0	CHEMBL5330	Homo sapiens	Activity	%	68.0
	15253641	CHEMBL3427819	Inhibition of GCK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	72.0	CHEMBL5330	Homo sapiens	Activity	%	72.0
	15253743	CHEMBL3427819	Inhibition of GCK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	69.0	CHEMBL5330	Homo sapiens	Activity	%	69.0
	15254409	CHEMBL3427819	Inhibition of GCK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	48.0	CHEMBL5330	Homo sapiens	Activity	%	48.0
	15254511	CHEMBL3427819	Inhibition of GCK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	26.0	CHEMBL5330	Homo sapiens	Activity	%	26.0
	15254613	CHEMBL3427819	Inhibition of GCK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	16.0	CHEMBL5330	Homo sapiens	Activity	%	16.0
	15255304	CHEMBL3427819	Inhibition of GCK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	47.0	CHEMBL5330	Homo sapiens	Activity	%	47.0
	15255406	CHEMBL3427819	Inhibition of GCK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	69.0	CHEMBL5330	Homo sapiens	Activity	%	69.0
	15255509	CHEMBL3427819	Inhibition of GCK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	73.0	CHEMBL5330	Homo sapiens	Activity	%	73.0
	15256240	CHEMBL3427819	Inhibition of GCK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	78.0	CHEMBL5330	Homo sapiens	Activity	%	78.0
	16413471	CHEMBL3742709	Inhibition of MAP4K2 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL5330	Homo sapiens	IC50	uM	10.0
	16431843	CHEMBL3748197	Inhibition of human GCK using MBP as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL5330	Homo sapiens	IC50	uM	10.0
	16450855	CHEMBL3762711	Inhibition of GCK (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21	Outside typical range	CHEMBL3758502	=	Inhibition	%	-13.3	CHEMBL5330	Homo sapiens	INH	%	-13.3
	16451719	CHEMBL3762711	Inhibition of GCK (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758602	=	Inhibition	%	6.4	CHEMBL5330	Homo sapiens	INH	%	6.4
	16496005	CHEMBL3779700	Inhibition of N-terminal His6-tagged recombinant human GCK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-18.0	CHEMBL5330	Homo sapiens	Activity	%	-18.0
	16508192	CHEMBL3779700	Inhibition of N-terminal His6-tagged recombinant human GCK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-6.0	CHEMBL5330	Homo sapiens	Activity	%	-6.0
	16509169	CHEMBL3779700	Inhibition of N-terminal His6-tagged recombinant human GCK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-15.0	CHEMBL5330	Homo sapiens	Activity	%	-15.0
	16611846	CHEMBL3816755	Inhibition of human GCK (2 to 812 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-83.0	CHEMBL5330	Homo sapiens	Activity	%	-83.0
	16614486	CHEMBL3816684	Inhibition of human GCK at 1 uM using MBP as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-9.0	CHEMBL5330	Homo sapiens	INH	%	-9.0
	16618208	CHEMBL3816346	Inhibition of full length recombinant human His-tagged GCK expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL5330	Homo sapiens	INH	%	50.0
	16804176	CHEMBL3869767	Inhibition of human recombinant full length His-tagged MAP4K2 expressed in baculovirus expression system at 200 nM by Z'-LYTE assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	Inhibition	%	57.0	CHEMBL5330	Homo sapiens	INH	%	57.0
Inactive	17913509	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913510	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913511	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913512	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913513	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913514	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	=	Kd	nM	110.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	110.0
Inactive	17913515	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913516	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913517	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913518	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913519	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913520	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913521	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	=	Kd	nM	122.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	122.0
Inactive	17913522	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913523	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913524	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913525	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913526	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913527	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	=	Kd	nM	3718.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	3718.0
Inactive	17913528	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913529	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	166.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	166.0
Inactive	17913530	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913531	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913532	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913533	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913534	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913535	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	1356.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	1356.0
Inactive	17913536	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913537	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913538	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913539	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913540	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	244.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	244.0
Active	17913541	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	352.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	352.0
Inactive	17913542	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913543	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913544	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913545	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913546	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Kd	nM	2276.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	2276.0
Inactive	17913547	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913548	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913549	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913550	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	63.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	63.0
Inactive	17913551	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913552	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913553	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913554	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913555	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	=	Kd	nM	1851.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	1851.0
Inactive	17913556	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913557	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913558	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913559	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913560	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913561	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913562	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913563	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913564	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	14043.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	14043.0
Inactive	17913565	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913566	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913567	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913568	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913569	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913570	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913571	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913572	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913573	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913574	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913575	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913576	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913577	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913578	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913579	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913580	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913581	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913582	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913583	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913584	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913585	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913586	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	2280.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	2280.0
Inactive	17913587	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913588	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913589	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913590	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	77.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	77.0
Inactive	17913591	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913592	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913593	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913594	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913595	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913596	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913597	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	922.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	922.0
Active	17913598	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	=	Kd	nM	2822.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	2822.0
Inactive	17913599	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913600	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913601	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	=	Kd	nM	186.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	186.0
Inactive	17913602	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913603	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913604	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913605	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913606	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913607	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913608	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913609	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	1729.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	1729.0
Inactive	17913610	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913611	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913612	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913613	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	Kd	nM	578.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	578.0
Inactive	17913614	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913615	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913616	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913617	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913618	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	50.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	50.0
Active	17913619	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Kd	nM	2075.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	2075.0
Inactive	17913620	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913621	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913622	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913623	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913624	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913625	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913626	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913627	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913628	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Kd	nM	2375.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	2375.0
Inactive	17913629	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913630	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913631	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913632	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913633	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913634	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913635	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913636	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913637	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913638	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913639	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	15891.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	15891.0
Inactive	17913640	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913641	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913642	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913643	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913644	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913645	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913646	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	182.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	182.0
Inactive	17913647	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913648	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	256.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	256.0
Inactive	17913649	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913650	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913651	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913652	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913653	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913654	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	862.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	862.0
Active	17913655	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	41.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	41.0
Inactive	17913656	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913657	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913658	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913659	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	=	Kd	nM	4575.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	4575.0
Inactive	17913660	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913661	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913662	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913663	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913664	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913665	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913666	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913667	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913668	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913669	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913670	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913671	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913672	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913673	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	=	Kd	nM	67.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	67.0
Inactive	17913674	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913675	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913676	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913677	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913678	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913679	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	3172.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	3172.0
Inactive	17913680	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913681	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	1062.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	1062.0
Inactive	17913682	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913683	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913684	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913685	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	=	Kd	nM	3534.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	3534.0
Inactive	17913686	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913687	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913688	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913689	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913690	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913691	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913692	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913693	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	=	Kd	nM	4161.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	4161.0
Inactive	17913694	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913695	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913696	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913697	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913698	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913699	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913700	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913701	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913702	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	131.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	131.0
Inactive	17913703	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913704	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913705	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913706	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913707	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913708	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913709	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913710	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913711	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913712	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Kd	nM	772.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	772.0
Inactive	17913713	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913714	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913715	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913716	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	631.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	631.0
Inactive	17913717	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913718	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Active	17913719	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	=	Kd	nM	1364.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	1364.0
Inactive	17913720	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913721	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913722	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913723	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913724	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913725	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913726	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913727	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913728	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913729	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913730	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913731	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913732	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913733	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913734	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913735	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913736	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913737	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913738	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913739	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913740	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913741	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913742	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913743	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913744	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913745	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913746	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913747	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913748	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913749	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913750	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17913751	CHEMBL3991765	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL5330	Homo sapiens	Kd apparent	nM	30000.0
	18031774	CHEMBL4007724	Inhibition of MAP4K2 (unknown origin) after 60 mins by TR-FRET assay	B	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	IC50	nM	115.0	CHEMBL5330	Homo sapiens	IC50	uM	0.115
	18031775	CHEMBL4007724	Inhibition of MAP4K2 (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12		CHEMBL4078893	=	IC50	nM	1570.0	CHEMBL5330	Homo sapiens	IC50	uM	1.57
	18031776	CHEMBL4007724	Inhibition of MAP4K2 (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12		CHEMBL4066664	=	IC50	nM	4760.0	CHEMBL5330	Homo sapiens	IC50	uM	4.76
	18031777	CHEMBL4007724	Inhibition of MAP4K2 (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	=	IC50	nM	2940.0	CHEMBL5330	Homo sapiens	IC50	uM	2.94
	18031778	CHEMBL4007724	Inhibition of MAP4K2 (unknown origin) after 60 mins by TR-FRET assay	B	Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12		CHEMBL4062803	=	IC50	nM	6240.0	CHEMBL5330	Homo sapiens	IC50	uM	6.24
	18114272	CHEMBL4025222	Inhibition of wild-type human partial length MAP4K2 (M1 to G318 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	94.0	CHEMBL5330	Homo sapiens	Activity	%	94.0
	18178647	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	COc1cccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)c1		CHEMBL4084376	=	Inhibition	%	97.2	CHEMBL5330	Homo sapiens	INH	%	97.2
	18178648	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	COc1ccccc1-c1cc2nccn2c(Nc2ncccc2C(N)=O)n1		CHEMBL4064188	=	Inhibition	%	100.0	CHEMBL5330	Homo sapiens	INH	%	100.0
	18178649	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	=	Inhibition	%	100.0	CHEMBL5330	Homo sapiens	INH	%	100.0
	18178671	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1		CHEMBL4062694	=	Inhibition	%	99.1	CHEMBL5330	Homo sapiens	INH	%	99.1
	18178672	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	NC(=O)c1cccnc1Nc1nc(-c2ccc3c(c2)OCO3)cc2nccn12		CHEMBL4097172	=	Inhibition	%	94.3	CHEMBL5330	Homo sapiens	INH	%	94.3
	18178673	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)c(OC)c1		CHEMBL4069976	=	Inhibition	%	100.0	CHEMBL5330	Homo sapiens	INH	%	100.0
	18178674	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	COc1cc(OC)cc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)c1		CHEMBL4104883	=	Inhibition	%	100.0	CHEMBL5330	Homo sapiens	INH	%	100.0
	18178675	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	CCCOc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1		CHEMBL4080652	=	Inhibition	%	86.0	CHEMBL5330	Homo sapiens	INH	%	86.0
	18178676	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	CCCCOc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1		CHEMBL4067263	=	Inhibition	%	47.0	CHEMBL5330	Homo sapiens	INH	%	47.0
	18178677	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	Cc1ccccc1-c1cc2nccn2c(Nc2ncccc2C(N)=O)n1		CHEMBL4088519	=	Inhibition	%	94.7	CHEMBL5330	Homo sapiens	INH	%	94.7
	18178678	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	Cc1cccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)c1		CHEMBL4078191	=	Inhibition	%	100.0	CHEMBL5330	Homo sapiens	INH	%	100.0
	18178679	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	Cc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1		CHEMBL4096243	=	Inhibition	%	99.2	CHEMBL5330	Homo sapiens	INH	%	99.2
	18178680	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	CNC(=O)c1cccnc1Nc1nc(-c2cccc(OC)c2)cc2nccn12		CHEMBL4086082	=	Inhibition	%	0.0	CHEMBL5330	Homo sapiens	INH	%	0.0
	18178681	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	CNC(=O)c1cccnc1Nc1nc(-c2ccc(OC)cc2)cc2nccn12		CHEMBL4104002	=	Inhibition	%	1.0	CHEMBL5330	Homo sapiens	INH	%	1.0
	18178682	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	CNC(=O)c1cccnc1Nc1nc(-c2ccc(OC)c(OC)c2)cc2nccn12		CHEMBL4084308	=	Inhibition	%	0.0	CHEMBL5330	Homo sapiens	INH	%	0.0
	18178683	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	CNC(=O)c1cccnc1Nc1nc(-c2ccc3c(c2)OCO3)cc2nccn12		CHEMBL4062607	=	Inhibition	%	1.0	CHEMBL5330	Homo sapiens	INH	%	1.0
	18178684	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	NC(=O)c1cccnc1Nc1nc(-c2ccccc2)cc2nccn12		CHEMBL4092062	=	Inhibition	%	99.5	CHEMBL5330	Homo sapiens	INH	%	99.5
	18178685	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	CNC(=O)c1cccnc1Nc1nc(-c2ccccc2)cc2nccn12		CHEMBL4071257	=	Inhibition	%	24.0	CHEMBL5330	Homo sapiens	INH	%	24.0
	18178686	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	CCNC(=O)c1cccnc1Nc1nc(-c2ccccc2)cc2nccn12		CHEMBL4076099	=	Inhibition	%	20.0	CHEMBL5330	Homo sapiens	INH	%	20.0
	18178687	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	CCCNC(=O)c1cccnc1Nc1nc(-c2ccccc2)cc2nccn12		CHEMBL4061788	=	Inhibition	%	16.0	CHEMBL5330	Homo sapiens	INH	%	16.0
	18178688	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	CC(C)NC(=O)c1cccnc1Nc1nc(-c2ccccc2)cc2nccn12		CHEMBL4073982	=	Inhibition	%	0.0	CHEMBL5330	Homo sapiens	INH	%	0.0
	18178689	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	CCCCNC(=O)c1cccnc1Nc1nc(-c2ccccc2)cc2nccn12		CHEMBL4100752	=	Inhibition	%	8.0	CHEMBL5330	Homo sapiens	INH	%	8.0
	18178690	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	CCC(C)NC(=O)c1cccnc1Nc1nc(-c2ccccc2)cc2nccn12		CHEMBL4086425	=	Inhibition	%	29.0	CHEMBL5330	Homo sapiens	INH	%	29.0
	18178691	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	O=C(NCc1ccccc1)c1cccnc1Nc1nc(-c2ccccc2)cc2nccn12		CHEMBL4077621	=	Inhibition	%	2.0	CHEMBL5330	Homo sapiens	INH	%	2.0
	18178692	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	CN(C)C(=O)c1cccnc1Nc1nc(-c2ccccc2)cc2nccn12		CHEMBL4086007	=	Inhibition	%	58.0	CHEMBL5330	Homo sapiens	INH	%	58.0
	18178693	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	COc1ccc(-c2cccc(-c3cc4nccn4c(Nc4ncccc4C(N)=O)n3)c2)cc1		CHEMBL4103925	=	Inhibition	%	84.0	CHEMBL5330	Homo sapiens	INH	%	84.0
	18178694	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	CNC(=O)c1cccnc1Nc1cc(-c2ccccc2)cc2[nH]ccc12		CHEMBL4078116	=	Inhibition	%	29.0	CHEMBL5330	Homo sapiens	INH	%	29.0
	18178695	CHEMBL4039103	Inhibition of human wild type GCK (M1 to G318 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	CNC(=O)c1cccnc1Nc1cc(-c2ccc(OC)cc2)cc2[nH]ccc12		CHEMBL4096171	=	Inhibition	%	2.0	CHEMBL5330	Homo sapiens	INH	%	2.0
	18178696	CHEMBL4039104	Binding affinity to human wild type GCK (M1 to G318 residues) expressed in mammalian expression system by KINOMEScan assay	B	COc1cccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)c1		CHEMBL4084376	=	Kd	nM	59.0	CHEMBL5330	Homo sapiens	Kd	nM	59.0
	18178697	CHEMBL4039104	Binding affinity to human wild type GCK (M1 to G318 residues) expressed in mammalian expression system by KINOMEScan assay	B	NC(=O)c1cccnc1Nc1nc(-c2ccc3c(c2)OCO3)cc2nccn12		CHEMBL4097172	=	Kd	nM	49.0	CHEMBL5330	Homo sapiens	Kd	nM	49.0
	18178698	CHEMBL4039104	Binding affinity to human wild type GCK (M1 to G318 residues) expressed in mammalian expression system by KINOMEScan assay	B	Cc1ccccc1-c1cc2nccn2c(Nc2ncccc2C(N)=O)n1		CHEMBL4088519	=	Kd	nM	100.0	CHEMBL5330	Homo sapiens	Kd	nM	100.0
	18178699	CHEMBL4039104	Binding affinity to human wild type GCK (M1 to G318 residues) expressed in mammalian expression system by KINOMEScan assay	B	COc1ccc(-c2cccc(-c3cc4nccn4c(Nc4ncccc4C(N)=O)n3)c2)cc1		CHEMBL4103925	=	Kd	nM	220.0	CHEMBL5330	Homo sapiens	Kd	nM	220.0
	18203746	CHEMBL4044033	Inhibition of wild-type human partial length MAP4K2 (M1 to G318 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL5330	Homo sapiens	Activity	%	100.0
	18253219	CHEMBL4054893	Inhibition of human GCK (M1 to G318 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by KINOMEscan assay relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	3.6	CHEMBL5330	Homo sapiens	Activity	%	3.6
	18253220	CHEMBL4054893	Inhibition of human GCK (M1 to G318 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by KINOMEscan assay relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	26.0	CHEMBL5330	Homo sapiens	Activity	%	26.0
	18440288	CHEMBL4157112	Binding affinity to wild-type human partial length MAP4K2 (M1 to G318 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	96.0	CHEMBL5330	Homo sapiens	Activity	%	96.0
	18449807	CHEMBL4178044	Inhibition of human GCK (2 to 812 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	133.0	CHEMBL5330	Homo sapiens	Activity	%	133.0
	18484244	CHEMBL4185891	Binding affinity to wild-type human partial length MAP4K2 (M1 to G318 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	92.0	CHEMBL5330	Homo sapiens	Activity	%	92.0
	18484728	CHEMBL4185891	Binding affinity to wild-type human partial length MAP4K2 (M1 to G318 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	97.0	CHEMBL5330	Homo sapiens	Activity	%	97.0
	18507778	CHEMBL4190984	Inhibition of recombinant human GCK (1 to 473 residues) at 1 uM using myelin basic protein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	52.0	CHEMBL5330	Homo sapiens	INH	%	52.0
	18558395	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL1214141	=	IC50	nM	8.0	CHEMBL5330	Homo sapiens	IC50	nM	8.0
	18558396	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(Nc3ccccc3)nc2N(C)C1=O		CHEMBL1214142	=	IC50	nM	47.0	CHEMBL5330	Homo sapiens	IC50	nM	47.0
	18558397	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	CCN1CCN(c2ccc(Nc3ncc4c(n3)N(C)C(=O)N(c3cc(NC(=O)c5cccc(C(F)(F)F)c5)ccc3C)C4)cc2)CC1		CHEMBL4209948	=	IC50	nM	8.0	CHEMBL5330	Homo sapiens	IC50	nM	8.0
	18558398	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	CCN1CCN(c2ccc(Nc3ncc4c(n3)N(C)C(=O)N(c3cc(NC(=O)c5cccc(C(F)(F)F)c5)ccc3C)C4)cn2)CC1		CHEMBL4214863	=	IC50	nM	7.0	CHEMBL5330	Homo sapiens	IC50	nM	7.0
	18558399	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	CC(=O)N1CCN(c2ccc(Nc3ncc4c(n3)N(C)C(=O)N(c3cc(NC(=O)c5cccc(C(F)(F)F)c5)ccc3C)C4)cn2)CC1		CHEMBL4214342	=	IC50	nM	1.0	CHEMBL5330	Homo sapiens	IC50	nM	1.0
	18558400	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	CCN1CCN(C(=O)c2ccc(Nc3ncc4c(n3)N(C)C(=O)N(c3cc(NC(=O)c5cccc(C(F)(F)F)c5)ccc3C)C4)cn2)CC1		CHEMBL4202685	=	IC50	nM	2.0	CHEMBL5330	Homo sapiens	IC50	nM	2.0
	18558401	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(Nc3cnn(C)c3)nc2N(C)C1=O		CHEMBL4217421	=	IC50	nM	6.0	CHEMBL5330	Homo sapiens	IC50	nM	6.0
	18558402	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1cc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)n(C)n1		CHEMBL4213673	=	IC50	nM	5.0	CHEMBL5330	Homo sapiens	IC50	nM	5.0
	18558403	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(NC3CC3)nc2N(C)C1=O		CHEMBL4210482	=	IC50	nM	42.0	CHEMBL5330	Homo sapiens	IC50	nM	42.0
	18558404	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(NC3CCCCC3)nc2N(C)C1=O		CHEMBL4211395	=	IC50	nM	925.0	CHEMBL5330	Homo sapiens	IC50	nM	925.0
	18558405	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(NCCO)nc2N(C)C1=O		CHEMBL4215989	=	IC50	nM	33.0	CHEMBL5330	Homo sapiens	IC50	nM	33.0
	18558406	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	IC50	nM	28.0	CHEMBL5330	Homo sapiens	IC50	nM	28.0
	18558407	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4ccccc4)ccc2C)C3)cn1		CHEMBL4209082	=	IC50	nM	1080.0	CHEMBL5330	Homo sapiens	IC50	nM	1080.0
	18558408	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4ccc(C)c(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL4212809	=	IC50	nM	39.0	CHEMBL5330	Homo sapiens	IC50	nM	39.0
	18558409	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cc(N5CCOCC5)cc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL4218831	=	IC50	nM	45.0	CHEMBL5330	Homo sapiens	IC50	nM	45.0
	18558410	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cc(N5CCC(O)CC5)cc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL4205942	=	IC50	nM	72.0	CHEMBL5330	Homo sapiens	IC50	nM	72.0
	18558411	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL4211880	=	IC50	nM	27.0	CHEMBL5330	Homo sapiens	IC50	nM	27.0
	18558412	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4ccc(-n5cccc5)c(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL4212150	=	IC50	nM	24.0	CHEMBL5330	Homo sapiens	IC50	nM	24.0
	18558413	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4ccc(N5CCN(C)CC5)c(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL4211976	=	IC50	nM	10.0	CHEMBL5330	Homo sapiens	IC50	nM	10.0
	18558414	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4ccc(CN5CCN(C)CC5)c(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL4207100	=	IC50	nM	5.0	CHEMBL5330	Homo sapiens	IC50	nM	5.0
	18558415	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL4207036	=	IC50	nM	2.0	CHEMBL5330	Homo sapiens	IC50	nM	2.0
	18558416	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	CCN1C(=O)N(c2cc(NC(=O)c3ccc(C)c(C(F)(F)F)c3)ccc2C)Cc2cnc(Nc3ccc(C)nc3)nc21		CHEMBL4203337	=	IC50	nM	34.0	CHEMBL5330	Homo sapiens	IC50	nM	34.0
	18558417	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(Nc2ncc3c(n2)N(C2CC2)C(=O)N(c2cc(NC(=O)c4ccc(C)c(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL4213945	=	IC50	nM	63.0	CHEMBL5330	Homo sapiens	IC50	nM	63.0
	18558418	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(Nc2ncc3c(n2)N(C2CCCCC2)C(=O)N(c2cc(NC(=O)c4ccc(C)c(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL4210185	=	IC50	nM	497.0	CHEMBL5330	Homo sapiens	IC50	nM	497.0
	18558419	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(Nc2ncc3c(n2)N(c2ccccc2)C(=O)N(c2cc(NC(=O)c4ccc(C)c(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL4215916	=	IC50	nM	55.0	CHEMBL5330	Homo sapiens	IC50	nM	55.0
	18558420	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(Nc2ncc3c(n2)N(Cc2ccccc2)C(=O)N(c2cc(NC(=O)c4ccc(C)c(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL4206139	=	IC50	nM	165.0	CHEMBL5330	Homo sapiens	IC50	nM	165.0
	18558421	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	CC(=O)N1CCN(c2ccc(Nc3ncc4c(n3)N(C)C(=O)N(c3cc(NC(=O)c5ccc(CN6CCC(N(C)C)C6)c(C(F)(F)F)c5)ccc3C)C4)cn2)CC1		CHEMBL4216786	=	IC50	nM	16.0	CHEMBL5330	Homo sapiens	IC50	nM	16.0
	18558422	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	CCN1CCN(C(=O)c2ccc(Nc3ncc4c(n3)N(C)C(=O)N(c3cc(NC(=O)c5ccc(CN6CCC(N(C)C)C6)c(C(F)(F)F)c5)ccc3C)C4)cn2)CC1		CHEMBL4213019	=	IC50	nM	14.0	CHEMBL5330	Homo sapiens	IC50	nM	14.0
	18558423	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCC(N(C)C)C3)c(C(F)(F)F)c2)cc1N1Cc2cnc(Nc3cnn(C)c3)nc2N(C)C1=O		CHEMBL4207753	=	IC50	nM	8.0	CHEMBL5330	Homo sapiens	IC50	nM	8.0
	18558424	CHEMBL4201009	Inhibition of GCK (unknown origin) by radiometric biochemical kinase assay	B	Cc1cc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc2C)C3)n(C)n1		CHEMBL4212663	=	IC50	nM	17.0	CHEMBL5330	Homo sapiens	IC50	nM	17.0
Active	18558614	CHEMBL4201034	Inhibition of GCK in human OCI-AML3 cells harboring NRAS Q61L mutant assessed as reduction in JNK phosphorylation at T183/Y185 at 1 uM after 2 hrs by Western blot analysis	B	CCN1CCN(C(=O)c2ccc(Nc3ncc4c(n3)N(C)C(=O)N(c3cc(NC(=O)c5cccc(C(F)(F)F)c5)ccc3C)C4)cn2)CC1		CHEMBL4202685		Inhibition	%		CHEMBL5330	Homo sapiens	INH		
Active	18558615	CHEMBL4201034	Inhibition of GCK in human OCI-AML3 cells harboring NRAS Q61L mutant assessed as reduction in JNK phosphorylation at T183/Y185 at 1 uM after 2 hrs by Western blot analysis	B	Cc1cc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)n(C)n1		CHEMBL4213673		Inhibition	%		CHEMBL5330	Homo sapiens	INH		
Active	18558616	CHEMBL4201034	Inhibition of GCK in human OCI-AML3 cells harboring NRAS Q61L mutant assessed as reduction in JNK phosphorylation at T183/Y185 at 1 uM after 2 hrs by Western blot analysis	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850		Inhibition	%		CHEMBL5330	Homo sapiens	INH		
Active	18558617	CHEMBL4201034	Inhibition of GCK in human OCI-AML3 cells harboring NRAS Q61L mutant assessed as reduction in JNK phosphorylation at T183/Y185 at 1 uM after 2 hrs by Western blot analysis	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL4207036		Inhibition	%		CHEMBL5330	Homo sapiens	INH		
Active	18558618	CHEMBL4201035	Inhibition of GCK in human OCI-AML3 cells harboring NRAS Q61L mutant assessed as reduction in p38 phosphorylation at Thr180/Tyr182 at 1 uM after 2 hrs by Western blot analysis	B	CCN1CCN(C(=O)c2ccc(Nc3ncc4c(n3)N(C)C(=O)N(c3cc(NC(=O)c5cccc(C(F)(F)F)c5)ccc3C)C4)cn2)CC1		CHEMBL4202685		Inhibition	%		CHEMBL5330	Homo sapiens	INH		
Active	18558619	CHEMBL4201035	Inhibition of GCK in human OCI-AML3 cells harboring NRAS Q61L mutant assessed as reduction in p38 phosphorylation at Thr180/Tyr182 at 1 uM after 2 hrs by Western blot analysis	B	Cc1cc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)n(C)n1		CHEMBL4213673		Inhibition	%		CHEMBL5330	Homo sapiens	INH		
Active	18558620	CHEMBL4201035	Inhibition of GCK in human OCI-AML3 cells harboring NRAS Q61L mutant assessed as reduction in p38 phosphorylation at Thr180/Tyr182 at 1 uM after 2 hrs by Western blot analysis	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850		Inhibition	%		CHEMBL5330	Homo sapiens	INH		
Active	18558621	CHEMBL4201035	Inhibition of GCK in human OCI-AML3 cells harboring NRAS Q61L mutant assessed as reduction in p38 phosphorylation at Thr180/Tyr182 at 1 uM after 2 hrs by Western blot analysis	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL4207036		Inhibition	%		CHEMBL5330	Homo sapiens	INH		
Dose-dependent effect	18558626	CHEMBL4201038	Inhibition of GCK in human OCI-AML3 cells harboring NRAS Q61L mutant assessed as reduction in p38 phosphorylation at Thr180/Tyr182 after 2 hrs by Western blot analysis	B	CC(=O)N1CCN(c2ccc(Nc3ncc4c(n3)N(C)C(=O)N(c3cc(NC(=O)c5cccc(C(F)(F)F)c5)ccc3C)C4)cn2)CC1		CHEMBL4214342		Inhibition	%		CHEMBL5330	Homo sapiens	INH		
Dose-dependent effect	18558627	CHEMBL4201038	Inhibition of GCK in human OCI-AML3 cells harboring NRAS Q61L mutant assessed as reduction in p38 phosphorylation at Thr180/Tyr182 after 2 hrs by Western blot analysis	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850		Inhibition	%		CHEMBL5330	Homo sapiens	INH		
	18558674	CHEMBL4201077	Inhibition of human GCK at 1 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	Inhibition	%	93.8	CHEMBL5330	Homo sapiens	INH	%	93.8
	18568728	CHEMBL4220241	Inhibition of MAP4K2 (unknown origin) at 2 uM relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4076837	=	Inhibition	%	69.0	CHEMBL5330	Homo sapiens	INH	%	69.0
	18653547	CHEMBL4230130	Inhibition of MAP4K2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	67.0	CHEMBL5330	Homo sapiens	INH	%	67.0
	18653548	CHEMBL4230130	Inhibition of MAP4K2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	24.0	CHEMBL5330	Homo sapiens	INH	%	24.0
	18655444	CHEMBL4230791	Binding affinity to wild-type human partial length MAP4K2 (M1 to G318 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL5330	Homo sapiens	Activity	%	100.0
	18665417	CHEMBL4233330	Inhibition of GCK (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	2500.0	CHEMBL5330	Homo sapiens	IC50	nM	2500.0
	18665485	CHEMBL4233330	Inhibition of GCK (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4251324	>	IC50	nM	5000.0	CHEMBL5330	Homo sapiens	IC50	nM	5000.0
	18725393	CHEMBL4259090	Inhibition of MAP4K2 (unknown origin)	B	CC(=O)n1nc(C)c(-c2ccc(Cl)c(Cl)c2)c1N		CHEMBL4276946	>	IC50	nM	100000.0	CHEMBL5330	Homo sapiens	IC50	uM	100.0
	18737822	CHEMBL4261417	Inhibition of recombinant human GCK (1 to 473 residues) using myelin basic protein as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	IC50	nM	387.0	CHEMBL5330	Homo sapiens	IC50	nM	387.0
	18751030	CHEMBL4263848	Inhibition of MAP4K2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	23.0	CHEMBL5330	Homo sapiens	INH	%	23.0
	18752017	CHEMBL4264380	Binding affinity to wild-type human partial length MAP4K2 (M1 to G318 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	56.0	CHEMBL5330	Homo sapiens	Activity	%	56.0
	18764626	CHEMBL4267111	Inhibition of human GCK at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL5330	Homo sapiens	INH	%	70.0
	18764627	CHEMBL4267111	Inhibition of human GCK at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL5330	Homo sapiens	INH	%	70.0
	18764628	CHEMBL4267111	Inhibition of human GCK at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL5330	Homo sapiens	INH	%	70.0
	18765603	CHEMBL4267279	Inhibition of human N-terminal GST-tagged full length MAP4K2 (1 to 820 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(Nc3cc(OC)ccc3OC)ncn2)c1		CHEMBL4288300	=	Inhibition	%	5.4	CHEMBL5330	Homo sapiens	INH	%	5.4
	18765604	CHEMBL4267279	Inhibition of human N-terminal GST-tagged full length MAP4K2 (1 to 820 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(Nc2cc(NC(=O)c3ccccc3)ncn2)cc1		CHEMBL4283823	=	Inhibition	%	-3.2	CHEMBL5330	Homo sapiens	INH	%	-3.2
	18765605	CHEMBL4267279	Inhibition of human N-terminal GST-tagged full length MAP4K2 (1 to 820 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(Nc2cccc(Cl)c2)ncn1		CHEMBL4282460	=	Inhibition	%	9.2	CHEMBL5330	Homo sapiens	INH	%	9.2
	18765606	CHEMBL4267279	Inhibition of human N-terminal GST-tagged full length MAP4K2 (1 to 820 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)c1ccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)cc1		CHEMBL4290750	=	Inhibition	%	5.5	CHEMBL5330	Homo sapiens	INH	%	5.5
	18765607	CHEMBL4267279	Inhibition of human N-terminal GST-tagged full length MAP4K2 (1 to 820 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)c1		CHEMBL4294156	=	Inhibition	%	10.5	CHEMBL5330	Homo sapiens	INH	%	10.5
	18765608	CHEMBL4267279	Inhibition of human N-terminal GST-tagged full length MAP4K2 (1 to 820 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(N2CCOCC2)ncn1		CHEMBL4283970	=	Inhibition	%	3.3	CHEMBL5330	Homo sapiens	INH	%	3.3
	18858044	CHEMBL4307890	Binding affinity to wild-type human partial length MAP4K2 (M1 to G318 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	85.0	CHEMBL5330	Homo sapiens	Activity	%	85.0
	18892874	CHEMBL4314840	Inhibition of recombinant human GCK assessed as residual activity at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	100.5	CHEMBL5330	Homo sapiens	Activity	%	100.5
	18919468	CHEMBL4322824	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged MAP4K2 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	6.0	CHEMBL5330	Homo sapiens	Kd	nM	6.0
	18919656	CHEMBL4322824	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged MAP4K2 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	7.0	CHEMBL5330	Homo sapiens	Kd	nM	7.0
	18958955	CHEMBL4333477	Binding affinity to wild-type human partial length MAP4K2 (M1 to G318 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL5330	Homo sapiens	Activity	%	100.0
	18964317	CHEMBL4335096	Inhibition of recombinant human GCK (1 to 473 residues) assessed as residual activity at 1 uM using myelin basic protein as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	81.0	CHEMBL5330	Homo sapiens	Activity	%	81.0
	18964318	CHEMBL4335096	Inhibition of recombinant human GCK (1 to 473 residues) assessed as residual activity at 1 uM using myelin basic protein as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	89.0	CHEMBL5330	Homo sapiens	Activity	%	89.0
	18971913	CHEMBL4336923	Inhibition of recombinant human GCK (1 to 473 residues) assessed as residual activity at 10 uM using myelin basic protein as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	75.0	CHEMBL5330	Homo sapiens	Activity	%	75.0
	18976010	CHEMBL4338193	Inhibition of GCK (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3oc(-c4ccc[nH]4)nc3I)c12		CHEMBL4555884	>	IC50	nM	10000.0	CHEMBL5330	Homo sapiens	IC50	uM	10.0
	18976011	CHEMBL4338193	Inhibition of GCK (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3cnc(-c4ccc(Br)[nH]4)o3)c12		CHEMBL4475097	>	IC50	nM	10000.0	CHEMBL5330	Homo sapiens	IC50	uM	10.0
	18976012	CHEMBL4338193	Inhibition of GCK (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	IC50	nM	600.0	CHEMBL5330	Homo sapiens	IC50	uM	0.6
	18976013	CHEMBL4338193	Inhibition of GCK (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3cnc(-c4ccc[nH]4)o3)c12		CHEMBL4446434	=	IC50	nM	1200.0	CHEMBL5330	Homo sapiens	IC50	uM	1.2
	18976014	CHEMBL4338193	Inhibition of GCK (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3cnc(-c4cc(Br)c[nH]4)o3)c12		CHEMBL4476426	>	IC50	nM	10000.0	CHEMBL5330	Homo sapiens	IC50	uM	10.0
	18976015	CHEMBL4338193	Inhibition of GCK (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]c(I)c(-c3cnc(-c4ccc[nH]4)o3)c12		CHEMBL4548361	=	IC50	nM	40000.0	CHEMBL5330	Homo sapiens	IC50	uM	40.0
	18976056	CHEMBL4338204	Inhibition of GCK (unknown origin) assessed as residual enzyme activity at 50 uM by [33P]-ATP filter binding kinase assay relative to control	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	Activity	%	7.0	CHEMBL5330	Homo sapiens	Activity	%	7.0
	18976065	CHEMBL4338213	Inhibition of GCK (unknown origin) assessed as residual enzyme activity at 1 uM by [33P]-ATP filter binding kinase assay relative to control	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	Activity	%	31.0	CHEMBL5330	Homo sapiens	Activity	%	31.0
	18976082	CHEMBL4338229	Binding affinity to wild-type human partial length GCK (M1 to G318 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by active-site directed competition binding assay based Kinomescan method relative to control	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	Activity	%	72.0	CHEMBL5330	Homo sapiens	Activity	%	72.0
	19021500	CHEMBL4347721	Inhibition of recombinant human GCK at 20 nM using Ulight-FLGFTYVAP as substrate measured after 60 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	-5.0	CHEMBL5330	Homo sapiens	INH	%	-5.0
	19021501	CHEMBL4347722	Inhibition of recombinant human GCK at 200 nM using Ulight-FLGFTYVAP as substrate measured after 60 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	26.0	CHEMBL5330	Homo sapiens	INH	%	26.0
Not Active	19039768	CHEMBL4351874	Inhibition of recombinant human GCK at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5330	Homo sapiens	INH		
	19059668	CHEMBL4357969	Binding affinity to wild-type human partial length MAP4K2 (M1 to G318 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL5330	Homo sapiens	Activity	%	100.0
	19090233	CHEMBL4365807	Inhibition of wild-type human partial length MAP4K2 (M1 to G318 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	27.0	CHEMBL5330	Homo sapiens	Activity	%	27.0
	19091939	CHEMBL4366413	Inhibition of human GCK at 100 nM using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	1.33	CHEMBL5330	Homo sapiens	INH	%	1.33
	19144854	CHEMBL4377870	Inhibition of recombinant human GCK (1 to 473 residues) at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	81.0	CHEMBL5330	Homo sapiens	INH	%	81.0
	19146942	CHEMBL4378850	Inhibition of recombinant human GCK (1 to 473 residues) at 10 uM using myelin basic protein as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1	Outside typical range	CHEMBL4459587	=	Inhibition	%	-20.0	CHEMBL5330	Homo sapiens	INH	%	-20.0
	19159496	CHEMBL4382600	Binding affinity to wild-type human partial length MAP4K2 (M1 to G318 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	77.0	CHEMBL5330	Homo sapiens	Activity	%	77.0
	19191511	CHEMBL4389319	Inhibition of wild-type human partial length MAP4K2 (M1 to G318 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	61.0	CHEMBL5330	Homo sapiens	INH	%	61.0
	19191982	CHEMBL4389796	Inhibition of wild-type human partial length MAP4K2 (M1 to G318 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	82.0	CHEMBL5330	Homo sapiens	INH	%	82.0
	19200238	CHEMBL4391422	Binding affinity to wild-type human partial length MAP4K2 (M1 to G318 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	9.2	CHEMBL5330	Homo sapiens	Activity	%	9.2
	19266435	CHEMBL4405385	Inhibition of wild-type human partial length MAP4K2 (M1 to G318 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5330	Homo sapiens	INH	%	50.0
	20600575	CHEMBL4603527	Inhibition of recombinant full length human HIs-tagged MAP4K2 expressed in baculovirus expression system using serine/threonine-7 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL5330	Homo sapiens	IC50	uM	100.0
	22455692	CHEMBL4681972	Inhibition of MAP4K2 human PBMC lysates at 1 uM by ActivX screen assay relative to control	B	CC(C)(Oc1ccc(-c2cnc(N)c(-c3ccc(Cl)cc3)c2)cc1)C(=O)O		CHEMBL4746566	>	Inhibition	%	70.0	CHEMBL5330	Homo sapiens	INH	%	70.0
	22844720	CHEMBL4721395	Inhibition of wild-type human partial length MAP4K2 (M1 to G318 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	90.22	CHEMBL5330	Homo sapiens	Activity	%	90.22
Not Active	22936047	CHEMBL4739744	Inhibition of human MAP4K2 at 1 uM using substrate peptide by off-chip mobility shift assay	B	CC(=O)c1ccc(C(N)=O)cc1Oc1ccc(OCCOC2CCOCC2)cc1		CHEMBL4749965		Inhibition	%		CHEMBL5330	Homo sapiens	INH		
	22952848	CHEMBL4766785	Inhibition of recombinant human GCK (1 to 473 residues) assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	43.0	CHEMBL5330	Homo sapiens	Activity	%	43.0
	23122654	CHEMBL4805005	Inhibition of human MAP4K2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	29.0	CHEMBL5330	Homo sapiens	Activity	%	29.0
	23122884	CHEMBL4805235	Inhibition of human MAP4K2 at 2000 nM by KINOMEscan assay	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	>	Inhibition	%	65.0	CHEMBL5330	Homo sapiens	INH	%	65.0
	23122892	CHEMBL4805240	Inhibition of human MAP4K2 by DiscoverX assay	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Kd	nM	940.0	CHEMBL5330	Homo sapiens	Kd	nM	940.0
	23122893	CHEMBL4805240	Inhibition of human MAP4K2 by DiscoverX assay	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4076837	=	Kd	nM	570.0	CHEMBL5330	Homo sapiens	Kd	nM	570.0
	23123349	CHEMBL4805593	Inhibition of human MAP4K2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	87.0	CHEMBL5330	Homo sapiens	Activity	%	87.0
	23123808	CHEMBL4806052	Inhibition of DNA-tagged human MAP4K2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	92.0	CHEMBL5330	Homo sapiens	Activity	%	92.0
	23124788	CHEMBL4806610	Inhibition of human MAP4K2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	84.0	CHEMBL5330	Homo sapiens	Activity	%	84.0
	23124789	CHEMBL4806610	Inhibition of human MAP4K2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	66.0	CHEMBL5330	Homo sapiens	Activity	%	66.0
	23125692	CHEMBL4807000	Inhibition of human MAP4K2 (M1 to G318 residues) expressed in mammalian expression system at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ncnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4076837	=	Inhibition	%	69.0	CHEMBL5330	Homo sapiens	INH	%	69.0
	23128254	CHEMBL4807893	Inhibition of MAP4K2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL5330	Homo sapiens	Activity	%	75.0
	23128255	CHEMBL4807893	Inhibition of MAP4K2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL5330	Homo sapiens	Activity	%	75.0
	23128256	CHEMBL4807893	Inhibition of MAP4K2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL5330	Homo sapiens	Activity	%	75.0
	23216100	CHEMBL4823615	Inhibition of recombinant human GCK (1 to 473 residues) using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4873571	>	IC50	nM	1000.0	CHEMBL5330	Homo sapiens	IC50	nM	1000.0
Not Active	23317489	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	97.0	CHEMBL5330	Homo sapiens	% Control	%	97.0
Not Active	23317957	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23318624	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23319107	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23319744	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	54.4	CHEMBL5330	Homo sapiens	% Control	%	54.4
Not Active	23320219	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23320897	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23321365	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23321995	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	79.0	CHEMBL5330	Homo sapiens	% Control	%	79.0
Not Active	23322463	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	98.0	CHEMBL5330	Homo sapiens	% Control	%	98.0
Not Active	23323152	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	87.0	CHEMBL5330	Homo sapiens	% Control	%	87.0
Not Active	23323620	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	99.0	CHEMBL5330	Homo sapiens	% Control	%	99.0
Not Active	23324474	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23325109	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23325577	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	97.0	CHEMBL5330	Homo sapiens	% Control	%	97.0
Not Active	23326224	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	84.0	CHEMBL5330	Homo sapiens	% Control	%	84.0
Not Active	23326692	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23327392	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23327860	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	91.0	CHEMBL5330	Homo sapiens	% Control	%	91.0
Not Active	23328447	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	88.0	CHEMBL5330	Homo sapiens	% Control	%	88.0
Not Active	23328915	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23329861	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	82.0	CHEMBL5330	Homo sapiens	% Control	%	82.0
Not Active	23330329	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	80.0	CHEMBL5330	Homo sapiens	% Control	%	80.0
Not Active	23331085	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	94.0	CHEMBL5330	Homo sapiens	% Control	%	94.0
Not Active	23331553	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23332140	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	53.1	CHEMBL5330	Homo sapiens	% Control	%	53.1
Not Active	23332606	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23333324	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23333963	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	91.0	CHEMBL5330	Homo sapiens	% Control	%	91.0
Not Active	23334431	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	97.0	CHEMBL5330	Homo sapiens	% Control	%	97.0
Not Active	23335410	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	69.0	CHEMBL5330	Homo sapiens	% Control	%	69.0
Not Active	23335878	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	81.0	CHEMBL5330	Homo sapiens	% Control	%	81.0
Not Active	23336505	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	92.0	CHEMBL5330	Homo sapiens	% Control	%	92.0
Not Active	23336973	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	84.0	CHEMBL5330	Homo sapiens	% Control	%	84.0
Not Active	23337659	CHEMBL4882030	MAP4K2 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	99.5	CHEMBL5330	Homo sapiens	% Ctrl	%	99.5
Not Active	23338054	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23338522	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	89.0	CHEMBL5330	Homo sapiens	% Control	%	89.0
Not Active	23339134	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	96.0	CHEMBL5330	Homo sapiens	% Control	%	96.0
Not Active	23339602	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	80.0	CHEMBL5330	Homo sapiens	% Control	%	80.0
Not Active	23340239	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23340707	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	91.0	CHEMBL5330	Homo sapiens	% Control	%	91.0
Not Active	23341364	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23341832	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23342448	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	96.0	CHEMBL5330	Homo sapiens	% Control	%	96.0
Not Active	23342916	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23343546	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	84.0	CHEMBL5330	Homo sapiens	% Control	%	84.0
Not Active	23344014	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	85.0	CHEMBL5330	Homo sapiens	% Control	%	85.0
Not Active	23344652	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	76.0	CHEMBL5330	Homo sapiens	% Control	%	76.0
Not Active	23345225	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23345693	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23346270	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23346738	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23347340	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	78.3	CHEMBL5330	Homo sapiens	% Control	%	78.3
Not Active	23347830	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23348409	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	92.0	CHEMBL5330	Homo sapiens	% Control	%	92.0
Not Active	23348877	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	82.0	CHEMBL5330	Homo sapiens	% Control	%	82.0
Not Active	23349464	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23350082	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23350550	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	80.0	CHEMBL5330	Homo sapiens	% Control	%	80.0
Not Active	23351155	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	87.0	CHEMBL5330	Homo sapiens	% Control	%	87.0
Not Active	23351623	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	90.0	CHEMBL5330	Homo sapiens	% Control	%	90.0
Not Active	23352111	CHEMBL4882800	MAP4K2 (GCK) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	30.89	CHEMBL5330	Homo sapiens	% Inhibition	%	30.8922
Not Active	23352647	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	76.0	CHEMBL5330	Homo sapiens	% Control	%	76.0
Not Active	23353115	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	81.0	CHEMBL5330	Homo sapiens	% Control	%	81.0
Not Active	23353997	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23354465	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23355197	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23355665	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23356301	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	98.0	CHEMBL5330	Homo sapiens	% Control	%	98.0
Not Active	23356769	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	73.0	CHEMBL5330	Homo sapiens	% Control	%	73.0
Not Active	23357378	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23358025	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23358493	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	80.0	CHEMBL5330	Homo sapiens	% Control	%	80.0
Not Active	23359079	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	83.0	CHEMBL5330	Homo sapiens	% Control	%	83.0
Not Active	23359677	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	99.0	CHEMBL5330	Homo sapiens	% Control	%	99.0
Not Active	23360145	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	90.0	CHEMBL5330	Homo sapiens	% Control	%	90.0
Not Active	23360730	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	95.0	CHEMBL5330	Homo sapiens	% Control	%	95.0
Not Active	23361198	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	90.0	CHEMBL5330	Homo sapiens	% Control	%	90.0
Not Active	23361771	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	76.0	CHEMBL5330	Homo sapiens	% Control	%	76.0
Not Active	23362307	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23362775	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23364417	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	83.0	CHEMBL5330	Homo sapiens	% Control	%	83.0
Not Active	23364885	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	76.0	CHEMBL5330	Homo sapiens	% Control	%	76.0
Not Active	23365624	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23366167	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23366757	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	94.0	CHEMBL5330	Homo sapiens	% Control	%	94.0
Not Active	23367225	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23367627	CHEMBL4883980	MAP4K2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	89.0	CHEMBL5330	Homo sapiens	% Residual activity with Skepinone-L	%	89.0
Not Active	23368103	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23368571	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	95.0	CHEMBL5330	Homo sapiens	% Control	%	95.0
Not Active	23369170	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23369638	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	69.0	CHEMBL5330	Homo sapiens	% Control	%	69.0
Not Active	23370606	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23371074	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	99.0	CHEMBL5330	Homo sapiens	% Control	%	99.0
Not Active	23371883	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	92.0	CHEMBL5330	Homo sapiens	% Control	%	92.0
Not Active	23372351	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23375312	CHEMBL4886294	mitogen-activated protein kinase kinase kinase kinase 2  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-5.0	CHEMBL5330	Homo sapiens	% inhibition	%	-5.0
Not Active	23375778	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	95.0	CHEMBL5330	Homo sapiens	% Control	%	95.0
Not Active	23376246	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23376823	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23377291	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	83.0	CHEMBL5330	Homo sapiens	% Control	%	83.0
Not Active	23378151	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	76.0	CHEMBL5330	Homo sapiens	% Control	%	76.0
Not Active	23378619	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	92.0	CHEMBL5330	Homo sapiens	% Control	%	92.0
Not Active	23379786	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	81.0	CHEMBL5330	Homo sapiens	% Control	%	81.0
Not Active	23380254	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	96.0	CHEMBL5330	Homo sapiens	% Control	%	96.0
Not Active	23380948	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23381596	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23382064	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23382688	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Slightly Active	23383156	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	39.0	CHEMBL5330	Homo sapiens	% Control	%	39.0
Not Active	23383860	CHEMBL4887484	MAP4K2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	99.0	CHEMBL5330	Homo sapiens	% Ctrl	%	99.0
Not Active	23385071	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
Not Active	23385538	CHEMBL4879795	KinomeScan assay: inhibition of MAP4K2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL5330	Homo sapiens	% Control	%	100.0
